false
0001855467
Chavant Capital Acquisition Corp.
0001855467
2023-12-19
2023-12-19
0001855467
dei:FormerAddressMember
2023-12-19
2023-12-19
0001855467
CLAY:UnitsEachConsistingOfOneOrdinaryShareParValue0.0001PerShareAndThreequartersOfOneRedeemableWarrantMember
2023-12-19
2023-12-19
0001855467
CLAY:RedeemableWarrantsEachWarrantExercisableForOneOrdinaryShareEachAtExercisePriceOf11.50PerShareMember
2023-12-19
2023-12-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 19, 2023
MOBIX LABS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
001-40621 |
85-2324794 |
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
15420 Laguna Canyon Rd., Suite 100
Irvine, California |
92618 |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including
area code: (949) 745-1086
Chavant Capital Acquisition Corp.
445 Park Avenue, 9th Floor
New York, NY 10022
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of
each exchange on which registered |
Class A Common Stock, par value $0.00001 per share |
|
MOBX |
|
Nasdaq Global Market |
Redeemable warrants, each warrant exercisable for one share of Class A Common Stock |
|
MOBXW |
|
Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company x
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Introductory Note
On December 21, 2023 (the “Closing Date”), the registrant
consummated the previously announced transactions pursuant to the Business Combination Agreement, dated November 15, 2022 (as amended,
supplemented or otherwise modified, the “Business Combination Agreement”), by and among Chavant Capital Acquisition Corp.,
a publicly-traded special purpose acquisition company incorporated under the laws of the Cayman Islands (“Chavant”), CLAY
Merger Sub II, Inc., a Delaware corporation and newly-formed, wholly-owned direct subsidiary of Chavant (“Merger Sub”), and
Mobix Labs, Inc., a Delaware corporation (“Mobix Labs”), pursuant to which, among other things, Merger Sub merged with and
into Mobix Labs, with Mobix Labs surviving the merger as a wholly-owned direct subsidiary of Chavant (the “Merger” and, together
with the other transactions related thereto, the “Transaction”). In connection with the consummation of the Transaction (the
“Closing”), the registrant changed its name from “Chavant Capital Acquisition Corp.” to “Mobix Labs, Inc.”
(hereinafter referred to as “New Mobix Labs”).
Terms used in this Current Report on Form 8-K (this “Report”)
but not defined herein, or for which definitions are not otherwise incorporated by reference herein, have the same meanings given to such
terms in the prospectus and definitive proxy statement dated November 13, 2023, and filed by Chavant with the Securities and Exchange
Commission (the “Commission”) on November 15, 2023 (as supplemented by Supplement No. 1 thereto dated November 30, 2023 and
Supplement No. 2 thereto dated December 12, 2023, the “Proxy Statement/Prospectus”), in the section entitled “Frequently
Used Terms” beginning on page 3 thereof, and such definitions are incorporated herein by reference.
In connection with the Transaction, Chavant entered into the PIPE Subscription
Agreements (as defined below) with certain accredited investors and Chavant Capital Partners LLC (the “Sponsor”), pursuant
to which, substantially concurrently with the Closing and on the terms and subject to the conditions of each such PIPE Subscription Agreement:
(i) as previously reported in the Current Report on Form 8-K filed by Chavant with the Commission on December 19, 2023 (the “December
19 Form 8-K”), Sage Hill Investors, LLC (“Sage Hill”) agreed to purchase 1,500,000 shares of Class A common stock, par
value $0.00001 per share, of Chavant following its de-registration as a Cayman Islands exempted company and domestication into a Delaware
corporation in the State of Delaware in connection with the Closing (the “Domestication”) at a price of $10.00 per share for
an aggregate amount of $15.0 million in cash (the “Sage Hill PIPE Subscription Agreement”) and received a warrant to purchase
1,500,000 shares of common stock of Mobix Labs (“Mobix Labs Stock”) at an exercise price of $0.01 per share, exercisable upon
obtaining stockholder approval, which is expected to be obtained in 2024, (ii) as described further in Item 1.01 below, the Sponsor agreed
to purchase 199,737 shares of Class A Common Stock at a price of $10.00 per share for an aggregate amount of approximately $2.0 million,
paid through the forgiveness of certain outstanding indebtedness and reimbursement obligations owed by the Company to the Sponsor and
its members, and received the Sponsor Warrant (as defined below) in connection therewith, and (iii) other investors agreed to purchase
a total of 475,000 shares of Class A Common Stock at a price of $10.00 per share for an aggregate amount of $4.75 million in cash and
received the Additional Warrants (as defined below) in connection therewith.
In addition, pursuant to the Non-Redemption Agreement (as defined below),
a shareholder of Chavant agreed with Chavant to withdraw its election to redeem 73,706 ordinary shares, par value $0.0001 per share, of
Chavant (“Ordinary Shares”) prior to the Domestication. In consideration for the withdrawal of the redemption of such Ordinary
Shares, Mobix Labs issued to the shareholder 202,692 warrants, each warrant exercisable to purchase one share of Mobix Labs Stock, and
such warrants converted into 202,489 shares of Class A Common Stock upon the Closing.
Item 1.01 |
Entry into a Material Definitive Agreement. |
PIPE Investments
Sponsor PIPE Subscription
Agreement, Sponsor Warrant and Sponsor Letter Agreement
On December 19, 2023, Chavant entered into
the subscription agreement (the “Sponsor PIPE Subscription Agreement”) with the Sponsor that was previously disclosed in the
December 19, 2023 Form 8-K, pursuant to which the Sponsor agreed to purchase, in a private placement that closed substantially concurrently
with the Closing, 199,737 shares of Class A Common Stock at a price of $10.00 per share for an aggregate purchase price of $1,997,370
paid through the forgiveness of the Forgiven Chavant Obligations (as defined below), on the terms and subject to the conditions set forth
in the Sponsor PIPE Subscription Agreement and the Sponsor Letter Agreement described below. The terms of the Sponsor PIPE Subscription
Agreement (other than the purchase amount, the form of consideration and voting rights) are substantially similar to those in the subscription
agreement entered into between Chavant and ACE SO4 Holdings Limited (the “ACE PIPE Subscription Agreement”) in connection
with the execution of the Business Combination Agreement on November 15, 2022, including those relating to issuance of additional shares
of Class A Common Stock in the event that the Adjustment Period VWAP is less than $10.00 and resale registration obligations, as described
on pp. 199 and 200 of the Proxy Statement/Prospectus.
In connection with the execution of the Sponsor
PIPE Subscription Agreement, Mobix Labs issued to the Sponsor a warrant to purchase 272,454 shares of Mobix Labs Stock at an exercise
price of $0.01 per share, exercisable upon the closing of the Sponsor PIPE Subscription Agreement (the “Sponsor Warrant”).
The Sponsor Warrant was exercised at the closing of the Sponsor PIPE Subscription Agreement and, following net settlement into 272,182
shares of Mobix Labs Stock, converted into 272,182 shares of Class A Common Stock of the Company in connection with the Closing.
On December 20, 2023, Chavant also entered
into a Sponsor Letter Agreement with the Sponsor (the “Sponsor Letter Agreement”). Pursuant to the Sponsor Letter Agreement,
as consideration for the 199,737 shares issued pursuant to the Sponsor PIPE Subscription Agreement, the Sponsor agreed to forgive, effective
upon the Closing, approximately $1,997,370 of aggregate outstanding obligations of Chavant owed to the Sponsor, consisting of (i) $1,150,000
aggregate principal amount of working capital loans outstanding under Chavant’s convertible promissory notes issued to the Sponsor,
(ii) $610,000 aggregate principal amount of working capital loans outstanding under Chavant’s non-convertible promissory notes issued
to the Sponsor (the accrued interest under which was forgiven), (iii) an estimated additional $40,000 in aggregate principal amount of
working capital loans incurred to pay additional expenses in connection with the Closing, (iv) approximately $165,000 of outstanding reimbursement
obligations owed to the Sponsor by Chavant for administrative services, as described on page 318 of the Proxy Statement/Prospectus under
the heading “Certain Chavant Relationships and Related Person Transactions—Administrative Services” and (v) approximately
$32,370 of reimbursement obligations owed to Dr. Jiong Ma, the Chief Executive Officer of Chavant, by Chavant for certain operating expenses
of Chavant paid by Dr. Ma (collectively, the “Forgiven Chavant Obligations”).
In addition, pursuant to the Sponsor Letter
Agreement, the Sponsor agreed to forfeit (1) 658,631 Founder Shares that it held (“Sponsor Forfeited Founder Shares”) and
(2) 400,000 Private Warrants that it held (“Sponsor Forfeited Private Warrants”), in each case upon the Closing.
The forfeiture of the Sponsor Forfeited Founder
Shares reduced the number of Founder Shares held by the Sponsor, which are subject to the lock-up agreement applicable to the Founder
Equityholders as set forth in the Amended and Restated Registration Rights and Lock-Up Agreement (the “Founder Share Lock-Up”),
to 922,182 Founder Shares. The Company expects that the Sponsor will distribute these Founder Shares to its members following the Closing
and the expiration of the Founder Share Lock-Up. In such distributions, (1) Dr. Ma or her controlled affiliate is expected to receive
(i) 724,600 shares of Class A Common Stock representing Founder Shares (including 40,000 Founder Shares held by the Sponsor that may be
allocated by Dr. Ma in her discretion), and (2) Dr. André-Jacques Auberton-Hervé, Chavant’s Chairman, or his controlled
affiliate is expected to receive (i) 197,582 shares of Class A Common Stock representing Founder Shares. The forfeiture of the Sponsor
Forfeited Private Warrants reduced the number of Private Warrants held by the Sponsor to 2,394,332 Private Warrants. None of the Private
Warrants are subject to the Founder Share Lock-Up, and the Sponsor distributed these Private Warrants to its members on December 21, 2023
following the Closing. In such distribution, (ii) Dr. Ma or her controlled affiliate received 1,241,552 Private Warrants, and (ii) Dr.
Auberton-Hervé or his controlled affiliate received 358,324 Private Warrants. In addition, the shares of Class A Common Stock the
Sponsor received upon the Closing pursuant to the Sponsor PIPE Subscription Agreement and the conversion of the Sponsor Warrant, as described
above, are not subject to the Founder Share Lock-Up. The Company expects that the Sponsor will distribute those shares to its members
after the Closing. In such distribution, (1) Dr. Ma is expected to receive approximately 71,399 shares of Class A Common Stock (reflecting
$140,000 of non-convertible debt that Dr. Ma had funded or would fund to the Sponsor in respect of working capital loans to Chavant, Dr.
Ma’s pro rata share in amount of approximately $130,000 of the outstanding reimbursement obligations owed to the Sponsor for administrative
services, and the outstanding reimbursement obligations of $32,370 owed to Dr. Ma, as described above, each forgiven pursuant to the Sponsor
Letter Agreement) and (2) Dr. Auberton-Hervé is expected to receive approximately 343,384 shares of Class A Common Stock (reflecting
$1.4 million of convertible and non-convertible debt that Dr. Auberton-Hervé had funded to the Sponsor in respect of working capital
loans to Chavant and Dr. Auberton-Hervé pro rata share of the outstanding reimbursement obligations owed to the Sponsor for administrative
services, each forgiven pursuant to the Sponsor Letter Agreement).
The foregoing descriptions of the Sponsor
PIPE Subscription Agreement, the Sponsor Warrant and the Sponsor Letter Agreement do not purport to be complete and are qualified in their
entirety by the terms and conditions of the Sponsor PIPE Subscription Agreement, the Sponsor Warrant and the Sponsor Letter Agreement,
filed as Exhibits 10.1, 10.2 and 10.3 hereto, respectively, and incorporated by reference herein.
Additional PIPE Subscription
Agreements and Additional Warrants
As of December 21, 2023, Chavant had entered
into additional subscription agreements (the “Additional PIPE Subscription Agreements” and, together with the Sage Hill PIPE
Subscription Agreement, the Sponsor PIPE Subscription Agreement, the “PIPE Subscription Agreements”) with other investors
(the “Other Investors”), pursuant to which the Other Investors agreed to purchase, in private placements that closed substantially
concurrently with the Closing, a total of 475,000 shares of Class A Common Stock in cash at a price of $10.00 per share for an aggregate
purchase price of $4,750,000, on the terms and subject to the conditions set forth in each such Additional PIPE Subscription Agreement.
The terms of each Additional PIPE Subscription Agreement (other than the purchase amount) are substantially similar to those in the subscription
agreement entered into between Chavant and the ACE PIPE Subscription Agreement, including those relating to issuance of additional shares
of Class A Common Stock in the event that the Adjustment Period VWAP is less than $10.00, resale registration obligations and voting rights,
as described on pp. 199 and 200 of the Proxy Statement/Prospectus.
In connection with the execution of the Additional
PIPE Subscription Agreements, Mobix Labs issued to the Other Investors warrants to purchase 450,000 shares of Mobix Labs Stock at an exercise
price of $0.01 per share (the “Additional Warrants”), of which Additional Warrants convertible into 199,800 shares of Class
A Common Stock (following net settlement) were exercisable upon the closing of the Additional PIPE Subscription Agreements (the “Converted
Additional Warrants”) and Additional Warrants convertible into 250,000 shares of Class A Common Stock are exercisable upon the closing
of the Additional PIPE Subscription Agreements and stockholder approval (the “Non-Converted Additional Warrants”; the shares
of Class A Common Stock underlying the Non-Converted Additional Warrants and the Sage Hill Warrant, the “Unregistered Warrant Shares”).
The Converted Additional Warrants were exercised at the closing of the Additional PIPE Subscription Agreements and, following net settlement
into 199,800 shares of Mobix Common Stock, converted into 199,800 shares of Class A Common Stock in connection with the Closing. The Non-Converted
Warrants remain outstanding, and stockholder approval for the exercise of the Non-Converted Warrants is expected to be obtained in 2024.
The foregoing descriptions of the Additional
PIPE Subscription Agreements and the Additional Warrants do not purport to be complete and are qualified in their entirety by the terms
and conditions of the Additional PIPE Subscription Agreements and the Additional Warrants, forms of which are filed as Exhibits 10.4,
10.5 and 10.6 hereto, and incorporated by reference herein.
Non-Redemption Agreement
On December 20, 2023, Chavant and Mobix Labs
entered into a non-redemption agreement (the “Non-Redemption Agreement”) with a shareholder of Chavant (the “Non-Redemption
Investor”), pursuant to which the Non-Redemption Investor agreed to withdraw its redemption of 73,706 Ordinary Shares (the “Non-Redemption
Shares”), and, in consideration therefor, Mobix Labs issued a warrant to purchase 202,692 shares of Mobix Labs Stock at an exercise
price of $0.01 per share, exercisable upon the Closing (the “Non-Redemption Warrant”). The Non-Redemption Warrant was exercised
at the Closing and, following net settlement into 202,489 shares of Mobix Common Stock, converted into 202,489 shares of Class A Common
Stock of the Company in connection with the Closing.
After giving effect to the withdrawal of the
Non-Redemption Shares, shareholders holding 667,907 Ordinary Shares exercised their right to redeem such shares for a pro rata portion
of the funds in Chavant’s trust account established in connection with its initial public offering, which funds were disbursed to
shareholders on December 22, 2023.
The foregoing descriptions of the Non-Redemption
Agreement and the Non-Redemption Warrant do not purport to be complete and are qualified in their entirety by the terms and conditions
of the Non-Redemption Agreement and Non-Redemption Warrant filed as Exhibits 10.7 and 10.8 hereto, respectively, and incorporated by reference
herein.
Item 3.02 |
Unregistered Sales of Equity Securities. |
The disclosure set forth above in Item 1.01
of this Report with respect to the issuance of the Additional PIPE Subscription Agreements, the Non-Converted Additional Warrants and
the Unregistered Warrant Shares is incorporated herein by reference. The Company issued, or will issue, the foregoing securities under
Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Rule 506 of Regulation D promulgated
under the Securities Act, as a transaction not requiring registration under Section 5 of the Securities Act. The parties receiving
the securities represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection
with any distribution, and appropriate restrictive legends were affixed to the certificates representing the securities (or reflected
in restricted book entry with the Company’s transfer agent). The parties also had adequate access, through business or other relationships,
to information about the Company.
Item 7.01 |
Regulation FD Disclosure. |
On December 21, 2023, the Company issued a press release announcing,
among other things, the Closing. The press release is attached to this Report as Exhibit 99.1 and incorporated herein by reference.
The information contained under this Item 7.01 in this Report, including
Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise
subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing of the Company under
the Securities Act or the Exchange Act, except as may be expressly set forth by specific reference in such filing.
Item 9.01 |
Financial Statements and Exhibits. |
Exhibit No. |
Description |
|
|
10.1 |
Subscription Agreement, dated December 19, 2023, by and among Chavant Capital Acquisition Corp., Mobix Labs, Inc. and Chavant Capital Partners LLC. |
|
|
10.2 |
Warrant to Purchase Shares of Common Stock, dated December 20, 2023, by and between Mobix Labs, Inc. and Chavant Capital Partners LLC. |
|
|
10.3 |
Sponsor Letter Agreement, dated December 20, 2023, by and among Chavant Capital Acquisition Corp., Mobix Labs, Inc. and Chavant Capital Partners LLC. |
|
|
10.4 |
Form of Additional PIPE Subscription Agreement. |
|
|
10.5 |
Form of Converted Additional Warrant to Purchase Shares of Common Stock of Mobix Labs, Inc. |
|
|
10.6 |
Form of Non-Converted Additional Warrant to Purchase Shares of Common Stock of Mobix Labs, Inc. |
|
|
10.7 |
Non-Redemption Agreement, dated December 20, 2023, by and among Chavant Capital Acquisition Corp., Mobix Labs, Inc. and a shareholder of Chavant. |
|
|
10.8 |
Non-Redemption Warrant, dated December 20, 2023, by and between Mobix Labs, Inc. and a shareholder of Chavant. |
|
|
99.1 |
Press Release, dated December 21, 2023. |
|
|
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Mobix Labs, Inc. |
|
|
|
|
By: |
/s/ Fabrizio Battaglia |
|
Name: |
Fabrizio Battaglia |
|
Title: |
Chief Executive Officer |
|
|
|
Date: December 26, 2023 |
|
|
Exhibit 10.1
SUBSCRIPTION AGREEMENT
Chavant Capital Acquisition Corp.
445 Park Avenue, 9th Floor
New York, NY 10022
Ladies and Gentlemen:
In connection with the proposed business combination (the “Transaction”)
between Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor
thereto, including after the Domestication (as defined below), the “Company”), and Mobix Labs, Inc., a Delaware corporation
(“Mobix”), Chavant Capital Partners LLC, the undersigned subscriber (the “Subscriber”) desires
to subscribe for and purchase from the Company, and the Company desires to sell and issue to the Subscriber, that number of shares of
Class A common stock of the Company (after giving effect to the Domestication), par value $0.00001 per share (referred to herein as the
“Common Shares”), set forth on the signature page hereof for a purchase price of $10.00 per share (the “Per
Share Price” and the aggregate of such Per Share Price for all Shares subscribed for by the Subscriber being referred to herein
as the “Purchase Price”), on the terms and subject to the conditions contained herein. In connection with the Transaction,
certain other “accredited investors” (as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities
Act”)) or “qualified institutional buyers” (as defined in Rule 144A under the Securities Act) may enter into separate
subscription agreements with the Company with terms no more favorable than the terms of this Subscription Agreement (the “Other
Subscription Agreements”), pursuant to which such investors (the “Other Subscribers”), together with the
Subscriber pursuant to this Subscription Agreement, would severally and not jointly, agree to purchase on the closing date of the Transaction
(the “Transaction Closing Date”) additional Common Shares at the Per Share Price (the Subscriber, together with any
Other Subscribers, are referred to herein collectively as the “Subscribers”). In connection therewith, the Subscriber
and the Company agree as follows:
1. Subscription; Additional Shares.
a. Subject to the terms and conditions set forth in this Subscription
Agreement, the Subscriber hereby subscribes for and agrees to purchase from the Company at the Subscription Closing (as defined herein),
and the Company agrees to issue and sell to the Subscriber, such number of Common Shares as is set forth on the signature page of this
Subscription Agreement (the “Shares”).
b. In the event that the Adjustment Period VWAP (as defined herein)
is less than $10.00 per Share (as adjusted for any stock split, reverse stock split or similar adjustment following the closing of the
Transaction), Subscriber (or its permitted assigns) shall be entitled to receive from the Company a number of additional newly issued
Common Shares equal to the product of (x) the number of Common Shares issued to Subscriber (or its permitted assigns) on the Transaction
Closing Date that Subscriber (or its permitted assigns) holds on the Measurement Date (as defined herein), multiplied by (y) a fraction,
(A) the numerator of which is $10.00 (as adjusted for any stock split, reverse stock split or similar adjustment following the closing
of the Transaction) minus the Adjustment Period VWAP, and (B) the denominator of which is the Adjustment Period VWAP (such additional
shares, the “Additional Shares”). Notwithstanding anything to the contrary herein, no fraction of a Common Share will
be issued pursuant to this Section 1(b), and if Subscriber (or its permitted assigns) would otherwise be entitled to a fraction of a
Common Share, the number of Additional Shares to be issued to Subscriber (or its permitted assigns) will instead be rounded down to the
nearest whole Common Share, without payment in lieu of such fractional Common Share. The Subscriber acknowledges and agrees that, as
a result of the Domestication, the Additional Shares, if any, issued pursuant to this Section 1(b) shall be shares of common stock in
a Delaware corporation (and not shares in a Cayman Islands exempted company).
c. For purposes of this Subscription Agreement: (i) the “Adjustment
Period VWAP” means the higher of (x) the average of the VWAP of a Common Share, determined for each of the Trading Days during
the Adjustment Period (as defined herein), and (y) $7.00 (as adjusted for any stock split, reverse stock split or similar adjustment
following the closing of the Transaction); (ii) the “Adjustment Period” means the thirty (30) calendar day period
beginning on and including the date that is thirty (30) calendar days after the Resale Shelf Effectiveness Date; (iii) “business
day” means a day, other than a Saturday, Sunday or other day on which commercial banks in New York, New York or governmental
authorities in the Cayman Islands (for so long as Company remains domiciled in Cayman Islands) are authorized or required by law to close;
(iv) the “Measurement Date” means the last day of the Adjustment Period; (v) “Stock Exchange” means
the securities exchange or market, if any, on which the Common Shares are then listed; (vi) “Trading Day” means any
day on which (A) there is no VWAP Market Disruption Event and (B) trading in the Common Shares generally occurs on the Stock Exchange;
provided that, if the Common Shares are not so listed or traded on a Stock Exchange, then “Trading Day” means a business
day; (vii) “VWAP Market Disruption Event” means, with respect to any date, (A) the failure by the Stock Exchange to
open for trading during its regular trading session on such date or (B) the occurrence or existence, for more than a one half-hour period
in the aggregate, of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the
relevant exchange or otherwise) in the Common Shares or in any options contracts or futures contracts relating to the Common Shares,
and such suspension or limitation occurs or exists at any time before 1:00 p.m., New York City time, on such date; (viii) “VWAP”
means, for any Trading Day, the per share volume weighted average price of the Common Shares as displayed under the heading “Bloomberg
VWAP” on the applicable Bloomberg page (or, if such page is not available, its equivalent successor page) in respect of the period
from the scheduled open of trading until the scheduled close of trading of the primary trading session on such Trading Day (or, if such
volume weighted average price is unavailable, the market value of one Common Share on such Trading Day, determined, using a volume weighted
average price method, by a nationally recognized independent investment banking firm selected by the Company); and (ix) “Resale
Shelf Effectiveness Date” means the date on which the Initial Registration Statement (as defined herein) is declared effective
by the Commission (as defined below). The VWAP will be determined without regard to after-hours trading or any other trading outside
of the regular trading session.
2. Closing; Additional Closing.
a. The consummation of the sale of the Shares contemplated hereby
(the “Subscription Closing”) is contingent upon the substantially concurrent consummation of the Transaction (the
“Transaction Closing”). The Subscription Closing shall occur on the date of, and immediately prior to, the Transaction
Closing, but after the Company’s de-registration as an exempted company in the Cayman Islands and domestication into the State
of Delaware pursuant to the applicable provisions of the Cayman Islands Companies Act (As Revised) and the Delaware General Corporation
Law, as amended (the “Domestication”). Not less than five business days prior to the scheduled Transaction Closing
Date, the Company shall provide written notice to the Subscriber (the “Closing Notice”) (i) setting forth the scheduled
Transaction Closing Date and (ii) stating that the Company reasonably expects all conditions to the Transaction Closing to be satisfied
or waived.. On the Transaction Closing Date, the Company shall deliver to the Subscriber (i) the Shares in book-entry form, or, if required
by the Subscriber, certificated form, free and clear of any liens or other restrictions whatsoever (other than those arising under state
or federal securities laws as set forth herein), in the name of the Subscriber (or its nominee in accordance with its delivery instructions)
or to a custodian designated by the Subscriber, as applicable, and (ii) a copy of the records of the Company’s transfer agent showing
the Subscriber (or such nominee or custodian) as the owner of the Shares on and as of the Transaction Closing Date. Upon delivery of
the Shares to the Subscriber (or its nominee or custodian, if applicable), the Purchase Price shall be deemed paid pursuant to the Sponsor
Letter Agreement to be entered into among the Sponsor, the Company and Mobix, on or before the Transaction Closing Date, with respect
to the forgiveness of certain indebtedness and other obligations owed to the Sponsor (the “Sponsor Letter Agreement”),
automatically and without further action by the Company or the Subscriber.
Notwithstanding the foregoing in this Section 2, if the Subscriber
informs the Company (1) that it is an investment company registered under the Investment Company Act of 1940, as amended (the “Investment
Company Act”), (2) that it is advised by an investment adviser subject to regulation under the Investment Advisers Act of 1940,
as amended (the “Investment Advisers Act”), or (3) that its internal compliance policies and procedures so require
it, then, in lieu of the settlement procedures provided above, the following shall apply: the Subscriber shall deliver as soon as practicable
prior to the Transaction Closing on the Transaction Closing Date, following receipt of evidence from the Company’s transfer agent
of the issuance to the Subscriber of the Shares, on and as of the Transaction Closing Date, the Purchase Price for the Shares by wire
transfer of United States dollars in immediately available funds to an account of the Company as specified by the Company in the Closing
Notice against delivery by the Company to the Subscriber of the Shares in book entry form, or if required by the Subscriber, certificated
form, free and clear of any liens or other restrictions (other than those arising under state or federal securities laws as set forth
herein), in the name of the Subscriber (or its nominee in accordance with its delivery instructions) and evidence from the Company’s
transfer agent of the issuance to the Subscriber of the Shares on and as of the Transaction Closing Date.
If the Transaction Closing does not occur within two business days
following the Subscription Closing, the Purchase Price shall deemed to be returned to the Subscriber, and any book-entries or certificates
representing the Shares shall be deemed repurchased and cancelled (and, in the case of certificated shares, the Subscriber shall promptly
return such certificates to the Company or, as directed by the Company, to the Company’s representative or agent); provided
that, unless this Subscription Agreement has been terminated pursuant to Section 8 hereof, such deemed return of consideration shall
not terminate this Subscription Agreement, and the Subscriber shall remain obliged to (i) pay the Purchase Price to the Company, as applicable,
in accordance with this Section 2 following the Company’s delivery to the Subscriber of a new Closing Notice not less than two
business days prior to the new scheduled Transaction Closing Date and (ii) consummate the Subscription Closing immediately prior to or
substantially concurrently with the Transaction Closing.
If this Subscription Agreement terminates in accordance with Section
8 hereof following the delivery by the Subscriber of the Purchase Price for the Shares, the Purchase Price shall be deemed to be returned
to the Subscriber.
b. If applicable, the issuance of the Additional Shares contemplated
hereby (the “Additional Closing” and together with the Subscription Closing, each, a “Closing”)
shall occur on the fifth (5th) business day following the Measurement Date (the “Additional Closing Date” and together
with the date of the Subscription Closing, each, a “Closing Date”). On the Additional Closing Date, the Company shall,
upon satisfaction (or, if applicable, waiver) of the conditions set forth in Section 3, issue the Additional Shares to Subscriber and
shall deliver (i) the Additional Shares in book entry form or, if required by the Subscriber, certificated form, free and clear of any
liens or other restrictions whatsoever (other than those arising under state or federal securities laws as set forth herein), in the
name of the Subscriber (or its nominee in accordance with its delivery instructions) or to a custodian designated by the Subscriber,
as applicable, and (ii) a copy of the records of the Company’s transfer agent showing the Subscriber (or such nominee or custodian)
as the owner of the Common Shares on and as of the Additional Closing Date.
3. Closing Conditions.
a. The obligations of the Company to consummate the transactions contemplated
hereunder are subject to the conditions that, at the applicable Closing Date:
|
i. |
all representations and warranties of the Subscriber
contained in this Subscription Agreement shall be true and correct in all material respects (other than representations and warranties
that are qualified as to materiality, which representations and warranties shall be true and correct in all respects) at and as of
such Closing Date as though made on such Closing Date (except for those representations and warranties that speak as of a specific
date, which shall be so true and correct in all material respects (other than representations and warranties that are qualified as
to materiality, which representations and warranties shall be true and correct in all respects) as of such specified date) (collectively,
the “Subscriber Bring-Down Condition”), and the Subscriber agrees that consummation of the transactions contemplated
hereunder on such Closing Date shall constitute a certification by the Subscriber to the Company that the Subscriber Bring-Down Condition
has been satisfied; and |
|
ii. |
the Subscriber shall have performed or complied in
all material respects with all agreements and covenants required by this Subscription Agreement to be performed or complied with
by the Subscriber at or prior to such Closing Date. |
b. The obligations of the Subscriber to consummate the transactions
contemplated hereunder are subject to the conditions that, at the applicable Closing Date:
|
i. |
all representations and warranties of the Company
contained in this Subscription Agreement shall be true and correct in all material respects (other than representations and warranties
that are qualified as to materiality or Material Adverse Effect (as defined herein), which representations and warranties shall be
true and correct in all respects) at and as of such Closing Date as though made on such Closing Date (except for those representations
and warranties that speak as of a specific date, which shall be so true and correct in all material respects (other than representations
and warranties that are qualified as to materiality or Material Adverse Effect, which representations and warranties shall be true
and correct in all respects) as of such specified date) (collectively, the “Company Bring-Down Condition”), and
the Company agrees that consummation of the transactions contemplated hereunder on such Closing Date shall constitute a certification
by the Company to the Subscriber that the Company Bring-Down Condition has been satisfied; |
|
ii. |
the Company shall have performed or complied in all
material respects with all agreements and covenants required by this Subscription Agreement; |
|
iii. |
no amendment, modification or waiver of any provision
of the Transaction Agreement (as defined below and as the same exists on the date hereof) shall have occurred that reasonably would
be expected to materially and adversely affect the economic benefits that the Subscriber reasonably would expect to receive under
this Subscription Agreement, without having received the Subscriber’s prior written consent, which such prohibition, for the
avoidance of doubt, shall not include the waiver of any minimum cash condition set forth in the Transaction Agreement by the Company
and/or Mobix; |
|
iv. |
no amendment, modification or waiver of one or more
of the Other Subscription Agreements (including via a side letter or other agreement) shall be executed that materially benefits
one or more Other Subscribers unless the Subscriber has been offered the same benefits; and |
|
v. |
the Company shall have filed with the Nasdaq Stock
Market LLC (“Nasdaq”), no later than fifteen calendar days prior to the Transaction Closing Date, a listing of
additional shares notification for the listing of the Shares, in accordance with Nasdaq Listing rule 5250 (e)(2). |
c. The obligations of each of the Company and the Subscriber to consummate
the transactions contemplated hereunder are subject to the conditions that, at the applicable Closing:
|
i. |
no governmental authority shall have enacted, issued,
promulgated, enforced or entered any judgment, order, law, rule or regulation (whether temporary, preliminary or permanent) which
is then in effect and has the effect of making consummation of the transactions contemplated hereby illegal or otherwise restraining
or prohibiting consummation of the transactions contemplated hereby, and no governmental authority shall have instituted or threatened
in writing a proceeding seeking to impose any such restraint or prohibition; |
|
ii. |
all consents, waivers, authorizations or orders of,
any notice required to be made to, and any filing or registration with, any court or other federal, state, local or other governmental
authority, self-regulatory organization or other person in connection with the execution, delivery and performance of this Subscription
Agreement (including, without limitation, the issuance of the Shares) required to be made in connection with the issuance and sale
of the Shares shall have been obtained or made, except where the failure to so obtain or make would not prevent the Company from
consummating the transactions contemplated hereby, including the issuance and sale of the Shares; |
|
iii. |
in the case of the Subscription Closing, all conditions
precedent to the Transaction Closing set forth in the Transaction Agreement (as in effect on the date hereof), including the approval
of the Company’s shareholders and regulatory approvals, if any, shall have been satisfied or waived as determined by the parties
to the Transaction Agreement (other than those conditions which, by their nature, are to be satisfied by a party to the Transaction
Agreement at the Transaction Closing, but subject to satisfaction or waiver by such party of such conditions as of the Transaction
Closing), and the Transaction Closing shall have been or will be scheduled to occur substantially concurrently with the Subscription
Closing; and |
|
iv. |
no suspension of the qualification of the Shares for
offering or trading in any jurisdiction, or initiation or written threats of any proceedings for any of such purposes, shall have
occurred and be continuing. |
d. |
The Subscriber agrees that upon the occurrence of each Closing, any condition
to the Subscriber’s obligations to consummate the transactions hereunder set forth in Sections 3(b) or 3(c) hereof that was
not satisfied as of such Closing shall be deemed to have been waived by the Subscriber; provided, however, that such waiver
shall only be deemed to be given if and to the extent the Subscriber has actual knowledge of the condition not being satisfied (with
no obligation on the part of the Subscriber to make any inquiry as to the satisfaction of any such condition). |
|
|
e. |
Prior to or at each Closing Date, Subscriber shall deliver to the Company
a duly completed and executed Internal Revenue Service Form W-9 or appropriate Form W-8. |
4. Further Assurances. At each Closing Date, the parties hereto
shall execute and deliver or cause to be executed and delivered such additional documents and take such additional actions as the parties
reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated by this Subscription Agreement.
5. Company Representations and Warranties. For purposes of
this Section 5, with respect to the Subscription Closing, the term “Company” shall refer to the Company as of the date hereof
and, for purposes of only the representations contained in paragraphs (h), (l), (p) and (q) of this Section 5, the combined company after
giving effect to the Transaction. For purposes of this Section 5, with respect to any Additional Closing, the term “Company”
shall refer to the combined company after giving effect to the Transaction, as applicable. The Company represents and warrants to the
Subscriber that:
a. The Company has been duly incorporated and is validly existing
and in good standing under the laws of the Cayman Islands, and, after giving effect to the Domestication, the Company will be a corporation
duly organized, validly existing and in good standing under the laws of the State of Delaware. The Company has the corporate power and
authority to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform
its obligations under this Subscription Agreement. As of the date hereof, CLAY Merger Sub II, Inc., a Delaware corporation (the “Merger
Sub”), is the only subsidiary of the Company, which Merger Sub is expected to merge with and into Mobix, with Mobix surviving
such merger. Except for the Merger Sub (or, after the completion of the Transaction, Mobix), the Company does not directly or indirectly
own any equity or similar interest in, or any interest convertible into or exchangeable or exercisable for any equity or similar interest
in, any corporation, partnership, joint venture or business association or other person. There are no outstanding contractual obligations
of the Company to provide funds to, or to make any investment (in the form of a loan, capital contribution or otherwise) in, any other
person.
b. The Shares have been duly authorized by the Company and, when issued
and delivered to the Subscriber against full payment therefor in accordance with the terms of this Subscription Agreement, the Shares
will be validly issued, fully paid and non-assessable, will be free and clear of any liens or other restrictions whatsoever (other than
those specified hereunder) and will not have been issued in violation of or subject to any preemptive or similar rights created under
the Company’s organizational documents (as in effect as of immediately prior to the Transaction Closing) or under the applicable
laws.
c. As of the date hereof, the authorized share capital of the Company
consists of (i) 200,000,000 ordinary shares, par value $0.0001, and (ii) 1,000,000 preference shares, par value $0.0001 per share. As
of the date hereof, (i) 2,778,912 ordinary shares, par value $0.0001 per share, were issued and outstanding (including ordinary shares
contained within the Company’s units), all of which are validly issued, fully paid and non-assessable and not subject to any preemptive
rights, (ii) no ordinary shares are held in the treasury of the Company, and (iii) 9,400,000 ordinary shares are reserved for future
issuance in respect of exercise of the Company’s outstanding warrants at an exercise price of $11.50 per ordinary share. Except
as described in the SEC Documents (as defined herein), there are no outstanding contractual obligations of the Company to repurchase,
redeem or otherwise acquire any equity securities of the Company. There are no securities or instruments issued by or to which the Company
is a party containing anti-dilution or similar provisions that will be triggered by the issuance of (i) the Shares or the Additional
Shares pursuant to this Subscription Agreement or (ii) the shares to be issued pursuant to any Other Subscription Agreement, except such
anti-dilution rights as may be triggered pursuant to Section 4.3.2 or 4.8 of the Warrant Agreement, dated July 19, 2021, by and between
the Company and Continental Stock Transfer & Trust Company. Except pursuant to this Subscription Agreement, the Other Subscription
Agreements, the Transaction Agreement, securities that may be issued by the Company pursuant to those certain unsecured convertible promissory
notes (or any similar unsecured convertible promissory notes) in the aggregate principal amount up to $1,500,000 issued by the Company
in exchange for working capital loans from the Company’s sponsor and other affiliates and as described in the SEC Documents (and,
following the consummation of the Transaction, as set forth in the Transaction Agreement and the schedules thereto), there are no outstanding
options, warrants, or other rights to subscribe for, purchase or acquire from the Company any ordinary shares or, after giving effect
to the Domestication, the Common Shares or any other equity interests in the Company, or securities convertible into or exchangeable
or exercisable for any such equity interests. There are no shareholder agreements, voting trusts or other agreements or understandings
to which the Company is a party or by which it is bound relating to the voting of any securities of the Company other than as set forth
in the SEC Documents, and as contemplated by the Transaction Agreement or described in the schedules thereto (as in effect on the date
hereof).
d. The Shares are not, and following the Transaction Closing and each
Closing Date will not be, subject to any Transfer Restriction. The term “Transfer Restriction” means any condition
to or restriction on the ability of the Subscriber to pledge, sell, assign or otherwise transfer the Shares under any organizational
document, policy or agreement of, by or with the Company, but excluding the restrictions on transfer described in paragraph 6(c) of this
Subscription Agreement with respect to the status of the Shares as “restricted securities” pending their registration for
resale or transfer under the Securities Act in accordance with the terms of this Subscription Agreement.
e. This Subscription Agreement and the Transaction Agreement have
been duly authorized, executed and delivered by the Company and, assuming the due authorization, execution and delivery of the same by
the Subscriber, are the legally binding obligations of the Company and are enforceable in accordance with their respective terms, except
as may be limited or otherwise affected by (i) bankruptcy, winding up, insolvency, fraudulent conveyance, reorganization, moratorium
or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or
equity.
f. The execution, delivery and performance of the Subscription Agreement,
the issuance and sale of the Shares and the compliance by the Company with all of the provisions of this Subscription Agreement and the
consummation of the transactions herein will not conflict with or result in a breach or violation of any of the terms or provisions of,
or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or
assets of the Company or its subsidiary pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan or credit agreement,
guarantee, note, bond, permit, lease, license or other agreement or instrument to which the Company or its subsidiary is a party or by
which the Company or its subsidiary is bound or to which any of the property or assets of the Company is subject, which would, in any
case, reasonably be expected, individually or in the aggregate, to have a material adverse effect on the business, properties, financial
condition, shareholders’ equity or results of operations of the Company and its subsidiary, taken as a whole, and including the
combined company after giving effect to the Transaction, or prevent, materially impair, materially delay or materially impede the ability
of the Company to enter into and timely perform its obligations under this Subscription Agreement or the Transaction Agreement, or materially
affect the validity of the Shares or the legal authority or ability of the Company to comply in all material respects with the terms
of this Subscription Agreement (a “Material Adverse Effect”); (ii) result in any violation of the provisions of the
organizational documents of the Company; or (iii) result in any violation of any statute or any judgment, order, rule or regulation of
any court or governmental agency, taxing authority or regulatory body, domestic or foreign, having jurisdiction over the Company or any
of its properties that would reasonably be expected to have a Material Adverse Effect.
g. Assuming the accuracy of the representations and warranties of
the Subscriber set forth in Section 6 of this Subscription Agreement, the Company is not required to obtain any consent, waiver, authorization
or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental
authority, self-regulatory organization or other person in connection with the execution, delivery and performance of this Subscription
Agreement (including, without limitation, the issuance of the Shares), other than (i) filings with the Securities and Exchange Commission
(the “Commission”), (ii) filings required by applicable state securities laws, (iii) filings required by Nasdaq, including
with respect to obtaining shareholder approval, (iv) filings required to consummate the Transaction as provided under the definitive
documents relating to the Transaction, (v) the filing of a notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
if applicable, and (vi) where the failure of which to obtain would not reasonably be expected to have a Material Adverse Effect or have
a material adverse effect on the Company’s ability to consummate the transactions contemplated hereby, including the issuance and
sale of the Shares.
h. The Company is in compliance with all applicable law, except where
such non-compliance would not reasonably be expected to have a Material Adverse Effect. The Company has not received any written communication
from a governmental entity that alleges that the Company is not in compliance with or is in default or violation of any applicable law,
except where such non-compliance, default or violation would not reasonably be expected to have a Material Adverse Effect.
i. As of the date hereof, the issued and outstanding ordinary shares
of the Company are registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and are listed for trading on Nasdaq under the symbol “CLAY” (it being understood that the trading symbol will be changed
in connection with the Transaction Closing). There is no suit, action, proceeding or investigation pending or, to the knowledge of the
Company, threatened against the Company by Nasdaq or the Commission, respectively, to prohibit or terminate the listing of the ordinary
shares or, after giving effect to the Domestication, the Common Shares on Nasdaq, suspend trading of such shares on Nasdaq or to deregister
such shares under the Exchange Act. The Company has taken no action that is designed to terminate or expected to result in the termination
of the registration of such shares under the Exchange Act. At each Closing Date and upon consummation of the Transaction, the issued
and outstanding Common Shares of the Company, including the Shares, will be registered pursuant to Section 12(b) of the Exchange Act,
and the Shares shall have been approved for listing on Nasdaq, subject to official notice of issuance.
j. Assuming the accuracy of the Subscriber’s representations
and warranties set forth in Section 6 of this Subscription Agreement, no registration under the Securities Act is required for the offer
and sale of the Shares by the Company to the Subscriber or to any Other Subscriber pursuant to the Other Subscription Agreements. The
Shares offered hereby and pursuant to each Other Subscription Agreement (i) were not offered by any form of general solicitation or general
advertising (within the meaning of Regulation D of the Securities Act) and (ii) are not being offered in a manner involving a public
offering under, or in a distribution in violation of, the Securities Act, or any state securities laws.
k. A copy of each form, report, statement, schedule, prospectus, registration
statement and other document, if any, filed by the Company with the Commission since its initial registration of the ordinary shares
under the Exchange Act (the “SEC Documents”) is available to the Subscriber via the Commission’s EDGAR system,
which SEC Documents, as of their respective filing dates, complied in all material respects with the requirements of the Exchange Act
applicable to the SEC Documents and the rules and regulations of the Commission promulgated thereunder applicable to the SEC Documents.
None of the SEC Documents contained, when filed or, if amended, as of the date of such amendment with respect to those disclosures that
are amended, any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that with
respect to the information about the Company’s affiliates contained in the Registration Statement on Form S-4 and related proxy
statement (or other SEC document) to be filed by the Company in connection with the Transaction, the representation and warranty in this
sentence is made to the Company’s knowledge. The Company has timely filed (giving effect to permissible extensions in accordance
with Rule 12b-25 under the Exchange Act) each report, statement, schedule, prospectus, and registration statement that the Company was
required to file with the Commission since its initial registration of the ordinary shares under the Exchange Act. The financial statements
of the Company included in the SEC Documents comply in all material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of filing and fairly present in all material respects the
financial position of the Company as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, year-end audit adjustments. As of the date hereof and upon the Transaction Closing
Date, there are no material outstanding or unresolved comments in comment letters from the Staff with respect to any of the SEC Documents.
l. Except for such matters as have not had and would not reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect, there is no (i) action, suit, claim or other proceeding,
in each case by or before any governmental authority pending, or, to the knowledge of the Company, threatened against the Company or
(ii) judgment, decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against the Company.
m. Other than the Other Subscription Agreements that the Company may
enter into prior to the Subscription Closing, the Company has not entered into and will not enter into any agreement or side letter with
any Other Subscriber in connection with such Other Subscriber’s direct or indirect investment in the Company in connection with
the Subscription Closing, and such Other Subscription Agreements will not be amended in any material respect following the date of this
Subscription Agreement and will reflect the same Per Share Purchase Price and terms that are not more favorable to such Other Subscriber
thereunder than the terms of this Subscription Agreement. The Other Subscription Agreements will not, without the prior written consent
of the Subscriber, be amended in any material respect following the date of this Subscription Agreement.
n. Neither the Company, nor any person acting on its behalf has, directly
or indirectly, made any offers or sales of any Company security or solicited any offers to buy any Company security under circumstances
that would adversely affect reliance by the Company on Section 4(a)(2) of the Securities Act for the exemption from registration of the
offer and sale of the Shares or would require registration of the issuance of the Shares under the Securities Act.
o. Neither the Company, nor any person acting on its behalf has entered
into any agreement or arrangement entitling any agent, broker, investment banker, financial advisor or other person to any broker’s
or finder’s fee or any other commission or similar fee in connection with the transactions contemplated by this Subscription Agreement
for which the Subscriber could become liable. No person has been or will be paid (directly or indirectly) remuneration for solicitation
of purchasers in connection with the sale of any Shares.
p. The Company is not, and immediately after receipt of payment for
the Shares will not be, an “investment company” within the meaning of the Investment Company Act.
q. The Company is not in default or violation (and no event has occurred
which, with notice or the lapse of time or both, would constitute a default or violation) of any term, condition or provision of (i)
the Company’s organizational documents, (ii) any loan or credit agreement, note, bond, mortgage, indenture, lease or other agreement,
permit, franchise or license to which the Company is now a party or by which the Company’s properties or assets are bound or (iii)
any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction
over the Company or any of its properties, except, in the case of clauses (ii) and (iii), for defaults or violations that have not had
and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect.
r. None of the Company or any of its directors and officers is (i)
a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by the U.S. Treasury Department’s
Office of Foreign Assets Control (“OFAC”) or in any sanctions-related Executive Order issued by the President of the
United States and administered by OFAC (collectively, the “OFAC List”), or a person or entity prohibited by any OFAC
sanctions program, or (ii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank.
6. Subscriber Representations and Warranties. The Subscriber
represents and warrants to the Company that:
a. The Subscriber is (i) a “qualified institutional buyer”
(as defined under the Securities Act) or (ii) an “accredited investor” (within the meaning of Rule 501(a) under the Securities
Act), in each case, satisfying the requirements set forth on Schedule A, and is acquiring Common Shares only for such Subscriber’s
own account and not for the account of others, or if the Subscriber is acquiring the Shares as a fiduciary or agent for one or more investor
accounts, each owner of such account is a qualified institutional buyer or accredited investor, and the Subscriber has full investment
discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and agreements
herein on behalf of each owner of each such account, and not on behalf of any other account or person or with a view to, or for offer
or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested information
on Schedule A following the signature page hereto).
b. The Subscriber (i) is a sophisticated investor, experienced in
investing in private equity transactions and capable of evaluating investment risks independently, both in general and with regard to
all transactions and investment strategies involving a security or securities and (ii) has exercised independent judgment in evaluating
its participation in the purchase of the Shares.
c. The Subscriber understands that the Shares (and any Additional
Shares) are being offered in a transaction not involving any public offering within the meaning of the Securities Act and that the Common
Shares have not been registered under the Securities Act. The Subscriber understands that the Shares (and any Additional Shares) may
not be resold, transferred, pledged or otherwise disposed of by the Subscriber absent an effective registration statement under the Securities
Act except (i) to the Company or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United
States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from the registration
requirements of the Securities Act (including, without limitation, a private resale or transfer pursuant to the so-called “Section
4(a)(11⁄2)” exemption), and in each of cases (i) and (iii) in accordance with any applicable securities laws of the states
and other jurisdictions of the United States, and that any certificates or book-entry positions representing the Shares (and any Additional
Shares) shall contain a legend to such effect. The Subscriber acknowledges that the Shares (and any Additional Shares) will not be immediately
eligible for resale or transfer pursuant to Rule 144 promulgated under the Securities Act, that Rule 144 will not be available until
12 months following the closing and, as a result, the Subscriber may not be able to readily resell or transfer the Shares (and any Additional
Shares) and may be required to bear the financial risk of an investment in the Shares for an indefinite period of time. The Subscriber
understands that such Subscriber has been advised to consult legal counsel prior to making any offer, resale, pledge or transfer of any
of the Shares (and any Additional Shares).
d. The Subscriber understands and agrees that the Subscriber is purchasing
Common Shares directly from the Company. The Subscriber further acknowledges that there have been no representations, warranties, covenants
and agreements made to the Subscriber by the Company, its officers or directors, or any other party to the Transaction or person or entity,
expressly or by implication, other than those representations, warranties, covenants and agreements included in this Subscription Agreement.
e. Either (A) the Subscriber is not, and will not be acquiring or
holding any Common Shares with the assets of, (i) an employee benefit plan (described in Section 3(3) of the Employee Retirement Income
Security Act of 1974, as amended (“ERISA”)), whether or not subject to ERISA, (ii) a plan described in Section 4975
of the Internal Revenue Code of 1986, as amended (the “Code”) (including, without limitation, an individual retirement
account) that is subject to Section 4975 of the Code or to any other federal, state, local, non-U.S. or other law or regulation that
is similar to the fiduciary responsibility or prohibited transaction provisions of Title I of ERISA or Section 4975 of the Code (collectively,
“Similar Laws”), (iii) a plan, fund or other similar program that is established or maintained outside of the United
States which provides for retirement income, a deferral of income in contemplation of retirement or payments to be made upon termination
of employment, or (iv) an entity whose assets constitute the assets of any of the foregoing described in clauses (i), (ii) and (iii),
pursuant to ERISA or otherwise or (B) the Subscriber’s acquisition and holding of the Common Shares will not constitute or result
in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code or a violation of any applicable Similar
Law.
f. The Subscriber acknowledges and agrees that the Subscriber has
received and has had an adequate opportunity to review, such audited and unaudited financial information of the Company and Mobix and
such other information as the Subscriber deems necessary in order to make an investment decision with respect to the Shares and made
its own assessment and is satisfied concerning the relevant tax and other economic considerations relevant to the Subscriber’s
investment in the Shares. The Subscriber acknowledges that the financial information of Mobix supplied to the Subscriber prior to the
date hereof in respect of the fiscal year ended September 30, 2022 is unaudited and subject to change. Without limiting the generality
of the foregoing, the Subscriber acknowledges that such Subscriber has reviewed the risk factors provided to the Subscriber by the Company.
The Subscriber represents and agrees that the Subscriber and the Subscriber’s professional advisor(s), if any, have had the opportunity
to ask such questions, receive such answers and obtain such information as the Subscriber and such Subscriber’s professional advisor(s),
if any, have deemed necessary to make an investment decision with respect to the Shares.
g. The Subscriber became aware of this offering of the Common Shares
solely by means of direct contact between the Subscriber and the Company or a representative of the Company, and the Common Shares were
offered to the Subscriber solely by direct contact between the Subscriber and the Company or a representative of the Company. The Subscriber
did not become aware of this offering of the Common Shares, nor were the Common Shares offered to the Subscriber, by any other means.
The Subscriber acknowledges the Company’s representation and warranty that the Common Shares (i) were not offered by any form of
general solicitation or general advertising and (ii) are not being offered to it in a manner involving a public offering under, or in
a distribution in violation of, the Securities Act, or any state securities laws.
h. The Subscriber acknowledges that such Subscriber is aware that
there are substantial risks incident to the purchase and ownership of the Shares (and any Additional Shares). The Subscriber is able
to fend for himself, herself or itself in the transactions completed herein, has such knowledge and experience in financial and business
matters as to be capable of evaluating the merits and risks of an investment in the Shares and has the ability to bear the economic risks
of such investment in the Shares and is able to sustain a complete loss of such investment. The Subscriber has sought such accounting,
legal and tax advice as the Subscriber has considered necessary to make an informed investment decision.
i. Alone, or together with any professional advisor(s), the Subscriber
has analyzed and considered the risks of an investment in the Shares and determined that the Shares are a suitable investment for the
Subscriber and that the Subscriber is able at this time and in the foreseeable future to bear the economic risk of a total loss of the
Subscriber’s investment in the Company. The Subscriber acknowledges specifically that a possibility of total loss exists.
j. In making its decision to purchase the Shares, the Subscriber has
relied solely upon independent investigation made by the Subscriber and the representations, warranties and covenants contained herein.
Subscriber acknowledges and agrees that Subscriber had access to, and an adequate opportunity to review, financial and other information
as Subscriber deems necessary in order to make an investment decision with respect to the Shares.
k. The Subscriber understands and agrees that no federal or state
agency has passed upon or endorsed the merits of the offering of the Shares or made any findings or determination as to the fairness
of this investment.
l. The Subscriber is validly existing in good standing under the laws
of its jurisdiction of incorporation or formation, with power and authority to enter into and perform its obligations under this Subscription
Agreement.
m. The execution, delivery and performance by the Subscriber of this
Subscription Agreement are within the powers of the Subscriber, have been duly authorized and will not constitute or result in a breach
or default under or conflict with any order, ruling or regulation of any court or other tribunal or of any governmental commission or
agency, or any agreement or other undertaking, to which the Subscriber is a party or by which the Subscriber is bound, and will not violate
any provisions of the Subscriber’s charter documents, including, without limitation, its incorporation or formation papers, bylaws,
indenture of trust or partnership or operating agreement, as may be applicable. The signature on this Subscription Agreement is genuine,
and the signatory has been duly authorized to execute the same, and assuming the due authorization, execution and delivery of the same
by the Company, this Subscription Agreement constitutes a legal, valid and binding obligation of the Subscriber, enforceable against
the Subscriber in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles
of equity, whether considered at law or equity.
n. Neither the due diligence investigation conducted by the Subscriber
in connection with making its decision to acquire the Shares (and any Additional Shares) nor any representations and warranties made
by the Subscriber herein shall modify, amend or affect the Subscriber’s right to rely on the truth, accuracy and completeness of
the Company’s representations and warranties contained herein.
o. The Subscriber, its affiliates, their agents, and any other persons
acting on their behalf is not (i) a person or entity named on the OFAC List, or a person or entity prohibited by any OFAC sanctions program,
(ii) is not owned, controlled, or acting on behalf of a person or entity prohibited by any OFAC sanctions program, (iii) located, operating,
or resident in any country or territory subject to comprehensive sanctions (currently, the Crimea, the so-called Donetsk People’s
Republic, and the so-called Luhansk People’s Republic regions of Ukraine, Cuba, Iran, North Korea and Syria), or (iv) a non-U.S.
shell bank or providing banking services indirectly to a non-U.S. shell bank. The Subscriber agrees to provide law enforcement agencies,
if requested thereby, such records as required by applicable law; provided that the Subscriber is permitted to do so under applicable
law. If the Subscriber is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.), as amended by the
USA PATRIOT Act of 2001, and its implementing regulations (collectively, the “BSA/PATRIOT Act”), the Subscriber maintains
policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. To the extent required,
the Subscriber maintains policies and procedures reasonably designed for the screening of its investors against the OFAC sanctions programs,
including the OFAC List. To the extent required, the Subscriber maintains policies and procedures reasonably designed to ensure that
the funds held by the Subscriber and used to purchase the Shares were legally derived. To the extent applicable, the Subscriber further
represents and warrants that the Subscriber: (x) has conducted thorough due diligence with respect to all of its beneficial owners, (y)
has established the identities of all beneficial owners and the source of each of the beneficial owners’ funds and (z) will retain
evidence of any such identities, any such source of funds and any such due diligence. Pursuant to anti-money laundering laws and regulations,
including the BSA/Patriot Act, the Company may be required to collect documentation verifying the Subscriber’s identity and the
source of funds used to acquire an interest before, and from time to time after, acceptance by the Company of this Subscription Agreement.
The Subscriber further represents and warrants that the Subscriber does not know or have any reason to suspect that (I) the monies used
to fund the Subscriber’s investment herein have been or will be derived from or related to any illegal activities, including but
not limited to, money laundering activities, or (II) the proceeds from the Subscriber’s investment herein will be used to finance
any illegal activities.
p.[Reserved].
q.[Reserved].
7. Registration Rights.
a. The Company agrees that, within forty-five (45) calendar days after
the Transaction Closing (the “Filing Deadline”), the Company will file with the Commission (at the Company’s
sole cost and expense) a registration statement registering the resale or transfer of the Shares (the “Initial Registration
Statement”), and the Company shall use its commercially reasonable efforts to have the Initial Registration Statement declared
effective as soon as practicable after the filing thereof, but no later than the earlier of, (i) if the Commission notifies the Company
that it will “review” the Initial Registration Statement, the ninetieth calendar day following the earlier of (A) the Filing
Deadline and (B) the initial filing date of the Initial Registration Statement, and (ii) the tenth business day after the date the Company
is notified (orally or in writing, whichever is earlier) by the Commission that the Initial Registration Statement will not be “reviewed”
or will not be subject to further review. If not included in the Initial Registration Statement, in the event that any Additional Shares
issued to Subscriber pursuant to the terms of this Subscription Agreement are not permitted by the Commission to be registered on the
Initial Registration Statement, the Company agrees that, within thirty (30) business days following the Additional Closing Date (the
“Additional Filing Deadline” and, together with the initial Filing Deadline, each, a “Filing Deadline”),
the Company will submit to or file with the Commission a registration statement for a shelf registration on Form S-1 or Form S-3 (if
the Company is then eligible to use a Form S-3 shelf registration) (an “Additional Registration Statement” and, together
with the Initial Registration Statement, each, a “Registration Statement”), in each case, covering the resale of the
Additional Shares acquired by the Subscriber pursuant to this Subscription Agreement which are eligible for registration (determined
as of two business days prior to such submission or filing). The Company’s obligations to include the Shares or Additional Shares,
as applicable, in a Registration Statement are contingent upon the Subscriber furnishing in writing to the Company such information regarding
the Subscriber, the securities of the Company held by the Subscriber and the intended method of disposition of the Shares or Additional
Shares, as applicable as shall be reasonably requested in writing by the Company to effect the registration of the Shares or the Additional
Shares, and shall execute such documents in connection with such registration as the Company may reasonably request that are customary
of a selling stockholder in similar situations; provided, however, that the Subscriber shall not in connection with the
foregoing be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability
to transfer the Shares or Additional Shares, as applicable. With respect to the information to be provided by the Subscriber pursuant
to this Section 7, the Company shall request such information prior to the anticipated initial filing date of a Registration Statement.
The Company will provide a draft of a Registration Statement to the Subscriber for review at least two (2) business days in advance of
its anticipated initial filing date. Notwithstanding the foregoing, if the Commission prevents the Company from including in a Registration
Statement any or all of the Shares or Additional Shares due to limitations on the use of Rule 415 of the Securities Act for the resale
or transfer of the Shares by the applicable stockholders or otherwise, the Registration Statement shall register for resale or transfer
such number of Common Shares which is equal to the maximum number of Shares (and Additional Shares, as applicable) as is permitted by
the Commission. In such event, the number of Shares (and Additional Shares, as applicable) to be registered for each selling stockholder
named in the Registration Statement shall be reduced pro rata among all such selling stockholders, and as promptly as practicable after
being permitted to register additional Shares (and Additional Shares, as applicable) under Rule 415 under the Securities Act, the Company
shall file a new Registration Statement to register such Shares not included in a filed Registration Statement and cause such Registration
Statement to become effective as promptly as practicable consistent with the terms of this Section 7. If the Commission requests that
the Subscriber be identified as a statutory underwriter in the Registration Statement, the Subscriber will have an opportunity to withdraw
from the Registration Statement. The Company will use its commercially reasonable efforts to maintain the continuous effectiveness of
any Registration Statement, or another shelf registration statement that includes the Shares (and Additional Shares, as applicable) to
be sold pursuant to this Subscription Agreement, until the earliest of (i) the date on which all such Shares, and any Additional Shares,
issued to Subscriber have actually been sold, (ii) the date which is three years after the relevant Registration Statement filed hereunder
is declared effective and (iii) the date on which the Shares (and Additional Shares, as applicable) may be resold without volume or manner
of sale limitations pursuant to Rule 144 promulgated under the Securities Act. For purposes of clarification, any failure by the Company
to file any Registration Statement by a Filing Deadline or to effect such Registration Statement by date of effectiveness shall not otherwise
relieve the Company of its obligations to file or cause the effectiveness of any Registration Statement set forth in this Section 7.
For purposes of this Section 7, “Shares” or “Additional Shares” shall mean, as of any date of determination,
the Common Shares acquired by the Subscriber pursuant to this Subscription Agreement and any other equity security issued or issuable
with respect to such Shares by way of stock split, dividend, distribution, recapitalization, merger, exchange, replacement or similar
event, and “Subscriber” shall include any affiliate of the Subscriber to which the rights under this Section 7 have been
duly assigned.
b. Notwithstanding anything to the contrary in this Subscription Agreement,
the Company shall be entitled to delay or postpone the effectiveness of any Registration Statement, and from time to time to require
the Subscriber not to sell under any Registration Statement or to suspend the effectiveness thereof, if the filing, initial effectiveness
or continued use of any Registration Statement at any time would require the Company to make an Adverse Disclosure (as defined below)
or would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons
beyond the Company’s control (each, a “Suspension Event”). In such case, the Company may, upon giving prompt
written notice of such action to the Subscriber, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement
for the shortest period of time, but in no event more than two occasions or for more than ninety (90) consecutive days, or more than
one hundred and fifty (150) total calendar days, in each case during any twelve-month period, determined in good faith by the Company
to be necessary for such purpose. Upon receipt of any such written notice from the Company or upon written notice from the Company that
any Registration Statement or related prospectus contains a Misstatement (as defined below), the Subscriber agrees that (i) it will immediately
discontinue offers and sales of the Common Shares under such Registration Statement (excluding, for the avoidance of doubt, sales conducted
pursuant to Rule 144) until (A) the Subscriber receives copies of a supplemental or amended prospectus (it being understood that the
Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice) that
corrects the Misstatement referred to above and receives notice that any post-effective amendment has become effective or (B) is otherwise
notified by the Company that it may resume such offers and sales, and (ii) it will maintain the confidentiality of any information included
in such written notice delivered by the Company unless otherwise required by law or subpoena. The Company shall immediately notify the
Holders of the expiration of any period during which it exercised its rights under this Section 7(b). Notwithstanding anything to the
contrary, the Company shall cause its transfer agent to deliver unlegended Common Shares to a transferee of the Subscriber in connection
with any sale of Shares (and Additional Shares, as applicable) with respect to which the Subscriber has entered into a contract for sale
prior to Subscriber’s receipt of the notice of a Suspension Event and which has not yet settled. If so directed by the Company,
the Subscriber will deliver to the Company or, in the Subscriber’s sole discretion destroy, all copies of the prospectus covering
the Shares (and Additional Shares, as applicable) in the Subscriber’s possession; provided, however, that this obligation
to deliver or destroy all copies of the prospectus covering the Shares (and any Additional Shares) shall not apply (i) to the extent
the Subscriber is required to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory, self-regulatory
or professional requirements or (b) in accordance with a bona fide pre-existing document retention policy or (ii) to copies stored electronically
on archival servers as a result of automatic data back-up. “Adverse Disclosure” shall mean any public disclosure of
material non-public information, which disclosure, in the good faith judgment of the Chief Executive Officer or principal financial officer
of the Company or the Company’s board of directors, after consultation with counsel to the Company, (x) would be required to be
made in any Registration Statement or the related prospectus in order for such Registration Statement or prospectus not to contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein, in the light
of the circumstances under which they were made, not misleading, (y) would not be required to be made at such time if any Registration
Statement were not being filed, declared effective or used, as the case may be, and (z) the Company has a bona fide business purpose
for not making such information public. “Misstatement” shall mean an untrue statement of a material fact or an omission
to state a material fact necessary in order to make the statements made in any Registration Statement or the related prospectus, in the
light of the circumstances under which they were made, not misleading.
c. In the case of the registration, qualification, exemption or compliance
effected by the Company pursuant to this Subscription Agreement, the Company shall inform the Subscriber as to the status of such registration,
qualification, exemption and compliance. At its expense the Company shall:
|
(i) |
Advise the Subscriber as promptly as reasonably practicable:
|
|
A. |
when any Registration Statement or any amendment thereto
has been filed with the Commission and when such Registration Statement or any post-effective amendment thereto has become effective;
|
|
B. |
of any request by the Commission for amendments or
supplements to any Registration Statement or the prospectus included therein or for additional information; |
|
C. |
of the issuance by the Commission of any stop order
suspending the effectiveness of any Registration Statement or the initiation of any proceedings for such purpose; |
|
D. |
of the receipt by the Company of any notification
with respect to the suspension of the qualification of the Shares (and Additional Shares, as applicable) included therein for sale
in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and |
|
E. |
subject to the provisions in this Subscription Agreement,
of the occurrence of any event that requires the making of any changes in any Registration Statement or prospectus so that, as of
such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary
to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading.
|
Notwithstanding anything to the contrary set forth herein,
the Company shall not, when so advising the Subscriber of such events, provide the Subscriber with any material, nonpublic information
regarding the Company other than to the extent that providing notice to the Subscriber of the occurrence of the events listed in (A)
through (E) above constitutes material, nonpublic information regarding the Company and Subscriber is notified that such events are material,
nonpublic information at the time of notification;
|
(ii) |
use reasonable best efforts to obtain the withdrawal
of any order suspending the effectiveness of any Registration Statement as soon as reasonably practicable; |
|
|
|
|
(iii) |
upon the occurrence of any Suspension Event, except
for such times as the Company is permitted hereunder to suspend, and has suspended, the use of a prospectus forming part of any Registration
Statement, the Company shall use its reasonable best efforts to as soon as reasonably practicable prepare a post-effective amendment
to such Registration Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter
delivered to purchasers of the Shares (and Additional Shares, as applicable) included therein, such prospectus will not include any
untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading; and |
|
|
|
|
(iv) |
use its reasonable best efforts to cause all Shares
(and any Additional Shares) to be listed on each securities exchange or market, if any, on which the Common Shares issued by the
Company have been listed. |
d. The Company will use commercially reasonable efforts to file in
a timely manner (giving effect to permissible extensions in accordance with Rule 12b-25 under the Exchange Act) all reports and other
documents under the Exchange Act necessary to enable the Subscriber to resell the Shares (and Additional Shares, as applicable), pursuant
to the Registration Statement. For as long as the Subscriber holds Shares (and Additional Shares, as applicable), the Company will use
commercially reasonable efforts to file in a timely manner (giving effect to permissible extensions in accordance with Rule 12b-25 under
the Exchange Act) all reports and other documents under the Exchange Act necessary to enable the Subscriber to resell the Shares (and
Additional Shares, as applicable) pursuant to Rule 144. The Company shall, at its sole expense, upon appropriate notice from the Subscriber
stating that Shares (and Additional Shares, as applicable) have been sold or transferred pursuant to an effective Registration Statement
or Rule 144, timely prepare and deliver certificates or evidence of book-entry positions representing the Shares (and Additional Shares,
as applicable) to be delivered to a transferee pursuant to such Registration Statement, which certificates or book-entry positions shall
be free of any restrictive legends and in such denominations and registered in such names as the Subscriber may request. Further, the
Company, at its sole expense, and subject to applicable law, shall use commercially reasonable efforts to cause its legal counsel to
(a) issue to the transfer agent and maintain a “blanket” legal opinion instructing the transfer agent that, in connection
with a sale or transfer of “restricted securities” (i.e., securities issued pursuant to an exemption from the registration
requirements of Section 5 of the Securities Act), the resale or transfer of which restricted securities has been registered pursuant
to an effective Registration Statement by the holder thereof named in such Registration Statement, upon receipt of an appropriate broker
representation letter acceptable to the Company and its counsel and other such documentation as the Company or the Company’s counsel
deems necessary and appropriate and after confirming compliance with relevant prospectus delivery requirements, is authorized to remove
any applicable restrictive legend in connection with such sale or transfer and (b) if the Shares (and any Additional Shares) are not
registered pursuant to an effective Registration Statement, issue to the transfer agent a legal opinion to facilitate the sale or transfer
of such Common Shares and removal of any restrictive legends pursuant to any exemption from the registration requirements of Section
5 of the Securities Act that may be available to a requesting Subscriber; provided that in the case of a request to remove such
restrictive legends in connection with a sale or transfer of Shares (and Additional Shares, as applicable) pursuant to clause (a) or
(b) above, the Company shall use its commercially reasonable efforts to cause the Company’s transfer agent to remove any such applicable
restrictive legends in connection with such sale or transfer within five business days of such request. The Company shall pay all transfer
agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company
and any exercise notice delivered by the Subscriber), stamp taxes and other taxes and duties levied in connection with the delivery of
any Shares (and Additional Shares, as applicable) to the Subscriber other than income and capital gains taxes of the Subscriber that
may be incurred in connection with the transactions contemplated hereby.
e. The Subscriber may deliver written notice (an “Opt-Out
Notice”) to the Company requesting that the Subscriber not receive notices from the Company otherwise required by this Section
7; provided, however, that the Subscriber may later revoke any such Opt-Out Notice in writing. Following receipt of an
Opt-Out Notice from the Subscriber (unless subsequently revoked), (i) the Company shall not deliver any such notices to the Subscriber
and the Subscriber shall no longer be entitled to the rights associated with any such notice and (ii) each time prior to the Subscriber’s
intended use of an effective Registration Statement, the Subscriber will notify the Company in writing at least five business days in
advance of such intended use, and if a notice of a Suspension Event was previously delivered (or would have been delivered but for the
provisions of this Section 7(e)) and the related suspension period remains in effect, the Company will so notify the Subscriber, within
two business days of the Subscriber’s notification to the Company, by delivering to the Subscriber a copy of such previous notice
of Suspension Event, and thereafter will provide the Subscriber with the related notice of the conclusion of such Suspension Event immediately
upon its availability.
f. The Company shall, notwithstanding any termination of this Subscription
Agreement, indemnify, defend and hold harmless the Subscriber (if the Subscriber is named as a selling shareholder under any Registration
Statement), its officers, directors, employees, investment advisers and agents, each person who controls the Subscriber (within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act) to the fullest extent permitted by applicable law, from and against
any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and investigation
and reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, that arise out of or are
based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any prospectus included
in any Registration Statement or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or
arising out of or relating to any omission or alleged omission to state a material fact required to be stated therein or necessary to
make the statements therein (in the case of any prospectus or form of prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading, or (ii) any violation or alleged violation by the Company of the Securities Act, Exchange
Act or any state securities law or any rule or regulation thereunder, in connection with the performance of its obligations under this
Section 7, except to the extent, but only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged
omissions are based upon information regarding the Subscriber furnished in writing to the Company by the Subscriber expressly for use
therein or the Subscriber has omitted a material fact from such information; provided, however, that the Company shall
not be liable for any Losses to the extent they arise out of or are based upon a violation which occurs (A) in reliance upon and in conformity
with written information furnished by a Subscriber, (B) in connection with any failure of such person to deliver or cause to be delivered
a prospectus made available by the Company in a timely manner, to the extent such person was required to deliver or caused to be delivered
such prospectus under applicable law, (C) as a result of offers or sales effected by or on behalf of any person by means of a free writing
prospectus (as defined in Rule 405 of the Securities Act) that was not authorized in writing by the Company, or (D) in connection with
any offers, sales or transfers effected by or on behalf of a Subscriber in violation of Section 7(d) hereof. Such indemnity shall remain
in full force and effect regardless of any investigation made by or on behalf of an indemnified party and shall survive the transfer
of the Shares (and Additional Shares, as applicable) by the Subscriber.
g. The Subscriber shall, severally and not jointly with any Other
Subscriber, indemnify and hold harmless the Company, its directors, officers, agents and employees, and each person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, arising out of or are based upon any untrue or alleged untrue statement
of a material fact contained in any Registration Statement, any prospectus included in any Registration Statement, or any form of prospectus,
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus,
or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading to the extent,
but only to the extent, that such untrue statements or omissions are based upon information regarding the Subscriber furnished in writing
to the Company by the Subscriber expressly for use therein. In no event shall the liability of any Subscriber be greater in amount than
the dollar amount of the net proceeds received by the Subscriber upon the sale of the Shares (and Additional Shares, as applicable) giving
rise to such indemnification obligation. Such indemnity shall remain in full force and effect regardless of any investigation made by
or on behalf of an indemnified party and shall survive the transfer of the Shares (and Additional Shares, as applicable) by the Subscriber.
h. Any person entitled to indemnification pursuant to this Section
7 shall (1) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided
that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such
failure has not prejudiced the indemnifying party) and (2) permit such indemnifying party to assume the defense of such claim with counsel
reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability
for any settlement made by the indemnified party without its consent (which consent shall not be unreasonably withheld, conditioned or
delayed). An indemnifying party who elects not to assume the defense of a claim shall not be obligated to pay the fees and expenses of
more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment
of legal counsel to any indemnified party a conflict of interest exists between such indemnified party and any other of such indemnified
parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of
any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid
by the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof
the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.
i. If the indemnification provided under this Section 7 from the indemnifying
party is unavailable or insufficient to hold harmless an indemnified party in respect of any Losses, in lieu of indemnifying the indemnified
party, the indemnifying party shall contribute to the amount paid or payable by the indemnified party as a result of such Losses in such
proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other
relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference
to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission
or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified
party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity
to correct or prevent such action. The amount paid or payable by a party as a result of the losses or other liabilities referred to above
shall be deemed to include, subject to the limitations set forth in this Section 7, any legal or other fees, charges or expenses reasonably
incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 7 from any person who was
not guilty of such fraudulent misrepresentation. Each indemnifying party’s obligation to make a contribution pursuant to this Section
7(i) shall be individual, not joint and several, and in no event shall the liability of the Subscriber hereunder be greater in amount
than the dollar amount of the net proceeds received by the Subscriber upon the sale of the Shares (and any Additional Shares) giving
rise to such indemnification obligation.
8. Termination. This Subscription Agreement shall terminate
and be void and of no further force and effect, and all rights and obligations of the parties hereunder shall terminate without any further
liability on the part of any party in respect thereof, upon the earliest to occur of (a) following the execution of a definitive agreement
among the Company, Merger Sub and Mobix with respect to the Transaction (together with the exhibits and schedules thereto and ancillary
agreements specifically referenced therein, the “Transaction Agreement”), such date and time as such Transaction Agreement
is terminated in accordance with its terms without the Transaction being consummated, (b) upon the mutual written agreement of each of
the parties hereto to terminate this Subscription Agreement, (c) if any of the conditions to the Subscription Closing set forth in Section
3 of this Subscription Agreement are not satisfied or waived upon or prior to the Subscription Closing and, as a result thereof, the
transactions contemplated by this Subscription Agreement are not consummated at the Subscription Closing, or (d) at the election of the
Subscriber, if the Transaction Closing shall not have occurred by the Outside Date (as defined in the Transaction Agreement); provided
that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and each
party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such breach. The Company
shall promptly notify the Subscriber of the termination of the Transaction Agreement after the termination of such agreement. For the
avoidance of doubt, if any termination hereof occurs after the delivery by the Subscriber of the Purchase Price for the Shares, the Company
shall promptly (but not later than one business day thereafter) return the Purchase Price to the Subscriber without any deduction for
or on account of any tax, withholding, charges or set-off.
9. Trust Account Waiver. The Subscriber acknowledges that the
Company is a special purpose acquisition company with the powers and privileges to effect a merger, asset acquisition, reorganization
or similar business combination involving the Company and one or more businesses or assets. The Subscriber further acknowledges that,
as described in the Company’s prospectus relating to its initial public offering dated July 19, 2021 and filed with the Commission
on July 21, 2021 and available at www.sec.gov, substantially all of the Company’s assets consist of the cash proceeds of the Company’s
initial public offering and private placements of its securities, and substantially all of those proceeds have been deposited in a trust
account (the “Trust Account”) for the benefit of the Company, its public shareholders and the underwriters of the
Company’s initial public offering, in their capacity as advisors pursuant to the Business Combination Marketing Agreement, dated
July 19, 2021, between the Company, Roth Capital Partners, LLC and Craig-Hallum Capital Group LLC. For and in consideration of the Company
entering into this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged, the Subscriber hereby irrevocably
waives any and all right, title and interest, or any claim of any kind it has or may have in the future, in or to any monies held in
the Trust Account, and agrees not to seek recourse against the Trust Account, in each case, as a result of, or arising out of, this Subscription
Agreement; provided that nothing in this Section 9 shall be deemed to limit the Subscriber’s right, title, interest or claim
to the Trust Account by virtue of the Subscriber’s record or beneficial ownership of Common Shares of the Company acquired by any
means other than pursuant to this Subscription Agreement.
10. No Short Sales. The Subscriber hereby agrees that, from
the date of this Agreement until any Additional Closing, that it will not, nor will any person acting at the Subscriber’s direction
or pursuant to any understanding with the Subscriber (including the Subscriber’s controlled affiliates), directly or indirectly,
offer, sell, pledge, contract to sell, sell any option in, or engage in hedging activities or execute any “short sales” (as
defined in Rule 200 of Regulation SHO under the Exchange Act) with respect to, any shares or any securities of the Company or any instrument
exchangeable for or convertible into any shares or any securities of the Company until the consummation of the Transaction (or such earlier
termination of this Subscription Agreement in accordance with its terms). Notwithstanding anything to the contrary contained herein,
the restrictions in this Section 10 shall not apply to (i) any sale (including the exercise of any redemption right) of securities of
the Company (A) held by the Subscriber, its controlled affiliates or any person or entity acting on behalf of the Subscriber or any of
its controlled affiliates prior to the execution of this Subscription Agreement or (B) purchased by the Subscriber, its controlled affiliates
or any person or entity acting on behalf of the Subscriber or any of its controlled affiliates in open market transactions after the
execution of this Subscription Agreement, or (ii) ordinary course hedging transactions so long as the sales or borrowings relating to
such hedging transactions are not settled with the Shares and any Additional Shares subscribed for hereunder and the number of securities
sold in such transactions does not exceed the number of securities owned or subscribed for at the time of such transactions. Notwithstanding
the foregoing, (i) nothing herein shall prohibit any entities under common management with the Subscriber that have no knowledge of this
Subscription Agreement or of the Subscriber’s participation in the transactions contemplated hereby (including the Subscriber’s
affiliates) from entering into any short sales; (ii) in the case that the Subscriber is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of the Subscriber’s assets and the portfolio managers have no knowledge of the investment
decisions made by the portfolio managers managing other portions of the Subscriber’s assets, this Section 10 shall only apply with
respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Shares (and Additional
Shares, as applicable) covered by this Subscription Agreement.
11. Miscellaneous.
a. The Company shall, no later than 9:00 a.m., New York City time,
on the first business day immediately following the date of this Subscription Agreement, issue one or more press releases or file with
the Commission a Current Report on Form 8-K (collectively, the “Disclosure Document”) disclosing all material terms
of the transactions contemplated hereby, the Transaction and any other material, nonpublic information that the Company, Mobix or any
of their respective officers, directors, employees or agents has provided to the Subscriber or any of the Subscriber’s affiliates,
attorneys, agents or representatives at any time prior to the filing of the Disclosure Document, except for any material, nonpublic information
that is the subject to a non-disclosure agreement between the Company, Mobix and Subscriber (such information, “Excluded MNPI”).
From and after the issuance of the Disclosure Document, the Subscriber and the Subscriber’s affiliates, attorneys, agents or representatives
shall not be in possession of any material, non-public information received from the Company, Mobix or any of their respective officers,
directors, employees or agents, except for Excluded MNPI, and the Subscriber shall no longer be subject to any confidentiality or similar
obligations under any current agreement, whether written or oral with the Company, Mobix, or any of their respective affiliates, except
for any agreement related to Excluded MNPI. Except with the express written consent of the Subscriber and unless prior thereto, the Subscriber
shall have executed a written agreement regarding the confidentiality and use of such information, the Company shall not, and shall cause
its officers, directors, employees and agents, not to, provide Subscriber with any material, non-public information regarding the Company
or the Transaction from and after the filing of the Disclosure Document, other than to the extent that providing notice to the Subscriber
of the occurrence of the events listed in (A) through (E) of Section 7(c)(i) herewith constitutes material, nonpublic information regarding
the Company. Notwithstanding anything in this Subscription Agreement to the contrary, the Company shall not (and shall cause its officers,
directors, employees or agents not to), without the prior written consent of the Subscriber, publicly disclose the name of the Subscriber,
its investment adviser or any of their respective affiliates or advisers, or include the name of the Subscriber, its investment adviser
or any of their respective affiliates or advisers (i) in any press release, marketing materials, media or similar circumstances or (ii)
in any filing with the SEC or any regulatory agency or trading market, other than the Registration Statement, the filing of this agreement
with a Current Report on Form 8-K of the Company upon the public announcement of the Transaction and any related description in such
Form 8-K (if deemed necessary or advisable by counsel to the Company) and except (A) as required by the federal securities law or pursuant
to other routine proceedings of regulatory authorities or (B) to the extent such disclosure is required by law, at the request of the
staff of the SEC or regulatory agency or under the regulations of any national securities exchange on which the Company’s securities
are listed for trading, provided that in the case of this clause (ii), the Company shall provide the Subscriber with prior written
notice (including by e-mail) of such permitted disclosure, and shall reasonably consult with the Subscriber regarding such disclosure.
b. Neither this Subscription Agreement nor any rights that may accrue
to the Subscriber hereunder (other than the Shares or Additional Shares acquired hereunder, if any) may be transferred or assigned without
the prior written consent of the other party hereto, except that this Subscription Agreement and any of the Subscriber’s rights
and obligations hereunder may be assigned to any member, limited partner or other investor in the Subscriber or any fund or other account
or entity managed by a member or by the same investment manager as the Subscriber or by an affiliate (as defined in Rule 12b-2 under
the Exchange Act) of such member or investment manager without the prior consent of the Company; provided that the Subscriber
gives prior written notice to the Company, and such assignee or transferee agrees in writing to be bound by and subject to the terms
and conditions of this Subscription Agreement, makes the representations and warranties in Section 6 hereof and completes Schedule
A hereto.
c. The Company may request from the Subscriber such additional information
as the Company may deem necessary to evaluate the eligibility of the Subscriber to acquire the Shares (and any Additional Shares), and
the Subscriber promptly shall provide such information as may reasonably be requested, to the extent readily available and to the extent
consistent with its internal policies and procedures, provided that the Company agrees to keep confidential any such information
to the extent such information is not in the public domain, was not provided lawfully to the Company by another source not under a duty
of confidentiality and except to the extent disclosure of such information by the Company is compelled by law, court order or a self-regulatory
organization such as Nasdaq or The Financial Industry Regulatory Authority (FINRA) or required to be included in the Registration Statement,
in which case, the Company shall provide the Subscriber with prior written notice of any disclosure of such information if reasonably
practicable and legally permitted.
d. The Subscriber acknowledges that the Company may rely on the acknowledgments,
understandings, agreements, representations and warranties of the Subscriber contained in this Subscription Agreement. The Company acknowledges
that the Subscriber will rely on the acknowledgements, understandings, agreements, representations and warranties of the Company contained
in this Subscription Agreement. Prior to any Additional Closing, each party hereto agrees to promptly notify the other party if any of
their respective acknowledgments, understandings, agreements, representations and warranties set forth in Section 5 or Section 6, as
applicable, above are no longer accurate in any material respect (other than those acknowledgments, understandings, agreements, representations
and warranties qualified by materiality, in which case such party shall notify the other party if they are no longer accurate in any
respect).
e. The Company and the Subscriber are entitled to rely upon this Subscription
Agreement, and each of the Company and the Subscriber is irrevocably authorized to produce this Subscription Agreement or a copy hereof
when required by law, governmental authority or self-regulatory organization to do so in any administrative or legal proceeding or official
inquiry with respect to the matters covered hereby.
f. All of the agreements, representations and warranties made by each
party to this Subscription Agreement shall survive the Subscription Closing.
g. This Subscription Agreement may not be modified, waived or terminated
(other than pursuant to the terms of Section 8 hereof) except by an instrument in writing, signed by the party against whom enforcement
of such modification, waiver, or termination is sought; provided that any rights (but not obligations) of a party under this Subscription
Agreement may be waived, in whole or in part, by such party on its own behalf without the prior consent of any other party. No failure
or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial
exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct,
preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties hereunder
are cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder.
h. This Subscription Agreement, together with the Sponsor Letter Agreement,
constitute the entire agreement, and supersede all other prior agreements, understandings, representations and warranties, both written
and oral, among the parties, with respect to the subject matter hereof. Except as otherwise expressly set forth in Section 7 and in subsection
(b) of this Section 11, this Subscription Agreement shall not confer any rights or remedies upon any person other than the parties hereto,
and their respective successor and assigns.
i. Except as otherwise provided herein, this Subscription Agreement
shall be binding upon, and inure to the benefit of the parties hereto and their heirs, executors, administrators, successors, legal representatives
and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed
to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.
j. If any provision of this Subscription Agreement shall be invalid,
illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not
in any way be affected or impaired thereby and shall continue in full force and effect.
k. This Subscription Agreement may be executed in one or more counterparts
(including by electronic signature or email of a .pdf) and by different parties in separate counterparts, with the same effect as if
all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed together and shall constitute
one and the same agreement.
l. The parties hereto agree that irreparable damage would occur in
the event that any of the provisions of this Subscription Agreement were not performed in accordance with their specific terms or were
otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of
this Subscription Agreement and to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition
to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise.
m. Any notice, request, claim, demand, waiver, consent, approval or
other communication which is required or permitted hereunder shall be in writing and shall be deemed given (a) when delivered by hand
(with written confirmation of receipt), (b) when received by the addressee if sent by a nationally recognized overnight courier postage
prepaid (receipt requested), (c) on the date sent by email (with no “bounceback” or notice of non-delivery), or (d) on the
third business day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications
must be sent to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice
given in accordance with this Section 11(m)):
|
i. |
if to the Subscriber, to such address or addresses
set forth on the Subscriber’s signature page hereto; |
|
|
|
|
ii. |
if to the Company prior to the Transaction Closing,
to: |
Chavant Capital Acquisition Corp.
445 Park Avenue, 9th Floor
New York, NY 10022
Attention: Jiong Ma
Email: [****]
With a required copy to (which shall not constitute notice):
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, NY 10017
Attention: John C. Ericson; Mark Brod
Email: jericson@stblaw.com; mbrod@stblaw.com
|
iii. |
If to Mobix prior to the Transaction
Closing, to: |
Mobix Labs, Inc.
15420 Laguna Canyon Rd., suite 100
Irvine, CA 92618
Attention: Keyvan Samini
Email: legal@mobixlabs.com
With a required copy to (which shall not constitute notice):
Greenberg Traurig, LLP
One Vanderbilt Avenue
New York, New York 10022
Attention: Alan I. Annex; Kevin Friedmann; Laurie Green
Email: Annexa@gtlaw.com; FriedmannK@gtlaw.com; GreenL@gtlaw.com
|
iv. |
If to the Company after the Transaction Closing, to: |
Mobix Labs, Inc.
15420 Laguna Canyon Rd., suite 100
Irvine, CA 92618
Attention: Keyvan Samini
Email: legal@mobixlabs.com
With a required copy to (which shall not constitute notice):
Greenberg Traurig, LLP
One Vanderbilt Avenue
New York, New York 10022
Attention: Alan I. Annex; Kevin Friedmann; Laurie Green
Email: Annexa@gtlaw.com; FriedmannK@gtlaw.com; GreenL@gtlaw.com
n. THIS SUBSCRIPTION AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED
IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS THAT WOULD OTHERWISE REQUIRE
THE APPLICATION OF THE LAW OF ANY OTHER STATE.
SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS
OF THIS SUBSCRIPTION AGREEMENT AND THE DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED
HEREBY, THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE Court of Chancery
of the State of Delaware; provided that if jurisdiction is not then available in the Court of Chancery of the State of Delaware,
then any ACTION, SUIT OR PROCEEDING hereunder may be brought in any federal court located in the State of Delaware or any other Delaware
state court. THE PARTIES HERETO HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION
OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT SUCH PARTY IS NOT SUBJECT TO SUCH JURISDICTION OR THAT SUCH ACTION, SUIT OR PROCEEDING
MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT
OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT
TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A DELAWARE STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT
TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING
OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 11(m) OR IN SUCH OTHER
MANNER AS MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.
EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY
ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES,
AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT
OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY
THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS
REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER;
(II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER
VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER
AND CERTIFICATIONS IN THIS SECTION 11(n).
12. Separate Obligations. For the avoidance of doubt, all obligations
of the Subscriber hereunder are separate and several from the obligations of any Other Subscriber. The decision of the Subscriber to
purchase the Shares pursuant to this Subscription Agreement has been made by Subscriber independently of any Other Subscriber or any
other investor and independently of any information, materials, statements or opinions as to the business, financial condition or results
of operations of the Company, Mobix, or any of their respective subsidiaries which may have been made or given by any Other Subscriber
or by any agent or employee of any Other Subscriber, and neither the Subscriber nor any of its agents or employees shall have any liability
to any Other Subscriber (or any other person) relating to or arising from any such information, materials, statements or opinions. Nothing
contained herein or in any Other Subscription Agreement, and no action taken by the Subscriber or Other Subscribers pursuant hereto or
thereto, shall be deemed to constitute the Subscriber and Other Subscriber as a partnership, an association, a joint venture or any other
kind of entity, or create a presumption that the Subscriber and the Other Subscribers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by this Subscription Agreement and the Other Subscription Agreements.
The Subscriber acknowledges that no Other Subscriber has acted as agent for the Subscriber in connection with making its investment hereunder
and no Other Subscriber will be acting as agent of the Subscriber in connection with monitoring its investment in the Shares or enforcing
its rights under this Subscription Agreement. The Subscriber shall be entitled to independently protect and enforce its rights, including,
without limitation, the rights arising out of this Subscription Agreement, and it shall not be necessary for any Other Subscriber to
be joined as an additional party in any proceeding for such purpose.
[SIGNATURE PAGES FOLLOW]
IN WITNESS WHEREOF, the Subscriber has executed or caused this
Subscription Agreement to be executed by its duly authorized representative as of the date set forth below.
Name of Subscriber: Chavant Capital Partners LLC |
|
State/Country of Formation or Domicile: Delaware |
|
|
|
By: |
/s/ Jiong Ma |
|
|
|
|
|
Name: |
Jiong Ma |
|
|
|
|
|
Title: |
Manager |
|
|
Name in which shares are to be registered
(if different): |
|
Date: December 19, 2023 |
|
|
|
Subscriber’s EIN: [****] |
|
|
|
|
|
Business Address-Street: c/o Chavant Capital Acquisition Corp., 445 Park Avenue, 9th Floor |
|
Mailing Address-Street (if different): |
|
|
|
City, State, Zip: New York, NY 10022 |
|
City, State, Zip: |
|
|
|
Attn: Jiong Ma |
|
Attn: |
|
|
|
Telephone No.: [****] |
|
Telephone No.: |
|
|
|
Email Address: [****] |
|
Email Address: |
|
|
|
Number of Shares subscribed for: |
|
|
199,737 |
|
|
|
|
|
Aggregate Subscription Amount: $1,997,370 |
|
Price Per Share: $10.00 |
[Signature Page to Subscription Agreement]
IN WITNESS WHEREOF, Chavant Capital Acquisition Corp. has accepted
this Subscription Agreement as of the date set forth below.
|
CHAVANT CAPITAL ACQUISITION CORP. |
|
|
|
By: |
/s/ Jiong Ma |
|
Name: |
Jiong Ma |
|
Title: |
Chief Executive Officer |
Date: December 19, 2023
[Signature Page to Subscription Agreement]
SCHEDULE A
ELIGIBILITY REPRESENTATIONS OF THE SUBSCRIBER
A. |
QUALIFIED INSTITUTIONAL BUYER STATUS |
(Please check the applicable subparagraphs):
|
1. |
¨ We
are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (a “QIB”)). |
|
2. |
¨ We
are subscribing for the Shares as a fiduciary or agent for one or more investor accounts, and each owner of such account is a QIB.
|
B. |
ACCREDITED INVESTOR STATUS |
(Please check the applicable subparagraphs):
|
1. |
x We
are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which all of
the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked
and initialed the appropriate box on the following pages indicating the provision under which we qualify as an “accredited
investor.” |
|
|
|
|
2. |
x We
are not a natural person. |
(Please check the applicable box)
THE SUBSCRIBER:
an “affiliate” (as defined in Rule 144 under the Securities
Act) of the Company or acting on behalf of an affiliate of the Company.
This page and the following pages on Schedule A should be completed
by the Subscriber and constitutes a part of the Subscription Agreement.
Rule 501(a), in relevant part, states that
an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the Company reasonably
believes comes within any of the below listed categories, at the time of the sale of the Shares to that person. Subscriber has indicated,
by marking and initialing the appropriate box below, the provision(s) below which apply to Subscriber and under which Subscriber accordingly
qualifies as an “accredited investor.”
¨
Any bank, as defined in Section 3(a)(2) of the Securities Act or any savings and loan association or other institution as defined
in Section 3(a)(5)(A) of the Securities Act, whether acting in an individual or a fiduciary capacity;
¨
Any broker or dealer registered under Section 15 of the Exchange Act;
¨
Any investment adviser registered pursuant to Section 203 of the Investment Advisers Act of 1940 or registered pursuant to the
laws of a state;
¨
Any investment adviser relying on the exemption from registering with the Commission under Section 203(l) or (m) of the Investment
Advisers Act of 1940;
¨
Any insurance company, as defined in Section 2(a)(13) of the Securities Act;
¨
Any investment company registered under the Investment Company Act of 1940 or a business development company, as defined in Section
2(a)(48) of that act;
¨
Any small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small
Business Investment Act of 1958;
¨
Any Rural Business Investment Company as defined in Section 384A of the Consolidated Farm and Rural Development Act;
¨
Any plan established and maintained by a state, its political subdivisions or any agency or instrumentality of a state or its
political subdivisions for the benefit of its employees, if the plan has total assets in excess of $5 million;
¨
Any employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, if the investment
decision is being made by a plan fiduciary, as defined in Section 3(21) of such act, and the plan fiduciary is either a bank, a savings
and loan association, an insurance company, or a registered investment adviser, or if the employee benefit plan has total assets in excess
of $5 million, or if the employee benefit plan is a self-directed plan in which investment decisions are made solely by persons that
are accredited investors;
¨
Any private business development company, as defined in Section 202(a)(22) of the Investment Advisers Act of 1940;
¨
Any corporation, Massachusetts or similar business trust, partnership, or limited liability company or an organization described
in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, that was not formed for the specific purpose of acquiring the
Shares, and that has total assets in excess of $5 million;
¨
Any trust with total assets in excess of $5 million not formed for the specific purpose of acquiring the Shares, whose purchase
is directed by a sophisticated person as described in Rule 506(b)(2)(ii) under the Securities Act;
x
Any entity in which all of the equity owners (whether entities themselves or natural persons) are accredited investors and meet
the criteria listed herein;
¨
Any entity of a type not listed above, that is not formed for the specific purpose of acquiring the Shares and owns investments
in excess of $5 million. For purposes of this test, “investments” means investments as defined in Rule 2a51-1(b) under the
Investment Company Act of 1940;
¨
Any family office, as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940, that (i) has assets under management
in excess of $5 million; (ii) is not formed for the specific purpose of acquiring the Shares and (iii) has a person directing the prospective
investment who has such knowledge and experience in financial and business matters so that the family office is capable of evaluating
the merits and risks of the prospective investment;
¨
Any family client, as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940, of a family office meeting the
requirements of the test immediately above and whose prospective investment in the issuer is directed by that family office pursuant
to clause (iii) immediately above;
¨
Any natural person whose individual net worth, or joint net worth with my spouse or spousal equivalent, exceeds $1,000,000;1
¨
Any natural person who had individual income exceeding $200,000 in each of the last two calendar years and has a reasonable expectation
of reaching the same income level in the current calendar year;2
¨
Any natural person who had joint income with spouse or spousal equivalent exceeding $300,000 in each of the last two calendar
years and has a reasonable expectation of reaching the same income level in the current calendar year, as defined above;
¨
Any director, executive officer, or general partner of the issuer of the Shares or sold, or any director, executive officer, or
general partner of a general partner of that issuer; or
¨
Any natural person who holds in good standing one or more professional certifications or
designations or credentials from an accredited educational institution that the Commission has designated as qualifying an individual
for accredited investor status.3
1
For purposes of this test, “net worth” means the excess of total assets at fair market value (including personal and real
property, but excluding the estimated fair market value of a person’s primary home) over total liabilities. “Total liabilities”
excludes any mortgage on the primary home in an amount of up to the home's estimated fair market value as long as the mortgage was incurred
more than 60 days before the Shares are purchased, but includes (i) any mortgage amount in excess of the home’s fair market value
and (ii) any mortgage amount that was borrowed during the 60-day period before the closing date for the sale of Shares for the purpose
of investing in the Shares. “Spousal equivalent” means a cohabitant occupying a relationship generally equivalent to that
of a spouse. “Joint net worth” can be the aggregate net worth of a person and spouse or spousal equivalent; assets do not
need to be held jointly to be included in the calculation.
2
For purposes of this test, “income” means adjusted gross income, as reported for federal income tax purposes, increased by
the following amounts: (a) the amount of any tax exempt interest income received, (b) the amount of losses claimed as a limited
partner in a limited partnership, (c) any deduction claimed for depletion under Section 611 et seq. of the Internal Revenue Code,
(d) amounts contributed to an IRA or Keogh retirement plan, (e) alimony paid, and (f) any amounts by which income from
long-term capital gains has been reduced in arriving at adjusted gross income pursuant to the provisions of Section 1202 of the Internal
Revenue Code.
3
In determining whether to designate a professional certification or designation or credential from an accredited educational institution
for purposes hereof, the Commission will consider, among others, the following attributes: (a) the certification, designation, or
credential arises out of an examination or series of examinations administered by a self-regulatory organization or other industry body
or is issued by an accredited educational institution; (b) the examination or series of examinations is designed to reliably and
validly demonstrate an individual’s comprehension and sophistication in the areas of securities and investing; (c) persons
obtaining such certification, designation, or credential can reasonably be expected to have sufficient knowledge and experience in financial
and business matters to evaluate the merits and risks of a prospective investment; and (d) an indication that an individual holds
the certification or designation is either made publicly available by the relevant self-regulatory organization or other industry body
or is otherwise independently verifiable. As of the date hereof, the Commission has designated three certifications and designations
administered by the Financial Industry Regulatory Authority, Inc. as qualifying for accredited investor status: (i) Licensed General
Securities Representative (Series 7); (ii) Licensed Investment Adviser Representative (Series 65); and (iii) Licensed Private
Securities Offerings Representative (Series 82).
Exhibit 10.2
Execution Version
NEITHER THIS WARRANT
NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY
STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN
OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATIONS ARE NOT REQUIRED; (III) RECEIPT OF
NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES; OR (IV) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS
WARRANT.
DECEMBER 20, 2023 | |
272,454 SHARES |
WARRANT TO PURCHASE SHARES
OF COMMON STOCK
The Warrant is issued
concurrently with the Subscription Agreement by and between Mobix Labs, Inc. (“Company”), Chavant Capital Acquisition
Corp., an exempted company incorporated under the Laws of the Cayman Islands (“SPAC”) and Holder (the “PIPE
Subscription Agreement”). For value received, Chavant Capital Partners LLC, and its permitted assignees (the “Holder”),
is entitled to purchase 272,454 shares (as may be adjusted pursuant to Section 4 hereof, the “Shares”)
of common stock, $0.00001 par value per share (the “Stock”), of MOBIX LABS, INC., a Delaware company, (the “Company”),
at an exercise price of $0.01 per share (such price and such other price as shall result, from time to time, from the adjustments specified
in Section 4 hereof is herein referred to as the “Warrant Price”), subject to the provisions and upon the
terms and conditions hereinafter set forth.
1. Term.
This Warrant shall terminate upon the earlier to occur of (i) the closing of the proposed business combination contemplated by the
Business Combination Agreement dated as of November 15, 2022, by and among the Company, SPAC and CLAY Merger Sub II, Inc., a
Delaware corporation (as amended, the “Business Combination Agreement”) and (ii) the termination of the Business
Combination Agreement (the “Termination Date”).
| 2. | Method of Exercise: Payment. |
a. Subject
to Section 1 hereof, and contingent upon the substantially concurrent occurrence of the Subscription Closing (as defined
in the PIPE Subscription Agreement, the purchase right represented by this Warrant shall be exercisable by the Holder hereof
immediately prior to the Closing (as such term is defined in the Business Combination Agreement), in whole or in part, by the
surrender of this Warrant (with the notice of exercise form attached hereto as EXHIBIT A duly executed (the
“Notice of Exercise”) at the principal office of the Company and by the payment to the Company by check or wire
transfer to an account designated by the Company of an amount equal to the then applicable Warrant Price multiplied by the number of
Shares then being purchased. For the avoidance of doubt, to the extent not previously exercised, contingent upon the substantially
concurrent occurrence of the Subscription Closing (as defined in the PIPE Subscription Agreement), this Warrant shall automatically
convert into the right to receive Class A common shares of the SPAC (the “SPAC Shares”) pursuant to the
merger in accordance with the terms of the Business Combination Agreement. The person in whose name any certificate representing
shares of Stock shall be issuable upon exercise of this Warrant shall be deemed to have become the holder of record of, and shall be
treated for all purposes as the record holder of, the shares represented thereby (and such shares shall be deemed to have been
issued) immediately prior to the close of business on the date or dates upon which this Warrant is exercised. In the event of any
exercise of the rights represented by this Warrant, certificates for the shares of Stock so purchased shall be delivered to the
Holder hereof as soon as reasonably practicable after such exercise; provided, that, as long as the Company is legally permitted to
reflect share issuances in book entry or dematerialized form, the Company may deliver an electronic representation or other evidence
of the valid issuance of the Shares as to which this Warrant has been exercised. Unless this Warrant has been fully exercised or
expired, a new Warrant representing the portion of the Shares, if any, with respect to which this Warrant shall not then have been
exercised shall also be issued to the Holder hereof as soon as practicable.
b. This
Warrant may be exercised for less than the full number of shares of Stock first shown above, provided that this Warrant may not be exercised
in part for less than a whole number of shares of Stock. Upon any such partial exercise, the Company at its expense will forthwith issue
to the Holder a new Warrant or Warrants of like tenor exercisable for the number of shares of Stock as to which rights have not been exercised
(subject to adjustment as herein provided).
3. Stock
Fully Paid: Reservation of Shares. All Shares that may be issued upon the exercise of the rights represented by this Warrant will,
upon issuance pursuant to the terms and conditions herein, be fully paid and nonassessable, and free from all preemptive or similar rights,
taxes, liens, and charges with respect to the issue thereof. During the period within which the rights represented by this Warrant may
be exercised, the Company will at all times have authorized, and reserved for the purpose of the issue upon exercise of the purchase rights
evidenced by this Warrant such number of its duly authorized shares of Stock as from time to time shall be issuable upon the exercise
of this Warrant and other similar Warrants.
4. Adjustment
of Warrant Price and Number of Shares. If the Company subdivides the outstanding shares of the class of Stock by reclassification
or otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant
Price shall be proportionately decreased. If the outstanding shares of the class of Stock are combined or consolidated, by reclassification
or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately
decreased. Each adjustment in the number of Shares issuable will be to the nearest whole share and each adjustment of the Warrant Price
will be calculated to the nearest cent.
5. Notice
of Adjustments. Whenever the Warrant Price or the number of Shares purchasable hereunder shall be adjusted pursuant to Section 4
hereof, the Company shall prepare a notice setting forth, in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, the Warrant Price, and the number of Shares purchasable hereunder after
giving effect to such adjustment, and promptly deliver the notice to the Holder.
6. Fractional
Shares. No fractional shares of Stock will be issued in connection with any exercise hereunder, but in lieu of such fractional shares,
the Company shall make a cash payment therefor based on the fair market value of the Stock on the date of exercise as reasonably determined
in good faith by the Company’s board of directors.
7. Compliance
with Securities Act and Other Laws: Disposition of Warrant or Shares.
a. Compliance
with Securities Act. The Holder, by acceptance hereof, agrees that this Warrant, and the shares of Stock to be issued upon exercise
hereof are being acquired for investment and that such Holder will not offer, sell or otherwise dispose of this Warrant, or any shares
of Stock to be issued upon exercise hereof, except under circumstances that will not result in a violation of the Securities Act of 1933,
as amended (the “Act”). Upon exercise of this Warrant, unless the Shares being acquired are registered under the Act
or an exemption from such registration is available, the Holder hereof shall confirm in writing that the shares of Stock so purchased
are being acquired for investment and not with a view toward distribution or resale. This Warrant and all shares of Stock issued upon
exercise of this Warrant (unless registered under the Act) shall be stamped, imprinted, or otherwise notated with a legend in substantially
the following form:
“THE SECURITIES EVIDENCED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE
EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATIONS ARE NOT REQUIRED; (III) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL
AUTHORITIES; OR (IV) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED,
DIRECTLY OR INDIRECTLY.”
In addition, in connection with the issuance of this Warrant,
the Holder specifically represents to the Company by acceptance of this Warrant that:
i. The
Holder is aware of the Company’s business affairs and financial condition, and has acquired information about the Company sufficient
to reach an informed and knowledgeable decision to acquire this Warrant. The Holder is acquiring this Warrant for its own account for
investment purposes only and not with a view to, or for the resale in connection with, any “distribution” thereof for purposes
of the Act.
ii. The
Holder understands that this Warrant and any securities issuable upon the exercise hereof have not been registered under the Act in reliance
upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment
intent as expressed herein. In this connection, the Holder understands that, in the view of the Securities and Exchange Commission (the
“SEC”), the statutory basis for such exemption may be unavailable if the Holder’s representation was predicated
solely upon a present intention to hold the Warrant for the minimum capital gains period specified under tax statutes, for a deferred
sale, for or until an increase or decrease in the market price of the Warrant, or for a period of one (1) year or any other fixed
period in the future.
iii. The
Holder further understands that this Warrant and any securities issuable upon the exercise hereof must be held indefinitely unless subsequently
registered under the Act and any applicable state securities laws, or unless exemptions from registration are otherwise available.
iv. The
Holder is aware of the provisions of Rule 144, promulgated under the Act, which, in substance, permit limited public resale of “restricted
securities” acquired, directly or indirectly, from the issuer thereof (or from an affiliate of such issuer), in a non-public offering
subject to the satisfaction of certain conditions, if applicable, including, among other things: (i) the availability of certain
public information about the Company, the resale occurring not less than one (1) year after the party has purchased and paid for
the securities to be sold; (ii) the sale being made through a broker in an unsolicited “broker’s transaction” or
in transactions directly with a market maker (as said term is defined under the Securities Exchange Act of 1934, as amended); and (iii) the
amount of securities being sold during any three (3) month period not exceeding the specified limitations stated therein.
v. The
Holder further understands that at the time it wishes to sell this Warrant and any securities issuable upon the exercise hereof there
may be no public market upon which to make such a sale, and that, even if such a public market then exists, the Company may not be satisfying
the current public information requirements of Rule 144, and that, in such event, the Holder may be precluded from selling this Warrant
and any securities issuable upon the exercise hereof under Rule 144 even if the one (1) year minimum holding period had been
satisfied.
vi. The
Holder further understands that in the event all of the requirements of Rule 144 are not satisfied, registration under the Act, compliance
with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rule 144 is not
exclusive, the staff of the SEC has expressed its opinion that persons proposing to sell private placement securities other than in a
registered offering and otherwise than pursuant to Rule 144 will have a substantial burden of proof in establishing that an exemption
from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions
do so at their own risk.
vii. The Holder is an “accredited investor”
as such term is defined in Rule 501 of Regulation D promulgated under the Act.
viii. At
no time was Holder presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of
general advertising or solicitation in connection with the offer, sale and purchase of the Warrant and any securities issuable upon the
exercise hereof.
b. Certain
Limitations on Voting, Access and Control. Notwithstanding the percentage of the outstanding Shares of the Company or the outstanding
SPAC Shares that the Holder may receive as a result of the exercise of the Warrant (or the automatic conversion of the Warrant into the
right to receive SPAC Shares pursuant to Section 2 hereof and subsequent exercise thereof), Holder agrees that it shall not exercise
voting rights relating to any such Shares of the Company or SPAC Shares representing a 10% or greater voting interest in the Company or
the SPAC on any matter subject to a vote of holders of Shares of the Company or SPAC Shares, and agrees that it shall not obtain or exercise,
as a result of its investment in the Company or the SPAC, (i) “Control,” as such term is defined at 31 C.F.R. 800.208,
of the Company, the SPAC or their respective subsidiaries, (ii) access to any “material non-public technical information”
within the meaning of 31 C.F.R. § 800.232 in the Company, the SPAC and their respective subsidiaries’ possession, (iii) the
right to appoint any board member or board observer to the board of directors of the Company or the SPAC or their respective subsidiaries
or (iv) any involvement in any “substantive decision-making” within the meaning of 31 C.F.R. § 800.245 related to
the Company, the SPAC or their respective subsidiaries.
c. Disposition
of Warrant or Shares. The Holder shall not transfer, assign, encumber or otherwise dispose of this Warrant without the
Company’s prior written consent, and any attempted transfer in violation of the foregoing shall be void ab initio. With
respect to any permitted offer, sale or other disposition of this Warrant or any shares of Stock acquired pursuant to the exercise
of this Warrant, in each case prior to registration of such Warrant or shares, the holder hereof and each subsequent holder of this
Warrant agrees to give written notice to the Company prior thereto, describing in sufficient detail the manner thereof, together
with a written opinion of such holder’s counsel (or other evidence of compliance reasonably satisfactory to the Company), if
requested by the Company, to the effect that such offer, sale or other disposition may be effected without registration or
qualification (under the Act as then in effect or any federal or state law then in effect) of this Warrant or such shares of Stock
and indicating whether or not under the Act certificates for this Warrant or such shares of Stock to be sold or otherwise disposed
of require any restrictive legend as to applicable restrictions on transferability in order to ensure compliance with such laws.
Promptly upon receiving such written notice and reasonably satisfactory opinion (or other evidence of compliance), if so requested,
the Company, as promptly as practicable, shall notify such holder whether such holder may sell or otherwise dispose of this Warrant
or such shares of Stock, all in accordance with the terms of the notice delivered to the Company. Notwithstanding the foregoing, at
any time that the Stock of the Company is publicly traded, such Stock may, as to such federal laws, be offered, sold or otherwise
disposed of in accordance with Rule 144 under the Act, provided that the Company shall have been furnished with such
information as the Company and its counsel may reasonably request to provide assurance that the provisions of Rule 144 have
been satisfied. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions.
d. Applicability
of Restrictions. Neither any restrictions of any legend described in this Warrant nor the requirements of Sections 7(a) or
7(c) above shall apply to any transfer of, or grant of a security interest in, this Warrant or any part hereof made in accordance
with all applicable securities laws: (i) to a partner of the Holder if the Holder is a partnership or to a member of the Holder if
the Holder is a limited liability company; (ii) to a partnership of which the Holder is a partner or to a limited liability company
of which the Holder is a member; (iii) to any affiliate of the Holder if the Holder is an entity; or (iv) if the Holder is a
natural person, during such Holder’s lifetime or on death by will or intestacy to such Holder’s immediate family or to any
custodian or trustee for the account of such Holder or such Holder’s spouse, lineal descendant, father, mother, brother, or sister
of the Holder; provided, however, in any such transfer or granting of security interest contemplated by clauses (i) through (iv) above,
if applicable, the transferee or grantee shall agree in writing to be bound by the terms of this Warrant as if an original holder hereof.
8. No
Rights as a Stockholder. No holder of this Warrant, as such, shall be entitled to vote or receive dividends or be deemed the holder
of Stock or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything
contained herein be construed to confer upon the holder of this Warrant, as such, any of the rights of a stockholder of the Company or
any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive notice
of meetings, or to receive dividends or subscription rights or otherwise until this Warrant shall have been exercised and the Shares purchasable
upon the exercise hereof shall have become deliverable, as provided herein.
9. Representations
and Warranties. The Company represents and warrants to the Holder as follows:
a. This
Warrant has been duly authorized and executed by the Company and is a valid and binding obligation of the Company enforceable in accordance
with its terms, subject to laws of general application relating to bankruptcy, insolvency, and the relief of debtors, and the rules of
law or principles at equity governing specific performance, injunctive relief, and other equitable remedies.
b. The
Shares have been duly authorized and reserved for issuance by the Company and, when issued in accordance with the terms hereof, will be
validly issued, fully paid, and nonassessable.
c. The
execution and delivery of this Warrant are not, and the issuance of the Shares upon exercise of this Warrant in accordance with the terms
hereof will not be, inconsistent with the Company’s Certificate of Incorporation, as amended, or its bylaws, do not and will not
contravene any law, governmental rule or regulation, judgment or order applicable to the Company.
a. Notice.
All notices and other communications relating to this Warrant shall be in writing and shall be deemed given upon the first to occur
of (x) deposit with the United States Postal Service or overnight courier service, properly addressed and postage prepaid;
(y) transmittal by e-mail properly addressed (with confirmation of transmission); or (z) actual receipt by the other party
or an employee or agent of the other party. Notice to the Company shall be given as follows:
If to the Company:
Mobix Labs, Inc.
15420 Laguna Canyon Drive, Suite 100
Irvine, California 92618
Attention: General Counsel
E-mail: Legal@mobixlabs.com
with a copy to:
Greenberg Traurig, LLP
18565 Jamboree Road, Suite 500
Irvine, California 92614
Attention: Raymond A. Lee
E-mail: leer@gtlaw.com
if to the Holder, to the address set forth on the signature
page hereof.
b. Severability.
Whenever possible, each provision of this Warrant will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in
any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this
Warrant will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never
been contained in this Warrant.
c. Entire
Agreement. This Warrant constitutes the entire agreement among the parties solely with respect to the subject matter hereof and thereof
and supersedes any prior understandings or agreements between or among the parties solely with respect to the subject matter hereof and
thereof. The parties hereto make no representations or warranties to each other, express (except as contained in this Warrant) or implied,
and any and all prior representations and warranties made by any party hereto or its representatives, whether verbally or in writing,
are deemed to have been merged into this Warrant and the contemplated hereby, it being intended that no such prior representations or
warranties shall survive the execution and delivery of this Warrant. The language used in this Warrant will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. Unless
expressly indicated otherwise, all section references are to sections of this Warrant.
d. Counterparts.
This Warrant may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other parties. In the event that any signature is delivered
by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature
page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the
same force and effect as if such signature page were an original thereof.
e. Successors
and Assigns. This Warrant shall be binding upon and inure to the benefit of the Company and the Holder and their respective successors
and permitted assigns. This Warrant is intended for the benefit of the parties hereto and their respective successors and permitted assigns,
and is not for the benefit of, nor may any provision hereof be enforced by, any other person.
f. Governing
Law; Venue and Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this
Warrant shall be governed by and construed in accordance with the internal laws of the state of Delaware, without giving effect to
any choice of law or conflict of law provision or rule that would cause the application of the laws of any jurisdictions other
than the state of Delaware. Each party hereby irrevocably submits to the exclusive jurisdiction of the state of California for the
adjudication and binding arbitration of any dispute hereunder, and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the jurisdiction of any such tribunal, that such arbitration,
action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. EACH
PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY OR COURT TRIAL FOR THE ADJUDICATION OF
ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT, AND AGREES THAT ALL DISPUTES ARISING HEREUNDER SHALL BE
ADJUDICATED BY ARBITRATION AS SET FORTH IN THIS WARRANT.
g. Mandatory
Arbitration. Any controversy, claim or dispute arising out of or relating to this Warrant, whether in contract or tort, shall be
settled solely and exclusively by a binding arbitration process administered by JAMS in Orange County, California. Such arbitration
shall be conducted in accordance with the then-existing JAMS Expedited Arbitration Procedures, as set forth in the JAMS Arbitration
Rules of Practice and Procedure, with the following exceptions if in conflict: (i) one arbitrator who is a retired judge
shall be chosen by JAMS; (ii) each party to the arbitration will pay one-half of the expenses and fees of the arbitrator,
together with other expenses of the arbitration incurred or approved by the arbitrator; and (iii) arbitration may proceed in
the absence of any party if written notice (pursuant to the JAMS rules and regulations) of the proceedings has been given to
such party. The parties agree to abide by all decisions and awards rendered in such proceedings. Such decisions and awards rendered
by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall be settled in this manner in lieu
of any action at law or equity; provided, however, that nothing in this subsection shall be construed as precluding the bringing of
an action for injunctive relief or specific performance as provided in this Warrant. This dispute resolution process and any
arbitration hereunder shall be confidential and no party shall disclose the existence, contents or results of such process without
the prior written consent of all parties, except where necessary or compelled in a court to enforce this arbitration provision or an
award from such arbitration or otherwise in a legal proceeding. If JAMS no longer exists or is otherwise unavailable, the parties
agree that the American Arbitration Association (“AAA”) shall administer the arbitration in accordance with its
then- existing Expedited Procedures as set forth in the Commercial Arbitration Rules as modified by this subsection. In such
event, all references herein to JAMS shall mean AAA. Notwithstanding the foregoing, recognizing the irreparable damage will result
to the parties in the event of the breach or threatened breach of any of the covenants hereof, and that the parties’ remedies
at law for any such breach or threatened breach will be inadequate, the parties shall be entitled to an injunction, including a
mandatory injunction, to be issued by any court of competent jurisdiction ordering compliance with this Warrant or enjoining and
restraining such breach.
h. Amendments
and Waivers. No provision of this Warrant may be amended or waived without the prior written consent or agreement of the Company and
Holder.
i. Business
Days. Whenever the terms of this Warrant call for the performance of a specific act on a specified date, which date falls on a Saturday,
Sunday or legal holiday, the date for the performance of such act shall be postponed to the next succeeding regular business day following
such Saturday, Sunday or legal holiday.
j. No
Third-Party Beneficiary. Except for the parties to this Warrant and their respective successors and assigns, nothing expressed or
implied in this Warrant is intended, or will be construed, to confer upon or give any person other than the parties hereto and their respective
successors and assigns any rights or remedies under or by reason of this Warrant.
k. Titles
and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in construing
or interpreting this Warrant.
l. Transfers
in Violation of Agreement. Any transfer or attempted transfer of the Shares, or any capital stock in violation of any provision of
this Warrant shall be void, and the Company shall not record such transfer on its books or treat any purported transferee of such Shares
or capital stock as the owner of such stock for any purpose.
m. Further
Assurances. Upon the request of a party hereto, each of the parties hereto shall execute and deliver such instruments, documents and
other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of
this Warrant.
n. Electronic
Execution. The words “execution,”
“signed,” “signature,” and words of similar import in this Warrant shall be deemed to include electronic and
digital signatures and the keeping of records in electronic form, each of which shall be of the same effect, validity, and
enforceability as manually executed signatures and paper-based recordkeeping systems, to the extent and as provided for under
applicable law, including the Electronic Signatures in Global and National Commerce Act of 2000 (15 U.S.C. § 7001 et
seq.), the Electronic Signatures and Records Act of 1999 (N.Y. State Tech. Law §§ 301-309), and any other similar state
laws based on the Uniform Electronic Transactions Act.
[REMAINDER OF THIS PAGE LEFT INTENTIONALLY BLANK]
IN WITNESS WHEREOF, the Company has executed
this Warrant on the date first above written.
|
COMPANY: |
|
MOBIX LABS, INC. |
|
|
|
|
|
By: |
/s/ Keyvan Samini |
|
Keyvan Samini |
|
President / CFO and |
|
General Counsel |
|
|
|
|
|
ACKNOWLEDGED AND ACCEPTED BY |
|
|
|
HOLDER: |
|
Chavant Capital Partners LLC |
|
|
|
By: Chavant Manager LLC, its Manager |
|
|
|
By: |
/s/ Jiong Ma |
|
Name: Jiong Ma |
|
Title: Manager |
|
Address: c/o Chavant Capital Acquisition
Corp., 445 Park Avenue, 9t Floor |
|
City, State, Zip: New York, NY 10022 |
|
Email: jma@chavantcapital.com |
APPENDIX A
NOTICE OF EXERCISE
Attn: General Counsel
15420 Laguna Canyon Rd., Suite 100
Irvine, CA 92618
1. The
undersigned (the “Holder”) hereby elects to exercise the attached warrant (the “Warrant”) as to
[____] shares of Common Stock of Mobix Labs, Inc., a Delaware corporation (the “Company”), pursuant to the terms
of the Warrant, and tenders herewith payment of the purchase price of such shares in full. The purchase price is being paid by (check
one):
|
¨ |
(i) |
check |
|
¨ |
(ii) |
wire transfer |
2. Please
issue the shares in the name of the Holder, or as set forth below (if information is filled out below).
3. The
Holder represents that the aforesaid shares are being acquired for the account of the Holder for investment and not with a view to, or
for resale in connection with, the distribution thereof and that the Holder has no present intention of distributing or reselling such
shares.
|
HOLDER: |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
Date: |
|
Exhibit 10.3
December 20, 2023
Chavant Capital Acquisition Corp.
445 Park Avenue, 9th
Floor
New York, NY 10022
Re: Subscription Agreement
Ladies and Gentlemen:
Reference is
made to that certain Subscription Agreement (the “Subscription Agreement”), dated as of December 19, 2023, by and among
Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor
thereto, including after the Domestication, the “Company”), Chavant Capital Partners LLC (the “Sponsor”)
and Mobix Labs, Inc., a Delaware corporation. Capitalized terms used but not defined herein have the meanings given to them in the Subscription
Agreement. Pursuant to the Subscription Agreement, the Sponsor has agreed to subscribe for and purchase from the Company a total of 199,737
shares of Class A common stock, par value $0.00001 per share, of the Company (after giving effect to the Domestication) (the “Shares”)
at a price of $10.00 per share for an aggregate purchase price of $1,997,370.00 (the “Purchase Price”), subject to
the terms and conditions set forth therein, on the closing date of the Transaction.
Notwithstanding
anything to the contrary in the Subscription Agreement and in lieu of any cash payments required to be paid by the Sponsor as contemplated
by the provisions therein, the Company and the Sponsor hereby agree that the Purchase Price for the Shares may be paid by the Sponsor
in the form of the Sponsor’s forgiveness of approximately $1,997,370.00 of aggregate obligations currently outstanding, or expected
to be owed, by the Company to the Sponsor, as set forth below (collectively, the “Forgiven Chavant Obligations”):
| (a) | Outstanding working capital loans under that certain Unsecured
Convertible Note due December 31, 2023, entered into on June 20, 2022, by and between the Company and the Sponsor, in an aggregate principal
amount of $360,000.00. |
| (b) | Outstanding working capital loans under that certain Unsecured
Convertible Note due December 31, 2023, entered into on July 18, 2022, by and between the Company and the Sponsor, in an aggregate principal
amount of $490,000.00. |
| (c) | Outstanding working capital loans under that certain Unsecured
Convertible Note due July 31, 2024, entered into on January 6, 2023, by and between the Company and the Sponsor, in an aggregate principal
amount of $300,000.00. |
| (a) | Outstanding working capital loans under that certain Promissory
Note, entered into on June 22, 2023, by and between the Company and the Sponsor, in an aggregate principal amount of $500,000.00, together
with all accrued interest thereon (the “June 2023 Non-Convertible Note”). |
2
| (b) | Outstanding working capital loans under that certain Promissory
Note, entered into on November 30, 2023, by and between the Company and the Sponsor, in an aggregate principal amount of $110,000.00,
together with all accrued interest thereon (the “November 2023 Non-Convertible Note” and, together with the June 2023
Non- Convertible Note, the “Non-Convertible Notes”). |
| 3. | Working Capital Loans for Transaction Closing Expenses.
An estimated $40,000 of additional working capital loans expected to be incurred pursuant to the November 2023 Non-Convertible Note by
the Company from the Sponsor to pay for additional expenses in connection with the closing of the Transaction, together with all accrued
interest thereon. |
| 4. | Reimbursement Obligations for Administrative Expenses.
$165,000 of outstanding reimbursement obligations owed by the Company to the Sponsor for administrative services provided by the Sponsor
to the Company. |
| 5. | Reimbursement Obligations for Operating Expenses. Approximately
$32,370 of outstanding reimbursement obligations owed by the Company to Dr. Jiong Ma for certain operating expenses of the Company paid
by Dr. Ma. |
The Sponsor hereby
agrees to forgive the Forgiven Chavant Obligations and waive any and all accrued and unpaid interest payable in connection with the Non-Convertible
Notes (collectively, the “Chavant Obligations Forgiveness”) concurrently with the closing of the Transaction. The Company
hereby agrees to accept the Chavant Obligations Forgiveness as full and complete payment by the Sponsor of the Purchase Price and in full
satisfaction of all obligations of the Sponsor under the Subscription Agreement relating to the Purchase Price and the Shares.
The Sponsor hereby
further agrees to surrender to the Company (x) a total of 400,000 Private Placement Warrants (as defined in the Warrant Agreement (as
defined below)) that it purchased from the Company pursuant to the Private Placement Warrants Purchase Agreement, dated July 19, 2021,
by and between the Company and the Sponsor (the “Warrant Agreement”) and (y) a total 658,631 Ordinary Shares that it
purchased from the Company pursuant to the Securities Subscription Agreement, dated April 7, 2021, by and between the Company and the
Sponsor, in each case upon closing of the Transaction.
Notwithstanding
anything to the contrary herein, if the Subscription Agreement is terminated on or prior to the closing of the Transaction, then the parties’
agreements in this letter agreement (this “Agreement”) shall also be terminated.
This Agreement
and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby shall be governed
by and construed in accordance with the laws of the State of New York, without giving effect to any choice of law or conflict of law provision
or rule (whether of the State of New York or any other jurisdiction) that would cause the application of the law of any jurisdiction other
than the State of New York.
This
Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each
of which shall be an original and all of which together shall constitute one and the same instrument. The words
“execution,” “signed,” “signature,” “delivery,” and words of like import in or
relating to this Agreement or any document to be signed in connection with this Agreement shall be deemed to include electronic
signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or
enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the
case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means.
[Remainder of page intentionally left blank; signatures
page(s) follow]
IN WITNESS WHEREOF, this Agreement
has been duly executed by the parties hereto as of the date first above written.
|
Sponsor: |
|
|
|
CHAVANT CAPITAL PARTNERS LLC |
|
|
|
By: |
/s/ Jiong Ma |
|
Name: |
Jiong Ma |
|
Title: |
Manager |
|
|
|
|
|
Company: |
|
|
|
CHAVANT CAPITAL ACQUISITION CORP. |
|
|
|
By: |
/s/ Jiong Ma |
|
Name: |
Jiong Ma |
|
Title: |
Chief Executive Officer |
|
|
|
|
|
Mobix Labs, Inc.: |
|
|
|
MOBIX LABS, INC. |
|
|
|
By: |
/s/ Keyvan Samini |
|
Name: |
Keyvan Samini |
|
Title: |
President/CFO |
[Signature Page to Sponsor
Letter Agreement]
Exhibit 10.4
FORM OF
SUBSCRIPTION AGREEMENT
Chavant Capital Acquisition Corp.
445 Park Avenue, 9th Floor
New York, NY 10022
Ladies and Gentlemen:
In
connection with the proposed business combination (the “Transaction”) between Chavant Capital Acquisition Corp., an
exempted company incorporated under the laws of the Cayman Islands (together with any successor thereto, including after the Domestication
(as defined below), the “Company”), and Mobix Labs, Inc., a Delaware corporation (“Mobix”),
[●], the undersigned subscriber (the “Subscriber”) desires to subscribe for and purchase from the Company, and
the Company desires to sell and issue to the Subscriber, that number of shares of Class A common stock of the Company (after giving
effect to the Domestication), par value $0.00001 per share (referred to herein as the “Common Shares”), set forth on
the signature page hereof for a purchase price of $10.00 per share (the “Per Share Price” and the aggregate of
such Per Share Price for all Shares subscribed for by the Subscriber being referred to herein as the “Purchase Price”),
on the terms and subject to the conditions contained herein. In connection with the Transaction, certain other “accredited investors”
(as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”)) or “qualified
institutional buyers” (as defined in Rule 144A under the Securities Act) may enter into separate subscription agreements with
the Company with terms no more favorable than the terms of this Subscription Agreement (the “Other Subscription Agreements”),
pursuant to which such investors (the “Other Subscribers”), together with the Subscriber pursuant to this Subscription
Agreement, would severally and not jointly, agree to purchase on the closing date of the Transaction (the “Transaction Closing
Date”) additional Common Shares at the Per Share Price (the Subscriber, together with any Other Subscribers, are referred to
herein collectively as the “Subscribers”). In connection therewith, the Subscriber and the Company agree as follows:
1. | Subscription; Additional Shares. |
a. Subject
to the terms and conditions set forth in this Subscription Agreement, the Subscriber hereby subscribes for and agrees to purchase from
the Company at the Subscription Closing (as defined herein), and the Company agrees to issue and sell to the Subscriber, such number
of Common Shares as is set forth on the signature page of this Subscription Agreement (the “Shares”).
b. In
the event that the Adjustment Period VWAP (as defined herein) is less than $10.00 per Share (as adjusted for any stock split, reverse
stock split or similar adjustment following the closing of the Transaction), Subscriber (or its permitted assigns) shall be entitled to
receive from the Company a number of additional newly issued Common Shares equal to the product of (x) the number of Common Shares
issued to Subscriber (or its permitted assigns) on the Transaction Closing Date that Subscriber (or its permitted assigns) holds on the
Measurement Date (as defined herein), multiplied by (y) a fraction, (A) the numerator of which is $10.00 (as adjusted for any
stock split, reverse stock split or similar adjustment following the closing of the Transaction) minus the Adjustment Period VWAP, and
(B) the denominator of which is the Adjustment Period VWAP (such additional shares, the “Additional Shares”).
Notwithstanding anything to the contrary herein, no fraction of a Common Share will be issued pursuant to this Section 1(b), and
if Subscriber (or its permitted assigns) would otherwise be entitled to a fraction of a Common Share, the number of Additional Shares
to be issued to Subscriber (or its permitted assigns) will instead be
rounded down to the nearest whole Common Share, without payment in lieu of such fractional Common Share. The Subscriber acknowledges and
agrees that, as a result of the Domestication, the Additional Shares, if any, issued pursuant to this Section 1(b) shall be
shares of common stock in a Delaware corporation (and not shares in a Cayman Islands exempted company).
c. For
purposes of this Subscription Agreement: (i) the “Adjustment Period VWAP” means the higher of (x) the average
of the VWAP of a Common Share, determined for each of the Trading Days during the Adjustment Period (as defined herein), and (y) $7.00
(as adjusted for any stock split, reverse stock split or similar adjustment following the closing of the Transaction); (ii) the “Adjustment
Period” means the thirty (30) calendar day period beginning on and including the date that is thirty (30) calendar days after
the Resale Shelf Effectiveness Date; (iii) “business day” means a day, other than a Saturday, Sunday or other
day on which commercial banks in New York, New York or governmental authorities in the Cayman Islands (for so long as Company remains
domiciled in Cayman Islands) are authorized or required by law to close; (iv) the “Measurement Date” means the
last day of the Adjustment Period; (v) “Stock Exchange” means the securities exchange or market, if any, on which
the Common Shares are then listed; (vi) “Trading Day” means any day on which (A) there is no VWAP Market
Disruption Event and (B) trading in the Common Shares generally occurs on the Stock Exchange; provided that, if the Common
Shares are not so listed or traded on a Stock Exchange, then “Trading Day” means a business day; (vii) “VWAP
Market Disruption Event” means, with respect to any date, (A) the failure by the Stock Exchange to open for trading during
its regular trading session on such date or (B) the occurrence or existence, for more than a one half-hour period in the aggregate,
of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant exchange
or otherwise) in the Common Shares or in any options contracts or futures contracts relating to the Common Shares, and such suspension
or limitation occurs or exists at any time before 1:00 p.m., New York City time, on such date; (viii) “VWAP” means,
for any Trading Day, the per share volume weighted average price of the Common Shares as displayed under the heading “Bloomberg
VWAP” on the applicable Bloomberg page (or, if such page is not available, its equivalent successor page) in respect of
the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such Trading Day
(or, if such volume weighted average price is unavailable, the market value of one Common Share on such Trading Day, determined, using
a volume weighted average price method, by a nationally recognized independent investment banking firm selected by the Company); and (ix) “Resale
Shelf Effectiveness Date” means the date on which the Initial Registration Statement (as defined herein) is declared effective
by the Commission (as defined below). The VWAP will be determined without regard to after-hours trading or any other trading outside of
the regular trading session.
2. | Closing; Additional Closing. |
a. The
consummation of the sale of the Shares contemplated hereby (the “Subscription Closing”) is contingent upon the
substantially concurrent consummation of the Transaction (the “Transaction Closing”). The Subscription Closing
shall occur on the date of, and immediately prior to, the Transaction Closing, but after the Company’s de-registration as an
exempted company in the Cayman Islands and domestication into the State of Delaware pursuant to the applicable provisions of the
Cayman Islands Companies Act (As Revised) and the Delaware General Corporation Law, as amended (the
“Domestication”). Not less than five business days prior to the scheduled Transaction Closing Date, the Company
shall provide written notice to the Subscriber (the “Closing Notice”) (i) setting forth the scheduled
Transaction Closing Date, (ii) stating that the Company reasonably expects all conditions to the Transaction Closing to be
satisfied or waived, and (iii) including wire instructions for delivery of the Purchase Price to the Escrow Agent (as defined
below). Following delivery of the Closing Notice, and upon satisfaction or waiver of the conditions set forth in Section 2 and
Section 3 below, the Subscriber shall deliver to a third-party escrow agent to be identified in the Closing Notice (the
“Escrow Agent”), at least two business days prior to the Transaction Closing Date specified in the Closing
Notice, the Purchase Price, which shall be held in a segregated escrow account for the benefit of the Subscriber (the
“Escrow Account”) until the Subscription Closing pursuant to the terms of a customary escrow agreement, to be
entered into by the Company and the Escrow Agent (the “Escrow Agreement”), by wire transfer of United States
dollars in immediately available funds to the account specified by the Company in the Closing Notice. On the Transaction Closing
Date, the Company shall deliver to the Subscriber (i) the Shares in book-entry form, or, if required by the Subscriber,
certificated form, free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal
securities laws as set forth herein), in the name of the Subscriber (or its nominee in accordance with its delivery instructions) or
to a custodian designated by the Subscriber, as applicable, and (ii) a copy of the records of the Company’s transfer
agent showing the Subscriber (or such nominee or custodian) as the owner of the Shares on and as of the Transaction Closing Date.
Upon delivery of the Shares to the Subscriber (or its nominee or custodian, if applicable), the Purchase Price shall be released
from the Escrow Account automatically and without further action by the Company or the Subscriber.
Notwithstanding the foregoing in this Section 2, if
the Subscriber informs the Company (1) that it is an investment company registered under the Investment Company Act of 1940, as amended
(the “Investment Company Act”), (2) that it is advised by an investment adviser subject to regulation under the
Investment Advisers Act of 1940, as amended (the “Investment Advisers Act”), or (3) that its internal compliance
policies and procedures so require it, then, in lieu of the settlement procedures provided above, the following shall apply: the Subscriber
shall deliver as soon as practicable prior to the Transaction Closing on the Transaction Closing Date, following receipt of evidence from
the Company’s transfer agent of the issuance to the Subscriber of the Shares, on and as of the Transaction Closing Date, the Purchase
Price for the Shares by wire transfer of United States dollars in immediately available funds to an account of the Company as specified
by the Company in the Closing Notice against delivery by the Company to the Subscriber of the Shares in book entry form, or if required
by the Subscriber, certificated form, free and clear of any liens or other restrictions (other than those arising under state or federal
securities laws as set forth herein), in the name of the Subscriber (or its nominee in accordance with its delivery instructions) and
evidence from the Company’s transfer agent of the issuance to the Subscriber of the Shares on and as of the Transaction Closing
Date.
If the Transaction Closing does not occur within two
business days following the Subscription Closing, the Company shall promptly (but not later than two business days thereafter) cause
the Purchase Price to be returned to the Subscriber by wire transfer of U.S. dollars in immediately available funds to the account
specified by the Subscriber, and any book-entries or certificates representing the Shares shall be deemed repurchased and cancelled
(and, in the case of certificated shares, the Subscriber shall promptly return such certificates to the Company or, as directed by
the Company, to the Company’s representative or agent); provided that, unless this Subscription Agreement has been
terminated pursuant to Section 8 hereof, such return of funds shall not terminate this Subscription Agreement, and the
Subscriber shall remain obliged to (i) redeliver funds to the Escrow Agent or the Company, as applicable, in accordance with
this Section 2 following the Company’s delivery to the Subscriber of a new Closing Notice not less than two business days
prior to the new scheduled Transaction Closing Date and (ii) consummate the Subscription Closing immediately prior to or
substantially concurrently with the Transaction Closing.
If this Subscription Agreement terminates in accordance
with Section 8 hereof following the delivery by the Subscriber of the Purchase Price for the Shares, the Company shall promptly (but
not later than two business days after such termination) cause the Purchase Price to be returned to the Subscriber by wire transfer of
U.S. dollars in immediately available funds to the account specified by the Subscriber.
b. If
applicable, the issuance of the Additional Shares contemplated hereby (the “Additional Closing” and together with the
Subscription Closing, each, a “Closing”) shall occur on the fifth (5th) business day following the Measurement Date
(the “Additional Closing Date” and together with the date of the Subscription Closing, each, a “Closing Date”).
On the Additional Closing Date, the Company shall, upon satisfaction (or, if applicable, waiver) of the conditions set forth in Section 3,
issue the Additional Shares to Subscriber and shall deliver (i) the Additional Shares in book entry form or, if required by the Subscriber,
certificated form, free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities
laws as set forth herein), in the name of the Subscriber (or its nominee in accordance with its delivery instructions) or to a custodian
designated by the Subscriber, as applicable, and (ii) a copy of the records of the Company’s transfer agent showing the Subscriber
(or such nominee or custodian) as the owner of the Common Shares on and as of the Additional Closing Date.
a. The
obligations of the Company to consummate the transactions contemplated hereunder are subject to the conditions that, at the applicable
Closing Date:
| i. | all representations and warranties of the Subscriber contained in this Subscription Agreement shall be true and correct in all material
respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be
true and correct in all respects) at and as of such Closing Date as though made on such Closing Date (except for those representations
and warranties that speak as of a specific date, which shall be so true and correct in all material respects (other than representations
and warranties that are qualified as to materiality, which representations and warranties shall be true and correct in all respects) as
of such specified date) (collectively, the “Subscriber Bring-Down Condition”), and the Subscriber agrees that consummation
of the transactions contemplated hereunder on such Closing Date shall constitute a certification by the Subscriber to the Company that
the Subscriber Bring-Down Condition has been satisfied; and |
| ii. | the Subscriber shall have performed or complied in all material respects with all agreements and covenants required by this Subscription
Agreement to be performed or complied with by the Subscriber at or prior to such Closing Date. |
b. The
obligations of the Subscriber to consummate the transactions contemplated hereunder are subject to the conditions that, at the applicable
Closing Date:
| i. | all representations and warranties of the Company contained in this Subscription Agreement shall be true and correct in all material
respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein),
which representations and warranties shall be true and correct in all respects) at and as of such Closing Date as though made on such
Closing Date (except for those representations and warranties that speak as of a specific date, which shall be so true and correct in
all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect, which
representations and warranties shall be true and correct in all respects) as of such specified date) (collectively, the “Company
Bring-Down Condition”), and the Company agrees that consummation of the transactions contemplated hereunder on such Closing
Date shall constitute a certification by the Company to the Subscriber that the Company Bring- Down Condition has been satisfied; |
| ii. | the Company shall have performed or complied in all material respects with all agreements and covenants required by this Subscription
Agreement; |
| iii. | no amendment, modification or waiver of any provision of the Transaction Agreement (as defined below and as the same exists on the
date hereof) shall have occurred that reasonably would be expected to materially and adversely affect the economic benefits that the Subscriber
reasonably would expect to receive under this Subscription Agreement, without having received the Subscriber’s prior written consent,
which such prohibition, for the avoidance of doubt, shall not include the waiver of any minimum cash condition set forth in the Transaction
Agreement by the Company and/or Mobix; |
| iv. | no amendment, modification or waiver of one or more of the Other Subscription Agreements (including via a side letter or other agreement)
shall be executed that materially benefits one or more Other Subscribers unless the Subscriber has been offered the same benefits; and |
| v. | the Company shall have filed with the Nasdaq Stock Market LLC (“Nasdaq”), no later
than fifteen calendar days prior to the Transaction Closing Date, a listing of additional shares notification for the listing of the Shares,
in accordance with Nasdaq Listing rule 5250 (e)(2). |
c. The
obligations of each of the Company and the Subscriber to consummate the transactions contemplated hereunder are subject to the conditions
that, at the applicable Closing:
| i. | no governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or regulation
(whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated
hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby, and no governmental authority
shall have instituted or threatened in writing a proceeding seeking to impose any such restraint or prohibition; |
| ii. | all consents, waivers, authorizations or orders of, any notice required to be made to, and any filing or registration with, any court
or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the execution,
delivery and performance of this Subscription Agreement (including, without limitation, the issuance of the Shares) required to be made
in connection with the issuance and sale of the Shares shall have been obtained or made, except where the failure to so obtain or make
would not prevent the Company from consummating the transactions contemplated hereby, including the issuance and sale of the Shares; |
| iii. | in the case of the Subscription Closing, all conditions precedent to the Transaction Closing set forth in the Transaction Agreement
(as in effect on the date hereof), including the approval of the Company’s shareholders and regulatory approvals, if any, shall
have been satisfied or waived as determined by the parties to the Transaction Agreement (other than those conditions which, by their nature,
are to be satisfied by a party to the Transaction Agreement at the Transaction Closing, but subject to satisfaction or waiver by such
party of such conditions as of the Transaction Closing), and the Transaction Closing shall have been or will be scheduled to occur substantially
concurrently with the Subscription Closing; and |
| iv. | no suspension of the qualification of the Shares for offering or trading in any jurisdiction, or initiation or written threats of
any proceedings for any of such purposes, shall have occurred and be continuing. |
d. | The Subscriber agrees that upon the occurrence of each Closing, any condition to the Subscriber’s obligations to consummate
the transactions hereunder set forth in Sections 3(b) or 3(c) hereof that was not satisfied as of such Closing shall be deemed
to have been waived by the Subscriber; provided, however, that such waiver shall only be deemed to be given if and to the extent
the Subscriber has actual knowledge of the condition not being satisfied (with no obligation on the part of the Subscriber to make any
inquiry as to the satisfaction of any such condition). |
e. | Prior to or at each Closing Date, Subscriber shall deliver to the Company a duly completed and executed Internal Revenue Service Form W-9
or appropriate Form W-8. |
4. Further
Assurances. At each Closing Date, the parties hereto shall execute and deliver or cause to be executed and delivered such additional
documents and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the
subscription as contemplated by this Subscription Agreement.
5. Company
Representations and Warranties. For purposes of this Section 5, with respect to the Subscription Closing, the term “Company”
shall refer to the Company as of the date hereof and, for purposes of only the representations contained in paragraphs (h), (l), (p) and
(q) of this Section 5, the combined company after giving effect to the Transaction. For purposes of this Section 5, with
respect to any Additional Closing, the term “Company” shall refer to the combined company after giving effect to the Transaction,
as applicable. The Company represents and warrants to the Subscriber that:
a. The
Company has been duly incorporated and is validly existing and in good standing under the laws of the Cayman Islands, and, after
giving effect to the Domestication, the Company will be a corporation duly organized, validly existing and in good standing under
the laws of the State of Delaware. The Company has the corporate power and authority to own, lease and operate its properties and
conduct its business as presently conducted and to enter into, deliver and perform its obligations under this Subscription
Agreement. As of the date hereof, CLAY Merger Sub II, Inc., a Delaware corporation (the “Merger Sub”), is
the only subsidiary of the Company, which Merger Sub is expected to merge with and into Mobix, with Mobix surviving such merger.
Except for the Merger Sub (or, after the completion of the Transaction, Mobix), the Company does not directly or indirectly own any
equity or similar interest in, or any interest convertible into or exchangeable or exercisable for any equity or similar interest
in, any corporation, partnership, joint venture or business association or other person. There are no outstanding contractual
obligations of the Company to provide funds to, or to make any investment (in the form of a loan, capital contribution or otherwise)
in, any other person.
b. The
Shares have been duly authorized by the Company and, when issued and delivered to the Subscriber against full payment therefor in accordance
with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable, will be free and clear
of any liens or other restrictions whatsoever (other than those specified hereunder) and will not have been issued in violation of or
subject to any preemptive or similar rights created under the Company’s organizational documents (as in effect as of immediately
prior to the Transaction Closing) or under the applicable laws.
c. As
of the date hereof, the authorized share capital of the Company consists of (i) 200,000,000 ordinary shares, par value $0.0001,
and (ii) 1,000,000 preference shares, par value $0.0001 per share. As of the date hereof, (i) 2,953,033 ordinary shares,
par value $0.0001 per share, were issued and outstanding (including ordinary shares contained within the Company’s units), all
of which are validly issued, fully paid and non-assessable and not subject to any preemptive rights, (ii) no ordinary shares
are held in the treasury of the Company, and (iii) 9,400,000 ordinary shares are reserved for future issuance in respect of
exercise of the Company’s outstanding warrants at an exercise price of $11.50 per ordinary share. Except as described
in the SEC Documents (as defined herein), there are no outstanding contractual obligations of the Company to repurchase, redeem or
otherwise acquire any equity securities of the Company. There are no securities or instruments issued by or to which the Company is
a party containing anti-dilution or similar provisions that will be triggered by the issuance of (i) the Shares or the
Additional Shares pursuant to this Subscription Agreement or (ii) the shares to be issued pursuant to any Other Subscription
Agreement, except such anti-dilution rights as may be triggered pursuant to Section 4.3.2 or 4.8 of the Warrant Agreement,
dated July 19, 2021, by and between the Company and Continental Stock Transfer & Trust Company. Except pursuant to
this Subscription Agreement, the Other Subscription Agreements, the Transaction Agreement, securities that may be issued by the
Company pursuant to those certain unsecured convertible promissory notes (or any similar unsecured convertible promissory notes) in
the aggregate principal amount up to $1,500,000 issued by the Company in exchange for working capital loans from the Company’s
sponsor and other affiliates and as described in the SEC Documents (and, following the consummation of the Transaction, as set forth
in the Transaction Agreement and the schedules thereto), there are no outstanding options, warrants, or other rights to subscribe
for, purchase or acquire from the Company any ordinary shares or, after giving effect to the Domestication, the Common Shares or any
other equity interests in the Company, or securities convertible into or exchangeable or exercisable for any such equity interests.
There are no shareholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which
it is bound relating to the voting of any securities of the Company other than as set forth in the SEC Documents, and as
contemplated by the Transaction Agreement or described in the schedules thereto (as in effect on the date hereof).
d. The
Shares are not, and following the Transaction Closing and each Closing Date will not be, subject to any Transfer Restriction. The term
“Transfer Restriction” means any condition to or restriction on the ability of the Subscriber to pledge, sell, assign
or otherwise transfer the Shares under any organizational document, policy or agreement of, by or with the Company, but excluding the
restrictions on transfer described in paragraph 6(c) of this Subscription Agreement with respect to the status of the Shares as “restricted
securities” pending their registration for resale or transfer under the Securities Act in accordance with the terms of this Subscription
Agreement.
e. This
Subscription Agreement and the Transaction Agreement have been duly authorized, executed and delivered by the Company and, assuming the
due authorization, execution and delivery of the same by the Subscriber, are the legally binding obligations of the Company and are enforceable
in accordance with their respective terms, except as may be limited or otherwise affected by (i) bankruptcy, winding up, insolvency,
fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles
of equity, whether considered at law or equity.
f. The
execution, delivery and performance of the Subscription Agreement, the issuance and sale of the Shares and the compliance by the Company
with all of the provisions of this Subscription Agreement and the consummation of the transactions herein will not conflict with or result
in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition
of any lien, charge or encumbrance upon any of the property or assets of the Company or its subsidiary pursuant to the terms of (i) any
indenture, mortgage, deed of trust, loan or credit agreement, guarantee, note, bond, permit, lease, license or other agreement or instrument
to which the Company or its subsidiary is a party or by which the Company or its subsidiary is bound or to which any of the property or
assets of the Company is subject, which would, in any case, reasonably be expected, individually or in the aggregate, to have a material
adverse effect on the business, properties, financial condition, shareholders’ equity or results of operations of the Company and
its subsidiary, taken as a whole, and including the combined company after giving effect to the Transaction, or prevent, materially impair,
materially delay or materially impede the ability of the Company to enter into and timely perform its obligations under this Subscription
Agreement or the Transaction Agreement, or materially affect the validity of the Shares or the legal authority or ability of the Company
to comply in all material respects with the terms of this Subscription Agreement (a “Material Adverse Effect”); (ii) result
in any violation of the provisions of the organizational documents of the Company; or (iii) result in any violation of any statute
or any judgment, order, rule or regulation of any court or governmental agency, taxing authority or regulatory body, domestic or
foreign, having jurisdiction over the Company or any of its properties that would reasonably be expected to have a Material Adverse Effect.
g. Assuming
the accuracy of the representations and warranties of the Subscriber set forth in Section 6 of this Subscription Agreement, the
Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other
person in connection with the execution, delivery and performance of this Subscription Agreement (including, without limitation, the
issuance of the Shares), other than (i) filings with the Securities and Exchange Commission (the
“Commission”), (ii) filings required by applicable state securities laws, (iii) filings required by
Nasdaq, including with respect to obtaining shareholder approval, (iv) filings required to consummate the Transaction as
provided under the definitive documents relating to the Transaction, (v) the filing of a notification under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, if applicable, and (vi) where the failure of which to obtain would not
reasonably be expected to have a Material Adverse Effect or have a material adverse effect on the Company’s ability to
consummate the transactions contemplated hereby, including the issuance and sale of the Shares.
h. The
Company is in compliance with all applicable law, except where such non-compliance would not reasonably be expected to have a Material
Adverse Effect. The Company has not received any written communication from a governmental entity that alleges that the Company is not
in compliance with or is in default or violation of any applicable law, except where such non- compliance, default or violation would
not reasonably be expected to have a Material Adverse Effect.
i. As
of the date hereof, the issued and outstanding ordinary shares of the Company are registered pursuant to Section 12(b) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are listed for trading on Nasdaq under the symbol
“CLAY” (it being understood that the trading symbol will be changed in connection with the Transaction Closing). There is
no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company by Nasdaq or
the Commission, respectively, to prohibit or terminate the listing of the ordinary shares or, after giving effect to the Domestication,
the Common Shares on Nasdaq, suspend trading of such shares on Nasdaq or to deregister such shares under the Exchange Act. The Company
has taken no action that is designed to terminate or expected to result in the termination of the registration of such shares under the
Exchange Act. At each Closing Date and upon consummation of the Transaction, the issued and outstanding Common Shares of the Company,
including the Shares, will be registered pursuant to Section 12(b) of the Exchange Act, and the Shares shall have been approved
for listing on Nasdaq, subject to official notice of issuance.
j. Assuming
the accuracy of the Subscriber’s representations and warranties set forth in Section 6 of this Subscription Agreement, no registration
under the Securities Act is required for the offer and sale of the Shares by the Company to the Subscriber or to any Other Subscriber
pursuant to the Other Subscription Agreements. The Shares offered hereby and pursuant to each Other Subscription Agreement (i) were
not offered by any form of general solicitation or general advertising (within the meaning of Regulation D of the Securities Act) and
(ii) are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act,
or any state securities laws.
k. A
copy of each form, report, statement, schedule, prospectus, registration statement and other document, if any, filed by the Company
with the Commission since its initial registration of the ordinary shares under the Exchange Act (the “SEC
Documents”) is available to the Subscriber via the Commission’s EDGAR system, which SEC Documents, as of their
respective filing dates, complied in all material respects with the requirements of the Exchange Act applicable to the SEC Documents
and the rules and regulations of the Commission promulgated thereunder applicable to the SEC Documents. None of the SEC
Documents contained, when filed or, if amended, as of the date of such amendment with respect to those disclosures that are amended,
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided that with respect
to the information about the Company’s affiliates contained in the Registration Statement on Form S-4 and related proxy
statement (or other SEC document) to be filed by the Company in connection with the Transaction, the representation and warranty in
this sentence is made to the Company’s knowledge. The Company has timely filed (giving effect to permissible extensions in
accordance with Rule 12b-25 under the Exchange Act) each report, statement, schedule, prospectus, and registration statement
that the Company was required to file with the Commission since its initial registration of the ordinary shares under the Exchange
Act. The financial statements of the Company included in the SEC Documents comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing
and fairly present in all material respects the financial position of the Company as of and for the dates thereof and the results of
operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit
adjustments. As of the date hereof and upon the Transaction Closing Date, there are no material outstanding or unresolved comments
in comment letters from the Staff with respect to any of the SEC Documents.
l. Except
for such matters as have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect,
there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the
knowledge of the Company, threatened against the Company or (ii) judgment, decree, injunction, ruling or order of any governmental
entity or arbitrator outstanding against the Company.
m. Other
than the Other Subscription Agreements that the Company may enter into prior to the Subscription Closing, the Company has not entered
into and will not enter into any agreement or side letter with any Other Subscriber in connection with such Other Subscriber’s direct
or indirect investment in the Company in connection with the Subscription Closing, and such Other Subscription Agreements will not be
amended in any material respect following the date of this Subscription Agreement and will reflect the same Per Share Purchase Price and
terms that are not more favorable to such Other Subscriber thereunder than the terms of this Subscription Agreement. The Other Subscription
Agreements will not, without the prior written consent of the Subscriber, be amended in any material respect following the date of this
Subscription Agreement.
n. Neither
the Company, nor any person acting on its behalf has, directly or indirectly, made any offers or sales of any Company security or solicited
any offers to buy any Company security under circumstances that would adversely affect reliance by the Company on Section 4(a)(2) of
the Securities Act for the exemption from registration of the offer and sale of the Shares or would require registration of the issuance
of the Shares under the Securities Act.
o. Neither
the Company, nor any person acting on its behalf has entered into any agreement or arrangement entitling any agent, broker, investment
banker, financial advisor or other person to any broker’s or finder’s fee or any other commission or similar fee in connection
with the transactions contemplated by this Subscription Agreement for which the Subscriber could become liable. No person has been or
will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Shares.
p. The
Company is not, and immediately after receipt of payment for the Shares will not be, an “investment company” within the meaning
of the Investment Company Act.
q. The
Company is not in default or violation (and no event has occurred which, with notice or the lapse of time or both, would constitute
a default or violation) of any term, condition or provision of (i) the Company’s organizational documents,
(ii) any loan or credit agreement, note, bond, mortgage, indenture, lease or other agreement, permit, franchise or license to
which the Company is now a party or by which the Company’s properties or assets are bound or (iii) any statute or any
judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over
the Company or any of its properties, except, in the case of clauses (ii) and (iii), for defaults or violations that have not
had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect.
r. None
of the Company or any of its directors and officers is (i) a person or entity named on the List of Specially Designated Nationals
and Blocked Persons administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”)
or in any sanctions-related Executive Order issued by the President of the United States and administered by OFAC (collectively, the “OFAC
List”), or a person or entity prohibited by any OFAC sanctions program, or (ii) a non-U.S. shell bank or providing banking
services indirectly to a non-U.S. shell bank.
6. Subscriber
Representations and Warranties. The Subscriber represents and warrants to the Company that:
a. The
Subscriber is (i) a “qualified institutional buyer” (as defined under the Securities Act) or (ii) an “accredited
investor” (within the meaning of Rule 501(a) under the Securities Act), in each case, satisfying the requirements set
forth on Schedule A, and is acquiring Common Shares only for such Subscriber’s own account and not for the account of others, or
if the Subscriber is acquiring the Shares as a fiduciary or agent for one or more investor accounts, each owner of such account is a qualified
institutional buyer or accredited investor, and the Subscriber has full investment discretion with respect to each such account, and the
full power and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account,
and not on behalf of any other account or person or with a view to, or for offer or sale in connection with, any distribution thereof
in violation of the Securities Act (and shall provide the requested information on Schedule A following the signature page hereto).
b. The
Subscriber (i) is a sophisticated investor, experienced in investing in private equity transactions and capable of evaluating investment
risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities
and (ii) has exercised independent judgment in evaluating its participation in the purchase of the Shares.
c. The
Subscriber understands that the Shares (and any Additional Shares) are being offered in a transaction not involving any public offering
within the meaning of the Securities Act and that the Common Shares have not been registered under the Securities Act. The Subscriber
understands that the Shares (and any Additional Shares) may not be resold, transferred, pledged or otherwise disposed of by the Subscriber
absent an effective registration statement under the Securities Act except (i) to the Company or a subsidiary thereof, (ii) to
non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities
Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act (including, without
limitation, a private resale or transfer pursuant to the so-called “Section 4(a)(11/2)”
exemption), and in each of cases (i) and (iii) in accordance with any applicable securities laws of the states and other jurisdictions
of the United States, and that any certificates or book-entry positions representing the Shares (and any Additional Shares) shall contain
a legend to such effect. The Subscriber acknowledges that the Shares (and any Additional Shares) will not be immediately eligible for
resale or transfer pursuant to Rule 144 promulgated under the Securities Act, that Rule 144 will not be available until 12 months
following the closing and, as a result, the Subscriber may not be able to readily resell or transfer the Shares (and any Additional Shares)
and may be required to bear the financial risk of an investment in the Shares for an indefinite period of time. The Subscriber understands
that such Subscriber has been advised to consult legal counsel prior to making any offer, resale, pledge or transfer of any of the Shares
(and any Additional Shares).
d. The
Subscriber understands and agrees that the Subscriber is purchasing Common Shares directly from the Company. The Subscriber further acknowledges
that there have been no representations, warranties, covenants and agreements made to the Subscriber by the Company, its officers or directors,
or any other party to the Transaction or person or entity, expressly or by implication, other than those representations, warranties,
covenants and agreements included in this Subscription Agreement.
e. Either
(A) the Subscriber is not, and will not be acquiring or holding any Common Shares with the assets of, (i) an employee benefit
plan (described in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”)),
whether or not subject to ERISA, (ii) a plan described in Section 4975 of the Internal Revenue Code of 1986, as amended (the
“Code”) (including, without limitation, an individual retirement account) that is subject to Section 4975 of the
Code or to any other federal, state, local, non-U.S. or other law or regulation that is similar to the fiduciary responsibility or prohibited
transaction provisions of Title I of ERISA or Section 4975 of the Code (collectively, “Similar Laws”), (iii) a
plan, fund or other similar program that is established or maintained outside of the United States which provides for retirement income,
a deferral of income in contemplation of retirement or payments to be made upon termination of employment, or (iv) an entity whose
assets constitute the assets of any of the foregoing described in clauses (i), (ii) and (iii), pursuant to ERISA or otherwise or
(B) the Subscriber’s acquisition and holding of the Common Shares will not constitute or result in a non-exempt prohibited
transaction under Section 406 of ERISA or Section 4975 of the Code or a violation of any applicable Similar Law.
f. The
Subscriber acknowledges and agrees that the Subscriber has received and has had an adequate opportunity to review, such audited and unaudited
financial information of the Company and Mobix and such other information as the Subscriber deems necessary in order to make an investment
decision with respect to the Shares and made its own assessment and is satisfied concerning the relevant tax and other economic considerations
relevant to the Subscriber’s investment in the Shares. The Subscriber acknowledges that the financial information of Mobix supplied
to the Subscriber prior to the date hereof in respect of the fiscal year ended September 30, 2022 is unaudited and subject to change.
Without limiting the generality of the foregoing, the Subscriber acknowledges that such Subscriber has reviewed the risk factors provided
to the Subscriber by the Company. The Subscriber represents and agrees that the Subscriber and the Subscriber’s professional advisor(s),
if any, have had the opportunity to ask such questions, receive such answers and obtain such information as the Subscriber and such Subscriber’s
professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares.
g. The
Subscriber became aware of this offering of the Common Shares solely by means of direct contact between the Subscriber and the
Company or a representative of the Company, and the Common Shares were offered to the Subscriber solely by direct contact between
the Subscriber and the Company or a representative of the Company. The Subscriber did not become aware of this offering of the
Common Shares, nor were the Common Shares offered to the Subscriber, by any other means. The Subscriber acknowledges the
Company’s representation and warranty that the Common Shares (i) were not offered by any form of general solicitation or
general advertising and (ii) are not being offered to it in a manner involving a public offering under, or in a distribution in
violation of, the Securities Act, or any state securities laws.
h. The
Subscriber acknowledges that such Subscriber is aware that there are substantial risks incident to the purchase and ownership of the
Shares (and any Additional Shares). The Subscriber is able to fend for himself, herself or itself in the transactions completed
herein, has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of
an investment in the Shares and has the ability to bear the economic risks of such investment in the Shares and is able to sustain a
complete loss of such investment. The Subscriber has sought such accounting, legal and tax advice as the Subscriber has considered
necessary to make an informed investment decision.
i. Alone,
or together with any professional advisor(s), the Subscriber has analyzed and considered the risks of an investment in the Shares and
determined that the Shares are a suitable investment for the Subscriber and that the Subscriber is able at this time and in the foreseeable
future to bear the economic risk of a total loss of the Subscriber’s investment in the Company. The Subscriber acknowledges specifically
that a possibility of total loss exists.
j. In
making its decision to purchase the Shares, the Subscriber has relied solely upon independent investigation made by the Subscriber and
the representations, warranties and covenants contained herein. Subscriber acknowledges and agrees that Subscriber had access to, and
an adequate opportunity to review, financial and other information as Subscriber deems necessary in order to make an investment decision
with respect to the Shares.
k. The
Subscriber understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares
or made any findings or determination as to the fairness of this investment.
l. The
Subscriber is validly existing in good standing under the laws of its jurisdiction of incorporation or formation, with power and authority
to enter into and perform its obligations under this Subscription Agreement.
m. The
execution, delivery and performance by the Subscriber of this Subscription Agreement are within the powers of the Subscriber, have been
duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any
court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the Subscriber is
a party or by which the Subscriber is bound, and will not violate any provisions of the Subscriber’s charter documents, including,
without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be
applicable. The signature on this Subscription Agreement is genuine, and the signatory has been duly authorized to execute the same, and
assuming the due authorization, execution and delivery of the same by the Company, this Subscription Agreement constitutes a legal, valid
and binding obligation of the Subscriber, enforceable against the Subscriber in accordance with its terms, except as may be limited or
otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or
affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.
n. Neither
the due diligence investigation conducted by the Subscriber in connection with making its decision to acquire the Shares (and any Additional
Shares) nor any representations and warranties made by the Subscriber herein shall modify, amend or affect the Subscriber’s right
to rely on the truth, accuracy and completeness of the Company’s representations and warranties contained herein.
o. The
Subscriber, its affiliates, their agents, and any other persons acting on their behalf is not (i) a person or entity named on
the OFAC List, or a person or entity prohibited by any OFAC sanctions program, (ii) is not owned, controlled, or acting on
behalf of a person or entity prohibited by any OFAC sanctions program, (iii) located, operating, or resident in any country or
territory subject to comprehensive sanctions (currently, the Crimea, the so-called Donetsk People’s Republic, and the
so-called Luhansk People’s Republic regions of Ukraine, Cuba, Iran, North Korea and Syria), or (iv) a non-U.S. shell
bank or providing banking services indirectly to a non-U.S. shell bank. The Subscriber agrees to provide law enforcement agencies,
if requested thereby, such records as required by applicable law; provided that the Subscriber is permitted to do so under
applicable law. If the Subscriber is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.),
as amended by the USA PATRIOT Act of 2001, and its implementing regulations (collectively, the “BSA/PATRIOT
Act”), the Subscriber maintains policies and procedures reasonably designed to comply with applicable obligations under
the BSA/PATRIOT Act. To the extent required, the Subscriber maintains policies and procedures reasonably designed for the screening
of its investors against the OFAC sanctions programs, including the OFAC List. To the extent required, the Subscriber maintains
policies and procedures reasonably designed to ensure that the funds held by the Subscriber and used to purchase the Shares were
legally derived. To the extent applicable, the Subscriber further represents and warrants that the Subscriber: (x) has
conducted thorough due diligence with respect to all of its beneficial owners, (y) has established the identities of all
beneficial owners and the source of each of the beneficial owners’ funds and (z) will retain evidence of any such
identities, any such source of funds and any such due diligence. Pursuant to anti-money laundering laws and regulations, including
the BSA/Patriot Act, the Company may be required to collect documentation verifying the Subscriber’s identity and the source
of funds used to acquire an interest before, and from time to time after, acceptance by the Company of this Subscription Agreement.
The Subscriber further represents and warrants that the Subscriber does not know or have any reason to suspect that (I) the
monies used to fund the Subscriber’s investment herein have been or will be derived from or related to any illegal activities,
including but not limited to, money laundering activities, or (II) the proceeds from the Subscriber’s investment herein
will be used to finance any illegal activities.
p. | Subscriber will have sufficient funds to pay the Purchase Price at the Subscription Closing. |
q. Notwithstanding
the percentage of the outstanding Common Shares represented by the Shares and any Additional Shares, Subscriber agrees that it shall not
exercise voting rights relating to such Shares, any Additional Shares or other Common Shares representing a 10% or greater voting interest
in the Company on any matter subject to a vote of holders of Common Shares, and agrees that it shall not obtain or exercise, as a result
of its investment in the Company, (i) “Control,” as such term is defined at 31 C.F.R. 800.208, of the Company or its
subsidiaries, (ii) access to any “material non- public technical information” within the meaning of 31 C.F.R. §
800.232 in the Company and its subsidiaries’ possession, (iii) the right to appoint any board member or board observer to the
board of directors of the Company or its subsidiaries or (iv) any involvement in any “substantive decision- making” within
the meaning of 31 C.F.R. § 800.245 related to the Company or its subsidiaries.
a. The
Company agrees that, within forty-five (45) calendar days after the Transaction Closing (the “Filing Deadline”),
the Company will file with the Commission (at the Company’s sole cost and expense) a registration statement registering the
resale or transfer of the Shares (the “Initial Registration Statement”), and the Company shall use its
commercially reasonable efforts to have the Initial Registration Statement declared effective as soon as practicable after the
filing thereof, but no later than the earlier of, (i) if the Commission notifies the Company that it will “review”
the Initial Registration Statement, the ninetieth calendar day following the earlier of (A) the Filing Deadline and
(B) the initial filing date of the Initial Registration Statement, and (ii) the tenth business day after the date the
Company is notified (orally or in writing, whichever is earlier) by the Commission that the Initial Registration Statement will not
be “reviewed” or will not be subject to further review. If not included in the Initial Registration Statement, in the
event that any Additional Shares issued to Subscriber pursuant to the terms of this Subscription Agreement are not permitted by the
Commission to be registered on the Initial Registration Statement, the Company agrees that, within thirty (30) business days
following the Additional Closing Date (the “Additional Filing Deadline” and, together with the initial Filing
Deadline, each, a “Filing Deadline”), the Company will submit to or file with the Commission a registration
statement for a shelf registration on Form S-1 or Form S-3 (if the Company is then eligible to use a Form S-3 shelf
registration) (an “Additional Registration Statement” and, together with the Initial Registration Statement,
each, a “Registration Statement”), in each case, covering the resale of the Additional Shares acquired by the
Subscriber pursuant to this Subscription Agreement which are eligible for registration (determined as of two business days prior to
such submission or filing). The Company’s obligations to include the Shares or Additional Shares, as applicable, in a
Registration Statement are contingent upon the Subscriber furnishing in writing to the Company such information regarding the
Subscriber, the securities of the Company held by the Subscriber and the intended method of disposition of the Shares or Additional
Shares, as applicable as shall be reasonably requested in writing by the Company to effect the registration of the Shares or the
Additional Shares, and shall execute such documents in connection with such registration as the Company may reasonably request that
are customary of a selling stockholder in similar situations; provided, however, that the Subscriber shall not in
connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be subject to any contractual
restriction on the ability to transfer the Shares or Additional Shares, as applicable. With respect to the information to be
provided by the Subscriber pursuant to this Section 7, the Company shall request such information prior to the anticipated
initial filing date of a Registration Statement. The Company will provide a draft of a Registration Statement to the Subscriber for
review at least two (2) business days in advance of its anticipated initial filing date. Notwithstanding the foregoing, if the
Commission prevents the Company from including in a Registration Statement any or all of the Shares or Additional Shares due to
limitations on the use of Rule 415 of the Securities Act for the resale or transfer of the Shares by the applicable
stockholders or otherwise, the Registration Statement shall register for resale or transfer such number of Common Shares which is
equal to the maximum number of Shares (and Additional Shares, as applicable) as is permitted by the Commission. In such event, the
number of Shares (and Additional Shares, as applicable) to be registered for each selling stockholder named in the Registration
Statement shall be reduced pro rata among all such selling stockholders, and as promptly as practicable after being permitted to
register additional Shares (and Additional Shares, as applicable) under Rule 415 under the Securities Act, the Company shall
file a new Registration Statement to register such Shares not included in a filed Registration Statement and cause such Registration
Statement to become effective as promptly as practicable consistent with the terms of this Section 7. If the Commission
requests that the Subscriber be identified as a statutory underwriter in the Registration Statement, the Subscriber will have an
opportunity to withdraw from the Registration Statement. The Company will use its commercially reasonable efforts to maintain the
continuous effectiveness of any Registration Statement, or another shelf registration statement that includes the Shares (and
Additional Shares, as applicable) to be sold pursuant to this Subscription Agreement, until the earliest of (i) the date on
which all such Shares, and any Additional Shares, issued to Subscriber have actually been sold, (ii) the date which is three
years after the relevant Registration Statement filed hereunder is declared effective and (iii) the date on which the Shares
(and Additional Shares, as applicable) may be resold without volume or manner of sale limitations pursuant to Rule 144
promulgated under the Securities Act. For purposes of clarification, any failure by the Company to file any Registration Statement
by a Filing Deadline or to effect such Registration Statement by date of effectiveness shall not otherwise relieve the Company of
its obligations to file or cause the effectiveness of any Registration Statement set forth in this Section 7. For purposes of
this Section 7, “Shares” or “Additional Shares” shall mean, as of any date of determination, the Common
Shares acquired by the Subscriber pursuant to this Subscription Agreement and any other equity security issued or issuable with
respect to such Shares by way of stock split, dividend, distribution, recapitalization, merger, exchange, replacement or similar
event, and “Subscriber” shall include any affiliate of the Subscriber to which the rights under this Section 7 have
been duly assigned.
b. Notwithstanding
anything to the contrary in this Subscription Agreement, the Company shall be entitled to delay or postpone the effectiveness of any
Registration Statement, and from time to time to require the Subscriber not to sell under any Registration Statement or to suspend
the effectiveness thereof, if the filing, initial effectiveness or continued use of any Registration Statement at any time would
require the Company to make an Adverse Disclosure (as defined below) or would require the inclusion in such Registration Statement
of financial statements that are unavailable to the Company for reasons beyond the Company’s control (each, a
“Suspension Event”). In such case, the Company may, upon giving prompt written notice of such action to the
Subscriber, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of
time, but in no event more than two occasions or for more than ninety (90) consecutive days, or more than one hundred and fifty
(150) total calendar days, in each case during any twelve-month period, determined in good faith by the Company to be necessary for
such purpose. Upon receipt of any such written notice from the Company or upon written notice from the Company that any Registration
Statement or related prospectus contains a Misstatement (as defined below), the Subscriber agrees that (i) it will immediately
discontinue offers and sales of the Common Shares under such Registration Statement (excluding, for the avoidance of doubt, sales
conducted pursuant to Rule 144) until (A) the Subscriber receives copies of a supplemental or amended prospectus (it being
understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time
of such notice) that corrects the Misstatement referred to above and receives notice that any post-effective amendment has become
effective or (B) is otherwise notified by the Company that it may resume such offers and sales, and (ii) it will maintain
the confidentiality of any information included in such written notice delivered by the Company unless otherwise required by law or
subpoena. The Company shall immediately notify the Holders of the expiration of any period during which it exercised its rights
under this Section 7(b). Notwithstanding anything to the contrary, the Company shall cause its transfer agent to deliver
unlegended Common Shares to a transferee of the Subscriber in connection with any sale of Shares (and Additional Shares, as
applicable) with respect to which the Subscriber has entered into a contract for sale prior to Subscriber’s receipt of the
notice of a Suspension Event and which has not yet settled. If so directed by the Company, the Subscriber will deliver to the
Company or, in the Subscriber’s sole discretion destroy, all copies of the prospectus covering the Shares (and Additional
Shares, as applicable) in the Subscriber’s possession; provided, however, that this obligation to deliver or
destroy all copies of the prospectus covering the Shares (and any Additional Shares) shall not apply (i) to the extent the
Subscriber is required to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory, self-
regulatory or professional requirements or (b) in accordance with a bona fide pre-existing document retention policy or
(ii) to copies stored electronically on archival servers as a result of automatic data back-up. “Adverse
Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith
judgment of the Chief Executive Officer or principal financial officer of the Company or the Company’s board of directors,
after consultation with counsel to the Company, (x) would be required to be made in any Registration Statement or the related
prospectus in order for such Registration Statement or prospectus not to contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements contained therein, in the light of the circumstances under which they were
made, not misleading, (y) would not be required to be made at such time if any Registration Statement were not being filed,
declared effective or used, as the case may be, and (z) the Company has a bona fide business purpose for not making such
information public. “Misstatement” shall mean an untrue statement of a material fact or an omission to state a
material fact necessary in order to make the statements made in any Registration Statement or the related prospectus, in the light
of the circumstances under which they were made, not misleading.
c. In
the case of the registration, qualification, exemption or compliance effected by the Company pursuant to this Subscription
Agreement, the Company shall inform the Subscriber as to the status of such registration, qualification, exemption and compliance.
At its expense the Company shall:
| (i) | Advise the Subscriber as promptly as reasonably practicable: |
| A. | when any Registration Statement or any amendment thereto has been filed with the Commission and when such Registration Statement or
any post-effective amendment thereto has become effective; |
| B. | of any request by the Commission for amendments or supplements to any Registration Statement or the prospectus
included therein or for additional information; |
| C. | of the issuance by the Commission of any stop order suspending the effectiveness of any Registration Statement or the initiation of
any proceedings for such purpose; |
| D. | of the receipt by the Company of any notification with respect to the suspension of the qualification of the Shares (and Additional
Shares, as applicable) included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose;
and |
| E. | subject to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in
any Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state
a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of
the circumstances under which they were made) not misleading. |
Notwithstanding anything to the contrary set forth herein,
the Company shall not, when so advising the Subscriber of such events, provide the Subscriber with any material, nonpublic information
regarding the Company other than to the extent that providing notice to the Subscriber of the occurrence of the events listed in (A) through
(E) above constitutes material, nonpublic information regarding the Company and Subscriber is notified that such events are material,
nonpublic information at the time of notification;
| (ii) | use reasonable best efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement as soon
as reasonably practicable; |
| (iii) | upon the occurrence of any Suspension Event, except for such times as the Company is permitted hereunder to suspend, and has suspended,
the use of a prospectus forming part of any Registration Statement, the Company shall use its reasonable best efforts to as soon as reasonably
practicable prepare a post-effective amendment to such Registration Statement or a supplement to the related prospectus, or file any other
required document so that, as thereafter delivered to purchasers of the Shares (and Additional Shares, as applicable) included therein,
such prospectus will not include any untrue statement of a material fact or omit to state any material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading; and |
| (iv) | use its reasonable best efforts to cause all Shares (and any Additional Shares) to be listed on each securities
exchange or market, if any, on which the Common Shares issued by the Company have been listed. |
d. The
Company will use commercially reasonable efforts to file in a timely manner (giving effect to permissible extensions in accordance
with Rule 12b-25 under the Exchange Act) all reports and other documents under the Exchange Act necessary to enable the
Subscriber to resell the Shares (and Additional Shares, as applicable), pursuant to the Registration Statement. For as long as the
Subscriber holds Shares (and Additional Shares, as applicable), the Company will use commercially reasonable efforts to file in a
timely manner (giving effect to permissible extensions in accordance with Rule 12b-25 under the Exchange Act) all reports and
other documents under the Exchange Act necessary to enable the Subscriber to resell the Shares (and Additional Shares, as
applicable) pursuant to Rule 144. The Company shall, at its sole expense, upon appropriate notice from the Subscriber stating
that Shares (and Additional Shares, as applicable) have been sold or transferred pursuant to an effective Registration Statement or
Rule 144, timely prepare and deliver certificates or evidence of book-entry positions representing the Shares (and Additional
Shares, as applicable) to be delivered to a transferee pursuant to such Registration Statement, which certificates or book-entry
positions shall be free of any restrictive legends and in such denominations and registered in such names as the Subscriber may
request. Further, the Company, at its sole expense, and subject to applicable law, shall use commercially reasonable efforts to
cause its legal counsel to (a) issue to the transfer agent and maintain a “blanket” legal opinion instructing the
transfer agent that, in connection with a sale or transfer of “restricted securities” (i.e., securities issued
pursuant to an exemption from the registration requirements of Section 5 of the Securities Act), the resale or transfer of
which restricted securities has been registered pursuant to an effective Registration Statement by the holder thereof named in such
Registration Statement, upon receipt of an appropriate broker representation letter acceptable to the Company and its counsel and
other such documentation as the Company or the Company’s counsel deems necessary and appropriate and after confirming
compliance with relevant prospectus delivery requirements, is authorized to remove any applicable restrictive legend in connection
with such sale or transfer and (b) if the Shares (and any Additional Shares) are not registered pursuant to an effective
Registration Statement, issue to the transfer agent a legal opinion to facilitate the sale or transfer of such Common Shares and
removal of any restrictive legends pursuant to any exemption from the registration requirements of Section 5 of the Securities
Act that may be available to a requesting Subscriber; provided that in the case of a request to remove such restrictive
legends in connection with a sale or transfer of Shares (and Additional Shares, as applicable) pursuant to clause (a) or
(b) above, the Company shall use its commercially reasonable efforts to cause the Company’s transfer agent to remove any
such applicable restrictive legends in connection with such sale or transfer within five business days of such request. The Company
shall pay all transfer agent fees (including, without limitation, any fees required for same-day processing of any instruction
letter delivered by the Company and any exercise notice delivered by the Subscriber), stamp taxes and other taxes and duties levied
in connection with the delivery of any Shares (and Additional Shares, as applicable) to the Subscriber other than income and capital
gains taxes of the Subscriber that may be incurred in connection with the transactions contemplated hereby.
e. The
Subscriber may deliver written notice (an “Opt-Out Notice”) to the Company requesting that the Subscriber not receive
notices from the Company otherwise required by this Section 7; provided, however, that the Subscriber may later revoke
any such Opt-Out Notice in writing. Following receipt of an Opt-Out Notice from the Subscriber (unless subsequently revoked), (i) the
Company shall not deliver any such notices to the Subscriber and the Subscriber shall no longer be entitled to the rights associated with
any such notice and (ii) each time prior to the Subscriber’s intended use of an effective Registration Statement, the Subscriber
will notify the Company in writing at least five business days in advance of such intended use, and if a notice of a Suspension Event
was previously delivered (or would have been delivered but for the provisions of this Section 7(e)) and the related suspension period
remains in effect, the Company will so notify the Subscriber, within two business days of the Subscriber’s notification to the Company,
by delivering to the Subscriber a copy of such previous notice of Suspension Event, and thereafter will provide the Subscriber with the
related notice of the conclusion of such Suspension Event immediately upon its availability.
f. The
Company shall, notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless the Subscriber (if
the Subscriber is named as a selling shareholder under any Registration Statement), its officers, directors, employees, investment advisers
and agents, each person who controls the Subscriber (within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act) to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable costs of preparation and investigation and reasonable attorneys’ fees) and expenses
(collectively, “Losses”), as incurred, that arise out of or are based upon (i) any untrue or alleged untrue statement
of a material fact contained in any Registration Statement, any prospectus included in any Registration Statement or any form of prospectus
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission
to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or form
of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, or (ii) any violation
or alleged violation by the Company of the Securities Act, Exchange Act or any state securities law or any rule or regulation thereunder,
in connection with the performance of its obligations under this Section 7, except to the extent, but only to the extent, that such
untrue statements, alleged untrue statements, omissions or alleged omissions are based upon information regarding the Subscriber furnished
in writing to the Company by the Subscriber expressly for use therein or the Subscriber has omitted a material fact from such information;
provided, however, that the Company shall not be liable for any Losses to the extent they arise out of or are based upon
a violation which occurs (A) in reliance upon and in conformity with written information furnished by a Subscriber, (B) in connection
with any failure of such person to deliver or cause to be delivered a prospectus made available by the Company in a timely manner, to
the extent such person was required to deliver or caused to be delivered such prospectus under applicable law, (C) as a result of
offers or sales effected by or on behalf of any person by means of a free writing prospectus (as defined in Rule 405 of the Securities
Act) that was not authorized in writing by the Company, or (D) in connection with any offers, sales or transfers effected by or on
behalf of a Subscriber in violation of Section 7(d) hereof. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of an indemnified party and shall survive the transfer of the Shares (and Additional Shares,
as applicable) by the Subscriber.
g. The
Subscriber shall, severally and not jointly with any Other Subscriber, indemnify and hold harmless the Company, its directors, officers,
agents and employees, and each person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20
of the Exchange Act), to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising out of or are
based upon any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any prospectus included
in any Registration Statement, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus,
or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make
the statements therein (in the case of any prospectus, or any form of prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading to the extent, but only to the extent, that such untrue statements or omissions are based upon
information regarding the Subscriber furnished in writing to the Company by the Subscriber expressly for use therein. In no event shall
the liability of any Subscriber be greater in amount than the dollar amount of the net proceeds received by the Subscriber upon the sale
of the Shares (and Additional Shares, as applicable) giving rise to such indemnification obligation. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of an indemnified party and shall survive the transfer of the Shares
(and Additional Shares, as applicable) by the Subscriber.
h. Any
person entitled to indemnification pursuant to this Section 7 shall (1) give prompt written notice to the indemnifying party
of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any
person’s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (2) permit
such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense
is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its
consent (which consent shall not be unreasonably withheld, conditioned or delayed). An indemnifying party who elects not to assume the
defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying
party with respect to such claim, unless in the reasonable judgment of legal counsel to any indemnified party a conflict of interest exists
between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without
the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all
respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which
settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release
from all liability in respect to such claim or litigation.
i. If
the indemnification provided under this Section 7 from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any Losses, in lieu of indemnifying the indemnified party, the indemnifying party shall
contribute to the amount paid or payable by the indemnified party as a result of such Losses in such proportion as is appropriate to
reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other
things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged
omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party,
and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity
to correct or prevent such action. The amount paid or payable by a party as a result of the losses or other liabilities referred to
above shall be deemed to include, subject to the limitations set forth in this Section 7, any legal or other fees, charges or
expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant
to this Section 7 from any person who was not guilty of such fraudulent misrepresentation. Each indemnifying party’s
obligation to make a contribution pursuant to this Section 7(i) shall be individual, not joint and several, and in no
event shall the liability of the Subscriber hereunder be greater in amount than the dollar amount of the net proceeds received by
the Subscriber upon the sale of the Shares (and any Additional Shares) giving rise to such indemnification obligation.
8. Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (a) following
the execution of a definitive agreement among the Company, Merger Sub and Mobix with respect to the Transaction (together with the exhibits
and schedules thereto and ancillary agreements specifically referenced therein, the “Transaction Agreement”), such
date and time as such Transaction Agreement is terminated in accordance with its terms without the Transaction being consummated, (b) upon
the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, (c) if any of the conditions
to the Subscription Closing set forth in Section 3 of this Subscription Agreement are not satisfied or waived upon or prior to the
Subscription Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement are not consummated at the
Subscription Closing, or (d) at the election of the Subscriber, if the Transaction Closing shall not have occurred by the Outside
Date (as defined in the Transaction Agreement); provided that nothing herein will relieve any party from liability for any willful
breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses,
liabilities or damages arising from such breach. The Company shall promptly notify the Subscriber of the termination of the Transaction
Agreement after the termination of such agreement. For the avoidance of doubt, if any termination hereof occurs after the delivery by
the Subscriber of the Purchase Price for the Shares, the Company shall promptly (but not later than one business day thereafter) return
the Purchase Price to the Subscriber without any deduction for or on account of any tax, withholding, charges or set-off.
9. Trust
Account Waiver. The Subscriber acknowledges that the Company is a special purpose acquisition company with the powers and
privileges to effect a merger, asset acquisition, reorganization or similar business combination involving the Company and one or
more businesses or assets. The Subscriber further acknowledges that, as described in the Company’s prospectus relating to its
initial public offering dated July 19, 2021 and filed with the Commission on July 21, 2021 and available at www.sec.gov,
substantially all of the Company’s assets consist of the cash proceeds of the Company’s initial public offering and
private placements of its securities, and substantially all of those proceeds have been deposited in a trust account (the
“Trust Account”) for the benefit of the Company, its public shareholders and the underwriters of the
Company’s initial public offering, in their capacity as advisors pursuant to the Business Combination Marketing Agreement,
dated July 19, 2021, between the Company, Roth Capital Partners, LLC and Craig- Hallum Capital Group LLC. For and in
consideration of the Company entering into this Subscription Agreement, the receipt and sufficiency of which are hereby
acknowledged, the Subscriber hereby irrevocably waives any and all right, title and interest, or any claim of any kind it has or may
have in the future, in or to any monies held in the Trust Account, and agrees not to seek recourse against the Trust Account, in
each case, as a result of, or arising out of, this Subscription Agreement; provided that nothing in this Section 9 shall
be deemed to limit the Subscriber’s right, title, interest or claim to the Trust Account by virtue of the Subscriber’s
record or beneficial ownership of Common Shares of the Company acquired by any means other than pursuant to this Subscription
Agreement.
10. No
Short Sales. The Subscriber hereby agrees that, from the date of this Agreement until any Additional Closing, that it will not, nor
will any person acting at the Subscriber’s direction or pursuant to any understanding with the Subscriber (including the Subscriber’s
controlled affiliates), directly or indirectly, offer, sell, pledge, contract to sell, sell any option in, or engage in hedging activities
or execute any “short sales” (as defined in Rule 200 of Regulation SHO under the Exchange Act) with respect to, any shares
or any securities of the Company or any instrument exchangeable for or convertible into any shares or any securities of the Company until
the consummation of the Transaction (or such earlier termination of this Subscription Agreement in accordance with its terms). Notwithstanding
anything to the contrary contained herein, the restrictions in this Section 10 shall not apply to (i) any sale (including the
exercise of any redemption right) of securities of the Company (A) held by the Subscriber, its controlled affiliates or any person
or entity acting on behalf of the Subscriber or any of its controlled affiliates prior to the execution of this Subscription Agreement
or (B) purchased by the Subscriber, its controlled affiliates or any person or entity acting on behalf of the Subscriber or any of
its controlled affiliates in open market transactions after the execution of this Subscription Agreement, or (ii) ordinary course
hedging transactions so long as the sales or borrowings relating to such hedging transactions are not settled with the Shares and any
Additional Shares subscribed for hereunder and the number of securities sold in such transactions does not exceed the number of securities
owned or subscribed for at the time of such transactions. Notwithstanding the foregoing, (i) nothing herein shall prohibit any entities
under common management with the Subscriber that have no knowledge of this Subscription Agreement or of the Subscriber’s participation
in the transactions contemplated hereby (including the Subscriber’s affiliates) from entering into any short sales; (ii) in
the case that the Subscriber is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of the
Subscriber’s assets and the portfolio managers have no knowledge of the investment decisions made by the portfolio managers managing
other portions of the Subscriber’s assets, this Section 10 shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Shares (and Additional Shares, as applicable) covered by this
Subscription Agreement.
a. The
Company shall, no later than 9:00 a.m., New York City time, on the first business day immediately following the date of this
Subscription Agreement, issue one or more press releases or file with the Commission a Current Report on Form 8-K
(collectively, the “Disclosure Document”) disclosing all material terms of the transactions contemplated hereby,
the Transaction and any other material, nonpublic information that the Company, Mobix or any of their respective officers,
directors, employees or agents has provided to the Subscriber or any of the Subscriber’s affiliates, attorneys, agents or
representatives at any time prior to the filing of the Disclosure Document, except for any material, nonpublic information that is
the subject to a non-disclosure agreement between the Company, Mobix and Subscriber (such information, “Excluded
MNPI”). From and after the issuance of the Disclosure Document, the Subscriber and the Subscriber’s affiliates,
attorneys, agents or representatives shall not be in possession of any material, non-public information received from the Company,
Mobix or any of their respective officers, directors, employees or agents, except for Excluded MNPI, and the Subscriber shall no
longer be subject to any confidentiality or similar obligations under any current agreement, whether written or oral with the
Company, Mobix, or any of their respective affiliates, except for any agreement related to Excluded MNPI. Except with the express
written consent of the Subscriber and unless prior thereto, the Subscriber shall have executed a written agreement regarding the
confidentiality and use of such information, the Company shall not, and shall cause its officers, directors, employees and agents,
not to, provide Subscriber with any material, non-public information regarding the Company or the Transaction from and after the
filing of the Disclosure Document, other than to the extent that providing notice to the Subscriber of the occurrence of the events
listed in (A) through (E) of Section 7(c)(i) herewith constitutes material, nonpublic information regarding the
Company. Notwithstanding anything in this Subscription Agreement to the contrary, the Company shall not (and shall cause its
officers, directors, employees or agents not to), without the prior written consent of the Subscriber, publicly disclose the name of
the Subscriber, its investment adviser or any of their respective affiliates or advisers, or include the name of the Subscriber, its
investment adviser or any of their respective affiliates or advisers (i) in any press release, marketing materials, media or
similar circumstances or (ii) in any filing with the SEC or any regulatory agency or trading market, other than the
Registration Statement, the filing of this agreement with a Current Report on Form 8-K of the Company upon the public
announcement of the Transaction and any related description in such Form 8-K (if deemed necessary or advisable by counsel to
the Company) and except (A) as required by the federal securities law or pursuant to other routine proceedings of regulatory
authorities or (B) to the extent such disclosure is required by law, at the request of the staff of the SEC or regulatory
agency or under the regulations of any national securities exchange on which the Company’s securities are listed for trading, provided that
in the case of this clause (ii), the Company shall provide the Subscriber with prior written notice (including by e-mail) of such
permitted disclosure, and shall reasonably consult with the Subscriber regarding such disclosure.
b. Neither
this Subscription Agreement nor any rights that may accrue to the Subscriber hereunder (other than the Shares or Additional Shares acquired
hereunder, if any) may be transferred or assigned without the prior written consent of the other party hereto, except that this Subscription
Agreement and any of the Subscriber’s rights and obligations hereunder may be assigned to any limited partner or other investor
in the Subscriber or any fund or other account managed by the same investment manager as the Subscriber or by an affiliate (as defined
in Rule 12b-2 under the Exchange Act) of such investment manager without the prior consent of the Company; provided that the
Subscriber gives prior written notice to the Company, and such assignee or transferee agrees in writing to be bound by and subject to
the terms and conditions of this Subscription Agreement, makes the representations and warranties in Section 6 hereof and completes
Schedule A hereto.
c. The
Company may request from the Subscriber such additional information as the Company may deem necessary to evaluate the eligibility of the
Subscriber to acquire the Shares (and any Additional Shares), and the Subscriber promptly shall provide such information as may reasonably
be requested, to the extent readily available and to the extent consistent with its internal policies and procedures, provided that
the Company agrees to keep confidential any such information to the extent such information is not in the public domain, was not provided
lawfully to the Company by another source not under a duty of confidentiality and except to the extent disclosure of such information
by the Company is compelled by law, court order or a self-regulatory organization such as Nasdaq or The Financial Industry Regulatory
Authority (FINRA) or required to be included in the Registration Statement, in which case, the Company shall provide the Subscriber with
prior written notice of any disclosure of such information if reasonably practicable and legally permitted.
d. The
Subscriber acknowledges that the Company may rely on the acknowledgments, understandings, agreements, representations and warranties
of the Subscriber contained in this Subscription Agreement. The Company acknowledges that the Subscriber will rely on the
acknowledgements, understandings, agreements, representations and warranties of the Company contained in this Subscription
Agreement. Prior to any Additional Closing, each party hereto agrees to promptly notify the other party if any of their respective
acknowledgments, understandings, agreements, representations and warranties set forth in Section 5 or Section 6, as
applicable, above are no longer accurate in any material respect (other than those acknowledgments, understandings, agreements,
representations and warranties qualified by materiality, in which case such party shall notify the other party if they are no longer
accurate in any respect).
e. The
Company and the Subscriber are entitled to rely upon this Subscription Agreement, and each of the Company and the Subscriber is irrevocably
authorized to produce this Subscription Agreement or a copy hereof when required by law, governmental authority or self-regulatory organization
to do so in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.
f. All
of the agreements, representations and warranties made by each party to this Subscription Agreement shall survive the Subscription Closing.
g. This
Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 8 hereof) except by
an instrument in writing, signed by the party against whom enforcement of such modification, waiver, or termination is sought; provided
that any rights (but not obligations) of a party under this Subscription Agreement may be waived, in whole or in part, by such party
on its own behalf without the prior consent of any other party. No failure or delay of any party in exercising any right or remedy hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance
of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any
other right or power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies
that they would otherwise have hereunder.
h. This
Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and
warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as otherwise expressly set forth
in Section 7 and in subsection (b) of this Section 11, this Subscription Agreement shall not confer any rights or remedies
upon any person other than the parties hereto, and their respective successor and assigns.
i. Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their
heirs, executors, administrators, successors, legal representatives and permitted assigns, and the agreements, representations, warranties,
covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators,
successors, legal representatives and permitted assigns.
j. If
any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the
remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force
and effect.
k. This
Subscription Agreement may be executed in one or more counterparts (including by electronic signature or email of a .pdf) and by
different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All
counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement.
l. The
parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were not
performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled
to an injunction or injunctions to prevent breaches of this Subscription Agreement and to enforce specifically the terms and provisions
of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in contract,
in tort or otherwise.
m. Any
notice, request, claim, demand, waiver, consent, approval or other communication which is required or permitted hereunder shall be in
writing and shall be deemed given (a) when delivered by hand (with written confirmation of receipt), (b) when received by the
addressee if sent by a nationally recognized overnight courier postage prepaid (receipt requested), (c) on the date sent by email
(with no “bounceback” or notice of non-delivery), or (d) on the third business day after the date mailed, by certified
or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the following
addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 11(m)):
| i. | if to the Subscriber, to such address or addresses set forth on the Subscriber’s signature page hereto; |
| ii. | if to the Company prior to the Transaction Closing, to: |
Chavant Capital Acquisition
Corp.
445 Park Avenue, 9th Floor
New York, NY 10022
Attention:
Jiong Ma
Email:
jma@chavantcapital.com
With a required copy to (which shall not constitute notice):
Simpson Thacher &
Bartlett LLP
425 Lexington Avenue
New York, NY 10017
Attention: John C. Ericson;
Mark Brod
Email:
jericson@stblaw.com; mbrod@stblaw.com
iii. If
to Mobix prior to the Transaction Closing, to:
Mobix
Labs, Inc.
15420 Laguna Canyon Rd., suite
100
Irvine, CA 92618
Attention:
Keyvan Samini
Email:
legal@mobixlabs.com
With a required copy to (which
shall not constitute notice):
Greenberg Traurig, LLP
One Vanderbilt Avenue
New York,
New York 10022
Attention: Alan I. Annex; Kevin
Friedmann; Laurie Green
Email:
Annexa@gtlaw.com; FriedmannK@gtlaw.com; GreenL@gtlaw.com
iv. If
to the Company after the Transaction Closing, to:
Mobix
Labs, Inc.
15420 Laguna Canyon Rd., suite
100
Irvine, CA 92618
Attention:
Keyvan Samini
Email:
legal@mobixlabs.com
With a required copy to (which shall not constitute notice):
Greenberg Traurig, LLP
One Vanderbilt Avenue
New York, New York 10022
Attention: Alan I. Annex; Kevin
Friedmann; Laurie Green
Email:
Annexa@gtlaw.com; FriedmannK@gtlaw.com; GreenL@gtlaw.com
n. THIS
SUBSCRIPTION AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD TO THE
PRINCIPLES OF CONFLICTS OF LAWS THAT WOULD OTHERWISE REQUIRE THE APPLICATION OF THE LAW OF ANY OTHER STATE.
SOLELY IN RESPECT OF THE INTERPRETATION AND
ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT AND THE DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN
RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE COURT OF
CHANCERY OF THE STATE OF DELAWARE; PROVIDED THAT IF JURISDICTION IS NOT THEN AVAILABLE IN THE COURT OF CHANCERY OF THE STATE
OF DELAWARE, THEN ANY ACTION, SUIT OR PROCEEDING HEREUNDER MAY BE BROUGHT IN ANY FEDERAL COURT LOCATED IN THE STATE OF DELAWARE
OR ANY OTHER DELAWARE STATE COURT. THE PARTIES HERETO HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR
PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT SUCH PARTY IS NOT SUBJECT TO SUCH JURISDICTION OR THAT
SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE
APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES
HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A
DELAWARE STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES
AND OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT
OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 11(m) OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW SHALL BE
VALID AND SUFFICIENT SERVICE THEREOF.
EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY
WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT
ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY
IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER
PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING
WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE
FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER THINGS,
THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 11(n).
12. Separate
Obligations. For the avoidance of doubt, all obligations of the Subscriber hereunder are separate and several from the
obligations of any Other Subscriber. The decision of the Subscriber to purchase the Shares pursuant to this Subscription Agreement
has been made by Subscriber independently of any Other Subscriber or any other investor and independently of any information,
materials, statements or opinions as to the business, financial condition or results of operations of the Company, Mobix, or any of
their respective subsidiaries which may have been made or given by any Other Subscriber or by any agent or employee of any Other
Subscriber, and neither the Subscriber nor any of its agents or employees shall have any liability to any Other Subscriber (or any
other person) relating to or arising from any such information, materials, statements or opinions. Nothing contained herein or in
any Other Subscription Agreement, and no action taken by the Subscriber or Other Subscribers pursuant hereto or thereto, shall be
deemed to constitute the Subscriber and Other Subscriber as a partnership, an association, a joint venture or any other kind of
entity, or create a presumption that the Subscriber and the Other Subscribers are in any way acting in concert or as a group with
respect to such obligations or the transactions contemplated by this Subscription Agreement and the Other Subscription Agreements.
The Subscriber acknowledges that no Other Subscriber has acted as agent for the Subscriber in connection with making its investment
hereunder and no Other Subscriber will be acting as agent of the Subscriber in connection with monitoring its investment in the
Shares or enforcing its rights under this Subscription Agreement. The Subscriber shall be entitled to independently protect and
enforce its rights, including, without limitation, the rights arising out of this Subscription Agreement, and it shall not be
necessary for any Other Subscriber to be joined as an additional party in any proceeding for such purpose.
[SIGNATURE PAGES FOLLOW]
IN
WITNESS WHEREOF, the Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized representative
as of the date set forth below.
Name of Subscriber:
[●] |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
Name in which shares are to be registered
(if different): |
Date: |
|
|
Subscriber’s TIN: |
|
|
|
Business Address-Street: |
Mailing Address-Street (if different): |
|
|
|
City, State, Zip: |
|
|
Attn: |
Attn: |
|
|
Telephone No.: |
Telephone No.: |
|
|
Email Address: |
Email Address: |
|
|
Number of Shares subscribed for: |
|
|
|
Aggregate Subscription Amount: $ |
Price Per Share: $ |
The above Subscriber agrees that it shall pay the Purchase Price by
wire transfer of United States dollars in immediately available funds to the account specified by the Company in the Closing Notice and
in accordance with the terms of the Subscription Agreement.
[Signature Page to Subscription Agreement]
IN
WITNESS WHEREOF, Chavant Capital Acquisition Corp. has accepted this Subscription Agreement as of the date set forth below.
|
CHAVANT CAPITAL ACQUISITION CORP. |
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
Date:
|
MOBIX LABS, INC. |
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
Date:
[Signature Page to Subscription Agreement]
Execution Copy
SCHEDULE A
ELIGIBILITY REPRESENTATIONS OF THE SUBSCRIBER
A. |
QUALIFIED INSTITUTIONAL BUYER STATUS |
(Please check the applicable subparagraphs):
|
1. |
¨ We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (a “QIB”)). |
|
2. |
¨ We are subscribing for the Shares as a fiduciary or agent for one or more investor accounts, and each owner of such account is a QIB. |
B. |
ACCREDITED INVESTOR STATUS |
(Please check the applicable subparagraphs):
|
1. |
¨ We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the appropriate box on the following pages indicating the provision under which we qualify as an “accredited investor.” |
|
|
|
|
2. |
¨ We are not a natural person. |
(Please check the applicable box)
THE SUBSCRIBER:
an “affiliate” (as defined in Rule 144 under the Securities
Act) of the Company or acting on behalf of an affiliate of the Company.
This page and the following pages on Schedule A should
be completed by the Subscriber and constitutes a part of the Subscription Agreement.
Rule 501(a), in relevant part, states that an “accredited
investor” shall mean any person who comes within any of the below listed categories, or who the Company reasonably believes comes
within any of the below listed categories, at the time of the sale of the Shares to that person. Subscriber has indicated, by marking
and initialing the appropriate box below, the provision(s) below which apply to Subscriber and under which Subscriber accordingly
qualifies as an “accredited investor.”
¨ Any bank, as defined in Section 3(a)(2) of the Securities
Act or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act, whether
acting in an individual or a fiduciary capacity;
¨ Any broker or dealer registered under Section 15 of the
Exchange Act;
¨ Any investment adviser registered pursuant to Section 203
of the Investment Advisers Act of 1940 or registered pursuant to the laws of a state;
¨ Any investment adviser relying on the exemption from registering
with the Commission under Section 203(l) or (m) of the Investment Advisers Act of 1940;
¨ Any insurance company, as defined in Section 2(a)(13) of
the Securities Act;
¨ Any investment company registered under the Investment Company
Act of 1940 or a business development company, as defined in Section 2(a)(48) of that act;
¨ Any small Business Investment Company licensed by the U.S. Small
Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958;
¨ Any Rural Business Investment Company as defined in Section 384A
of the Consolidated Farm and Rural Development Act;
¨ Any plan established and maintained by a state, its political
subdivisions or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if the plan has
total assets in excess of $5 million;
¨ Any employee benefit plan within the meaning of Title I of the
Employee Retirement Income Security Act of 1974, if the investment decision is being made by a plan fiduciary, as defined in Section 3(21)
of such act, and the plan fiduciary is either a bank, a savings and loan association, an insurance company, or a registered investment
adviser, or if the employee benefit plan has total assets in excess of $5 million, or if the employee benefit plan is a self-directed
plan in which investment decisions are made solely by persons that are accredited investors;
¨ Any private business development company, as defined in Section 202(a)(22)
of the Investment Advisers Act of 1940;
¨ Any corporation, Massachusetts or similar business trust, partnership,
or limited liability company or an organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended,
that was not formed for the specific purpose of acquiring the Shares, and that has total assets in excess of $5 million;
¨ Any trust with total assets in excess of $5 million not formed
for the specific purpose of acquiring the Shares, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) under
the Securities Act;
¨ Any entity in which all of the equity owners (whether entities
themselves or natural persons) are accredited investors and meet the criteria listed herein;
¨ Any entity of a type not listed above, that is not formed for
the specific purpose of acquiring the Shares and owns investments in excess of $5 million. For purposes of this test, “investments”
means investments as defined in Rule 2a51-1(b) under the Investment Company Act of 1940;
¨ Any family office, as defined in Rule 202(a)(11)(G)-1 under
the Investment Advisers Act of 1940, that (i) has assets under management in excess of $5 million; (ii) is not formed for the
specific purpose of acquiring the Shares and (iii) has a person directing the prospective investment who has such knowledge and experience
in financial and business matters so that the family office is capable of evaluating the merits and risks of the prospective investment;
¨ Any family client, as defined in Rule 202(a)(11)(G)-1 under
the Investment Advisers Act of 1940, of a family office meeting the requirements of the test immediately above and whose prospective investment
in the issuer is directed by that family office pursuant to clause (iii) immediately above;
¨ Any natural person whose individual net worth, or joint net worth
with my spouse or spousal equivalent, exceeds $1,000,000;1
¨ Any natural person who had individual income exceeding $200,000
in each of the last two calendar years and has a reasonable expectation of reaching the same income level in the current calendar year;2
¨ Any natural person who had joint income with spouse or spousal
equivalent exceeding $300,000 in each of the last two calendar years and has a reasonable expectation of reaching the same income level
in the current calendar year, as defined above;
¨ Any director, executive officer, or general partner of the issuer
of the Shares or sold, or any director, executive officer, or general partner of a general partner of that issuer; or
¨ Any natural person who holds in good standing one or more professional
certifications or designations or credentials from an accredited educational institution that the Commission has designated as qualifying
an individual for accredited investor status.3
1
For purposes of this test, “net worth” means the excess of total assets at fair market value (including personal and real
property, but excluding the estimated fair market value of a person’s primary home) over total liabilities. “Total liabilities”
excludes any mortgage on the primary home in an amount of up to the home's estimated fair market value as long as the mortgage was incurred
more than 60 days before the Shares are purchased, but includes (i) any mortgage amount in excess of the home’s fair market
value and (ii) any mortgage amount that was borrowed during the 60-day period before the closing date for the sale of Shares for
the purpose of investing in the Shares. “Spousal equivalent” means a cohabitant occupying a relationship generally equivalent
to that of a spouse. “Joint net worth” can be the aggregate net worth of a person and spouse or spousal equivalent; assets
do not need to be held jointly to be included in the calculation.
2
For purposes of this test, “income” means adjusted gross income, as reported for federal income tax purposes,
increased by the following amounts: (a) the amount of any tax exempt interest income received, (b) the amount of losses claimed
as a limited partner in a limited partnership, (c) any deduction claimed for depletion under Section 611 et seq. of the Internal
Revenue Code, (d) amounts contributed to an IRA or Keogh retirement plan, (e) alimony paid, and (f) any amounts by which
income from long-term capital gains has been reduced in arriving at adjusted gross income pursuant to the provisions of Section 1202
of the Internal Revenue Code.
3
In determining whether to designate a professional certification or designation or credential from an accredited educational
institution for purposes hereof, the Commission will consider, among others, the following attributes: (a) the certification, designation,
or credential arises out of an examination or series of examinations administered by a self-regulatory organization or other industry
body or is issued by an accredited educational institution; (b) the examination or series of examinations is designed to reliably
and validly demonstrate an individual’s comprehension and sophistication in the areas of securities and investing; (c) persons
obtaining such certification, designation, or credential can reasonably be expected to have sufficient knowledge and experience in financial
and business matters to evaluate the merits and risks of a prospective investment; and (d) an indication that an individual holds
the certification or designation is either made publicly available by the relevant self-regulatory organization or other industry body
or is otherwise independently verifiable. As of the date hereof, the Commission has designated three certifications and designations administered
by the Financial Industry Regulatory Authority, Inc. as qualifying for accredited investor status: (i) Licensed General Securities
Representative (Series 7); (ii) Licensed Investment Adviser Representative (Series 65); and (iii) Licensed Private
Securities Offerings Representative (Series 82).
Exhibit 10.5
Execution Version
NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED
THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATIONS ARE NOT REQUIRED;
(Ill) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES; OR (IV) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION
7 OF THIS WARRANT.
FORM OF
WARRANT TO PURCHASE SHARES
OF COMMON STOCK
The Warrant is
issued concurrently with the Written Consent (as defined below), and certifies that, for value received, [●], and its permitted
assignees (the “Holder”), is entitled to purchase 100,000 shares (as may be adjusted pursuant to Section 4
hereof, the “Shares”) of common stock, $0.00001 par value per share (the “Stock”), of MOBIX LABS, INC.,
a Delaware company, (the “Company”), at an exercise price of $0.01 per share (such price and such other price as shall
result, from time to time, from the adjustments specified in Section 4 hereof is herein referred to as the “Warrant
Price”), subject to the provisions and upon the terms and conditions hereinafter set forth. This Warrant shall be effective
upon (i) execution and delivery of the funds set forth the Subscription Agreement (“PIPE Subscription Agreement) concurrently
entered into by and between Holder, the Company, and Chavant Capital Acquisition Corp. (“Chavant”), and (ii) the closing
of the Business Combination Agreement, whereby the Company becomes a public listed company on the Nasdaq Global Market.
1. Term.
This Warrant shall terminate upon the earlier to occur of (i) the closing of the proposed business combination contemplated by the
Business Combination Agreement and (ii) the termination of the Business Combination Agreement (the “Termination Date”).
2. Method of Exercise: Payment.
a. Subject
to Section 1 hereof, and contingent upon the substantially concurrent occurrence of the Subscription Closing (as defined in
the PIPE Subscription Agreement), the purchase right represented by this Warrant shall be exercisable by the Holder hereof immediately
prior to the Closing (as such term is defined in the Business Combination Agreement), in whole or in part, by the surrender of this Warrant
(with the notice of exercise form attached hereto as EXHIBIT A duly executed (the “Notice of Exercise”)
at the principal office of the Company and by the payment to the Company by check or wire transfer to an account designated by the Company
of an amount equal to the then applicable Warrant Price multiplied by the number of Shares then being purchased. For the avoidance of
doubt, to the extent not previously exercised, contingent upon the substantially concurrent occurrence of the Subscription Closing (as
defined in the PIPE Subscription Agreement), this Warrant shall automatically convert into the right to receive Class A common shares
of the SPAC (the “SPAC Shares”) pursuant to the merger in accordance with the terms of the Business Combination Agreement.
The person in whose name any certificate representing shares of Stock shall be issuable upon exercise of this Warrant shall be deemed
to have become the holder of record of, and shall be treated for all purposes as the record holder of, the shares represented thereby
(and such shares shall be deemed to have been issued) immediately prior to the close of business on the date or dates upon which this
Warrant is exercised. In the event of any exercise of the rights represented by this Warrant, certificates for the shares of Stock so
purchased shall be delivered to the Holder hereof as soon as reasonably practicable after such exercise; provided, that, as long as the
Company is legally permitted to reflect share issuances in book entry or dematerialized form, the Company may deliver an electronic representation
or other evidence of the valid issuance of the Shares as to which this Warrant has been exercised. Unless this Warrant has been fully
exercised or expired, a new Warrant representing the portion of the Shares, if any, with respect to which this Warrant shall not then
have been exercised shall also be issued to the Holder hereof as soon as practicable.
b. This
Warrant may be exercised for less than the full number of shares of Stock first shown above, provided that this Warrant may not be exercised
in part for less than a whole number of shares of Stock. Upon any such partial exercise, the Company at its expense will forthwith issue
to the Holder a new Warrant or Warrants of like tenor exercisable for the number of shares of Stock as to which rights have not been exercised
(subject to adjustment as herein provided).
3. Stock
Fully Paid: Reservation of Shares. All Shares that may be issued upon the exercise of the rights represented by this Warrant will,
upon issuance pursuant to the terms and conditions herein, be fully paid and nonassessable, and free from all preemptive or similar rights,
taxes, liens, and charges with respect to the issue thereof. During the period within which the rights represented by this Warrant may
be exercised, the Company will at all times have authorized, and reserved for the purpose of the issue upon exercise of the purchase rights
evidenced by this Warrant such number of its duly authorized shares of Stock as from time to time shall be issuable upon the exercise
of this Warrant and other similar Warrants.
4. Adjustment
of Warrant Price and Number of Shares. If the Company subdivides the outstanding shares of the class of Stock by reclassification
or otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant
Price shall be proportionately decreased. If the outstanding shares of the class of Stock are combined or consolidated, by reclassification
or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately
decreased. Each adjustment in the number of Shares issuable will be to the nearest whole share and each adjustment of the Warrant Price
will be calculated to the nearest cent.
5. Notice
of Adjustments. Whenever the Warrant Price or the number of Shares purchasable hereunder shall be adjusted pursuant to Section 4
hereof, the Company shall prepare a notice setting forth, in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, the Warrant Price, and the number of Shares purchasable hereunder after
giving effect to such adjustment, and promptly deliver the notice to the Holder.
6. Fractional
Shares. No fractional shares of Stock will be issued in connection with any exercise hereunder, but in lieu of such fractional shares,
the Company shall make a cash payment therefor based on the fair market value of the Stock on the date of exercise as reasonably determined
in good faith by the Company’s board of directors.
7. Compliance
with Securities Act and Other Laws: Disposition of Warrant or Shares.
a. Compliance
with Securities Act. The Holder, by acceptance hereof, agrees that this Warrant, and the shares of Stock to be issued upon exercise
hereof are being acquired for investment and that such Holder will not offer, sell or otherwise dispose of this Warrant, or any shares
of Stock to be issued upon exercise hereof, except under circumstances that will not result in a violation of the Securities Act of 1933,
as amended (the “Act”). Upon exercise of this Warrant, unless the Shares being acquired are registered under the Act
or an exemption from such registration is available, the Holder hereof shall confirm in writing that the shares of Stock so purchased
are being acquired for investment and not with a view toward distribution or resale. This Warrant and all shares of Stock issued upon
exercise of this Warrant (unless registered under the Act) shall be stamped, imprinted, or otherwise notated with a legend in substantially
the following form:
“THE SECURITIES EVIDENCED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE
EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATIONS ARE NOT REQUIRED; (III) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL
AUTHORITIES; OR (IV) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED,
DIRECTLY OR INDIRECTLY.”
In addition, in connection with the issuance of this Warrant,
the Holder specifically represents to the Company by acceptance of this Warrant that:
i. The
Holder is aware of the Company’s business affairs and financial condition, and has acquired information about the Company sufficient
to reach an informed and knowledgeable decision to acquire this Warrant. The Holder is acquiring this Warrant for its own account for
investment purposes only and not with a view to, or for the resale in connection with, any “distribution” thereof for purposes
of the Act.
ii. The
Holder understands that this Warrant and any securities issuable upon the exercise hereof have not been registered under the Act in reliance
upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment
intent as expressed herein. In this connection, the Holder understands that, in the view of the Securities and Exchange Commission (the
“SEC”), the statutory basis for such exemption may be unavailable if the Holder’s representation was predicated
solely upon a present intention to hold the Warrant for the minimum capital gains period specified under tax statutes, for a deferred
sale, for or until an increase or decrease in the market price of the Warrant, or for a period of one (1) year or any other fixed
period in the future.
iii. The
Holder further understands that this Warrant and any securities issuable upon the exercise hereof must be held indefinitely unless subsequently
registered under the Act and any applicable state securities laws, or unless exemptions from registration are otherwise available.
iv. The
Holder is aware of the provisions of Rule 144, promulgated under the Act, which, in substance, permit limited public resale of “restricted
securities” acquired, directly or indirectly, from the issuer thereof (or from an affiliate of such issuer), in a non-public offering
subject to the satisfaction of certain conditions, if applicable, including, among other things: (i) the availability of certain
public information about the Company, the resale occurring not less than one (1) year after the party has purchased and paid for
the securities to be sold; (ii) the sale being made through a broker in an unsolicited “broker’s transaction” or
in transactions directly with a market maker (as said term is defined under the Securities Exchange Act of 1934, as amended); and (iii) the
amount of securities being sold during any three (3) month period not exceeding the specified limitations stated therein.
v. The
Holder further understands that at the time it wishes to sell this Warrant and any securities issuable upon the exercise hereof there
may be no public market upon which to make such a sale, and that, even if such a public market then exists, the Company may not be satisfying
the current public information requirements of Rule 144,
and that, in such event, the Holder may be precluded from selling this Warrant and any securities issuable upon the exercise hereof under
Rule 144 even if the one (1) year
minimum holding period had been satisfied.
vi. The
Holder further understands that in the event all of the requirements of Rule 144
are not satisfied, registration under the Act, compliance with Regulation A, or some other registration exemption will be required; and
that, notwithstanding the fact that Rule 144 is not exclusive, the
staff of the SEC has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering
and otherwise than pursuant to Rule 144 will have a substantial burden
of proof in establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective
brokers who participate in such transactions do so at their own risk.
vii. The
Holder is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the Act.
viii. At
no time was Holder presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of
general advertising or solicitation in connection with the offer, sale and purchase of the Warrant and any securities issuable upon the
exercise hereof.
b. Certain
Limitations on Voting, Access and Control. Notwithstanding the percentage of the outstanding Shares of the Company or the outstanding
SPAC Shares that the Holder may receive as a result of the exercise of the Warrant (or the automatic conversion of the Warrant into the
right to receive SPAC Shares pursuant to Section 2 hereof and subsequent exercise thereof), Holder agrees that it shall not exercise
voting rights relating to any such Shares of the Company or SPAC Shares representing a 10% or greater voting interest in the Company or
the SPAC on any matter subject to a vote of holders of Shares of the Company or SPAC Shares, and agrees that it shall not obtain or exercise,
as a result of its investment in the Company or the SPAC, (i) “Control,” as such term is defined at 31 C.F.R. 800.208,
of the Company, the SPAC or their respective subsidiaries, (ii) access to any “material non-public technical information”
within the meaning of 31 C.F.R. § 800.232 in the Company, the SPAC and their respective subsidiaries’ possession, (iii) the
right to appoint any board member or board observer to the board of directors of the Company or the SPAC or their respective subsidiaries
or (iv) any involvement in any “substantive decision-making” within the meaning of 31 C.F.R. § 800.245 related to
the Company, the SPAC or their respective subsidiaries.
c. Disposition
of Warrant or Shares. The Holder shall not transfer, assign, encumber or otherwise dispose of this Warrant without the Company’s
prior written consent, and any attempted transfer in violation of the foregoing shall be void ab initio. With respect to any permitted
offer, sale or other disposition of this Warrant or any shares of Stock acquired pursuant to the exercise of this Warrant, in each case
prior to registration of such Warrant or shares, the holder hereof and each subsequent holder of this Warrant agrees to give written notice
to the Company prior thereto, describing in sufficient detail the manner thereof, together with a written opinion of such holder’s
counsel (or other evidence of compliance reasonably satisfactory to the Company), if requested by the Company, to the effect that such
offer, sale or other disposition may be effected without registration or qualification (under the Act as then in effect or any federal
or state law then in effect) of this Warrant or such shares of Stock and indicating whether or not under the Act certificates for this
Warrant or such shares of Stock to be sold or otherwise disposed of require any restrictive legend as to applicable restrictions on transferability
in order to ensure compliance with such laws. Promptly upon receiving such written notice and reasonably satisfactory opinion (or other
evidence of compliance), if so requested, the Company, as promptly as practicable, shall notify such holder whether such holder may sell
or otherwise dispose of this Warrant or such shares of Stock, all in accordance with the terms of the notice delivered to the Company.
Notwithstanding the foregoing, at any time that the Stock of the Company is publicly traded, such Stock may, as to such federal laws,
be offered, sold or otherwise disposed of in accordance with Rule 144 under the Act, provided that the Company shall have been furnished
with such information as the Company and its counsel may reasonably request to provide assurance that the provisions of Rule 144
have been satisfied. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions.
d. Applicability
of Restrictions. Neither any restrictions of any legend described in this Warrant nor the requirements of Sections 7(a) or
7(c) above shall apply to any transfer of, or grant of a security interest in, this Warrant or any part hereof made in accordance
with all applicable securities laws: (i) to a partner of the Holder if the Holder is a partnership or to a member of the Holder if
the Holder is a limited liability company; (ii) to a partnership of which the Holder is a partner or to a limited liability company
of which the Holder is a member; (iii) to any affiliate of the Holder if the Holder is an entity; or (iv) if the Holder is a
natural person, during such Holder’s lifetime or on death by will or intestacy to such Holder’s immediate family or to any
custodian or trustee for the account of such Holder or such Holder’s spouse, lineal descendant, father, mother, brother, or sister
of the Holder; provided, however, in any such transfer or granting of security interest contemplated by clauses (i) through (iv) above,
if applicable, the transferee or grantee shall agree in writing to be bound by the terms of this Warrant as if an original holder hereof.
8. No
Rights as a Stockholder. No holder of this Warrant, as such, shall be entitled to vote or receive dividends or be deemed the holder
of Stock or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything
contained herein be construed to confer upon the holder of this Warrant, as such, any of the rights of a stockholder of the Company or
any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive notice
of meetings, or to receive dividends or subscription rights or otherwise until this Warrant shall have been exercised and the Shares purchasable
upon the exercise hereof shall have become deliverable, as provided herein.
9. Representations
and Warranties. The Company represents and warrants to the Holder as follows:
a. This
Warrant has been duly authorized and executed by the Company and is a valid and binding obligation of the Company enforceable in accordance
with its terms, subject to laws of general application relating to bankruptcy, insolvency, and the relief of debtors, and the rules of
law or principles at equity governing specific performance, injunctive relief, and other equitable remedies.
b. The
Shares have been duly authorized and reserved for issuance by the Company and, when issued in accordance with the terms hereof, will be
validly issued, fully paid, and nonassessable.
c. The
execution and delivery of this Warrant are not, and the issuance of the Shares upon exercise of this Warrant in accordance with the terms
hereof will not be, inconsistent with the Company’s Certificate of Incorporation, as amended, or its bylaws, do not and will not
contravene any law, governmental rule or regulation, judgment or order applicable to the Company.
10. Miscellaneous.
a. Notice.
All notices and other communications relating to this Warrant shall be in writing and shall be deemed given upon the first to occur
of (x) deposit with the United
States Postal Service or overnight courier service, properly addressed and postage prepaid; (y) transmittal
by e-mail properly addressed (with confirmation of transmission); or (z) actual
receipt by the other party or an employee or agent of the other party. Notice to the Company shall be given as follows:
If to the Company:
Mobix
Labs, Inc.
15420
Laguna Canyon Drive, Suite 100
Irvine, California 92618
Attention: General Counsel
E-mail: Legal@mobixlabs.com
with a copy to:
Greenberg Traurig, LLP
18565
Jamboree Road, Suite 500
Irvine, California 92614
Attention: Raymond A. Lee
E-mail:
leer@gtlaw.com
if
to the Holder, to the address set forth on the signature page hereof.
b. Severability.
Whenever possible, each provision of this Warrant will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in
any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this
Warrant will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never
been contained in this Warrant.
c. Entire
Agreement. This Warrant constitutes the entire agreement among the parties solely with respect to the subject matter hereof and thereof
and supersedes any prior understandings or agreements between or among the parties solely with respect to the subject matter hereof and
thereof. The parties hereto make no representations or warranties to each other, express (except as contained in this Warrant) or implied,
and any and all prior representations and warranties made by any party hereto or its representatives, whether verbally or in writing,
are deemed to have been merged into this Warrant and the contemplated hereby, it being intended that no such prior representations or
warranties shall survive the execution and delivery of this Warrant. The language used in this Warrant will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of
strict construction will be applied against any party. Unless expressly indicated otherwise, all section references are to sections of
this Warrant.
d. Counterparts.
This Warrant may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other parties. In the event that any signature is delivered
by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature
page shall create a valid and
binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such signature page were
an original thereof.
e. Successors
and Assigns. This Warrant shall be binding upon and inure to the benefit of the Company and the Holder and their respective successors
and permitted assigns. This Warrant is intended for the benefit of the parties hereto and their respective successors and permitted assigns,
and is not for the benefit of, nor may any provision hereof be enforced by, any other person.
f. Governing
Law; Venue and Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this
Warrant shall be governed by and construed in accordance with the internal laws of the state of Delaware, without giving effect to any
choice of law or conflict of law provision or rule that
would cause the application of the laws of any jurisdictions other than the state of Delaware. Each party hereby irrevocably submits
to the exclusive jurisdiction of the state of California for the adjudication and binding arbitration of any dispute hereunder, and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of any such tribunal, that such arbitration, action or proceeding is brought in an inconvenient forum or that the venue of such suit,
action or proceeding is improper. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY OR COURT TRIAL FOR THE ADJUDICATION OF
ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT, AND AGREES THAT ALL DISPUTES ARISING HEREUNDER SHALL BE ADJUDICATED
BY ARBITRATION AS SET FORTH IN THIS WARRANT.
g. Mandatory
Arbitration. Any controversy, claim or dispute arising out of or relating to this Warrant, whether in contract or tort, shall be
settled solely and exclusively by a binding arbitration process administered by JAMS in Orange County, California. Such arbitration
shall be conducted in accordance with the then-existing JAMS Expedited Arbitration Procedures, as set forth in the JAMS Arbitration
Rules of Practice and Procedure, with the following exceptions if in conflict: (i) one arbitrator who is a retired judge
shall be chosen by JAMS; (ii) each party to the arbitration will pay one-half of the expenses and fees of the arbitrator,
together with other expenses of the arbitration incurred or approved by the arbitrator; and (iii) arbitration may proceed in
the absence of any party if written notice (pursuant to the JAMS rules and regulations) of the proceedings has been given to
such party. The parties agree to abide by all decisions and awards rendered in such proceedings. Such decisions and awards rendered
by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall be settled in this manner in lieu
of any action at law or equity; provided, however, that nothing in this subsection shall be construed as precluding the bringing of
an action for injunctive relief or specific performance as provided in this Warrant. This dispute resolution process and any
arbitration hereunder shall be confidential and no party shall disclose the existence, contents or results of such process without
the prior written consent of all parties, except where necessary or compelled in a court to enforce this arbitration provision or an
award from such arbitration or otherwise in a legal proceeding. If JAMS no longer exists or is otherwise unavailable, the parties
agree that the American Arbitration Association (“AAA”) shall administer the arbitration in accordance with its
then- existing Expedited Procedures as set forth in the Commercial Arbitration Rules as modified by this subsection. In such
event, all references herein to JAMS shall mean AAA. Notwithstanding the foregoing, recognizing the irreparable damage will
result to the parties in the event of the breach or threatened breach of any of the covenants hereof, and that the parties’
remedies at law for any such breach or threatened breach will be inadequate, the parties shall be entitled to an injunction,
including a mandatory injunction, to be issued by any court of competent jurisdiction ordering compliance with this Warrant or
enjoining and restraining such breach.
h. Amendments
and Waivers. No provision of this Warrant may be amended or waived without the prior written consent or agreement of the Company and
Holder.
i. Business
Days. Whenever the terms of this Warrant call for the performance of a specific act on a specified date, which date falls on a Saturday,
Sunday or legal holiday, the date for the performance of such act shall be postponed to the next succeeding regular business day following
such Saturday, Sunday or legal holiday.
j. No
Third-Party Beneficiary. Except for the parties to this Warrant and their respective successors and assigns, nothing expressed or
implied in this Warrant is intended, or will be construed, to confer upon or give any person other than the parties hereto and their respective
successors and assigns any rights or remedies under or by reason of this Warrant.
k. Titles
and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in construing
or interpreting this Warrant.
l. Transfers
in Violation of Agreement. Any transfer or attempted transfer of the Shares, or any capital stock in violation of any provision of
this Warrant shall be void, and the Company shall not record such transfer on its books or treat any purported transferee of such Shares
or capital stock as the owner of such stock for any purpose.
m. Further
Assurances. Upon the request of a party hereto, each of the parties hereto shall execute and deliver such instruments, documents and
other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of
this Warrant.
n. Electronic
Execution. The words “execution,”
“signed,” “signature,” and words of similar import in this Warrant shall be deemed to include electronic and digital
signatures and the keeping of records in electronic form, each of which shall be of the same effect, validity, and enforceability as manually
executed signatures and paper-based recordkeeping systems, to the extent and as provided for under applicable law, including the Electronic
Signatures in Global and National Commerce Act of 2000 (15 U.S.C. § 7001 et seq.), the Electronic Signatures and Records Act of 1999
(N.Y. State Tech. Law §§ 301-309), and any other similar state laws based on the Uniform Electronic Transactions Act.
[REMAINDER OF THIS PAGE LEFT INTENTIONALLY BLANK]
IN WITNESS WHEREOF, the Company has
executed this Warrant on the date first above written.
|
COMPANY: |
|
MOBIX LABS, INC. |
|
|
|
By: |
|
Keyvan Samini |
|
President / CFO and |
|
General Counsel |
|
|
|
ACKNOWLEDGED AND ACCEPTED BY |
|
|
|
HOLDER: |
|
|
|
Name: |
|
|
Title: |
|
|
Address: |
|
City, State, Zip: |
|
Email: |
APPENDIX A
NOTICE OF EXERCISE
To: |
Mobix Labs, Inc. |
|
Attn: General Counsel |
|
15420 Laguna Canyon Rd., Suite 100 |
|
Irvine, CA 92618 |
1. The
undersigned (the “Holder”) hereby elects to exercise the attached warrant (the “Warrant”) as to
[ ] shares of Common Stock of Mobix Labs, Inc., a Delaware corporation (the “Company”),
pursuant to the terms of the Warrant, and tenders herewith payment of the purchase price of such shares in full. The purchase price is
being paid by (check one):
|
(i) |
check |
|
(ii) |
wire transfer |
2. Please
issue the shares in the name of the Holder, or as set forth below (if information is filled out below).
3. The
Holder represents that the aforesaid shares are being acquired for the account of the Holder for investment and not with a view to, or
for resale in connection with, the distribution thereof and that the Holder has no present intention of distributing or reselling such
shares.
|
HOLDER: |
|
|
|
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
Date: |
|
Exhibit 10.6
NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE
UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO
SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF
COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATIONS ARE NOT REQUIRED; (III) RECEIPT OF NO-ACTION
LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES; OR (IV) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS
WARRANT.
FORM OF
WARRANT TO PURCHASE SHARES
OF COMMON
STOCK
The Warrant is issued concurrently
with the Written Consent (as defined below), and certifies that, for value received, [●], and his permitted assignees (the “Holder”),
is entitled to purchase [●] shares (as may be adjusted pursuant to Section 4 hereof, the “Shares”)
of common stock, $0.00001 par value per share (the “Stock”), of MOBIX LABS, INC., a Delaware company, (the “Company”),
at an exercise price of $0.01 per share (such price and such other price as shall result, from time to time, from the adjustments specified
in Section 4 hereof is herein referred to as the “Warrant Price”), subject to the provisions and upon the
terms and conditions hereinafter set forth. This Warrant shall be effective upon (i) execution and delivery of the funds set forth
the Subscription Agreement (“PIPE Subscription Agreement) concurrently entered into by and between Holder, the Company, and Chavant
Capital Acquisition Corp. (“Chavant”), and (ii) the closing of the Business Combination Agreement, whereby the Company
becomes a public listed company on the Nasdaq Global Market.
1. Term.
This Warrant shall terminate upon the earlier to occur of (i) the closing of the proposed business combination contemplated by the
Business Combination Agreement and (ii) the termination of the Business Combination Agreement (the “Termination Date”).
2. Method of Exercise: Payment.
a. Subject
to Section 1 hereof, and contingent upon the substantially concurrent occurrence of the Subscription Closing (as defined
in the PIPE Subscription Agreement), and prior approval of this Warrant by the Shareholders of the Company, of its purchase right represented
by this Warrant, the purchase right represented by this Warrant shall be exercisable by the Holder hereof immediately prior to the Closing
(as such term is defined in the Business Combination Agreement), in whole or in part, by the surrender of this Warrant (with the notice
of exercise form attached hereto as EXHIBIT A duly executed (the “Notice of Exercise”) at the principal
office of the Company and by the payment to the Company by check or wire transfer to an account designated by the Company of an amount
equal to the then applicable Warrant Price multiplied by the number of Shares then being purchased. For the avoidance of doubt, to the
extent not previously exercised, contingent upon the substantially concurrent occurrence of the Subscription Closing (as defined in the
PIPE Subscription Agreement), this Warrant shall automatically convert into the right to receive Class A common shares of the SPAC
(the “SPAC Shares”) pursuant to the merger in accordance with the terms of the Business Combination Agreement. The
person in whose name any certificate representing shares of Stock shall be issuable upon exercise of this Warrant shall be deemed to
have become the holder of record of, and shall be treated for all purposes as the record holder of, the shares represented thereby (and
such shares shall be deemed to have been issued) immediately prior to the close of business on the date or dates upon which this Warrant
is exercised. In the event of any exercise of the rights represented by this Warrant, certificates for the shares of Stock so purchased
shall be delivered to the Holder hereof as soon as reasonably practicable after such exercise; provided, that, as long as the Company
is legally permitted to reflect share issuances in book entry or dematerialized form, the Company may deliver an electronic representation
or other evidence of the valid issuance of the Shares as to which this Warrant has been exercised. Unless this Warrant has been fully
exercised or expired, a new Warrant representing the portion of the Shares, if any, with respect to which this Warrant shall not then
have been exercised shall also be issued to the Holder hereof as soon as practicable.
b. This
Warrant may be exercised for less than the full number of shares of Stock first shown above, provided that this Warrant may not be exercised
in part for less than a whole number of shares of Stock. Upon any such partial exercise, the Company at its expense will forthwith issue
to the Holder a new Warrant or Warrants of like tenor exercisable for the number of shares of Stock as to which rights have not been exercised
(subject to adjustment as herein provided).
3. Stock
Fully Paid: Reservation of Shares. All Shares that may be issued upon the exercise of the rights represented by this Warrant will,
upon issuance pursuant to the terms and conditions herein, be fully paid and nonassessable, and free from all preemptive or similar rights,
taxes, liens, and charges with respect to the issue thereof. During the period within which the rights represented by this Warrant may
be exercised, the Company will at all times have authorized, and reserved for the purpose of the issue upon exercise of the purchase rights
evidenced by this Warrant such number of its duly authorized shares of Stock as from time to time shall be issuable upon the exercise
of this Warrant and other similar Warrants.
4. Adjustment
of Warrant Price and Number of Shares. If the Company subdivides the outstanding shares of the class of Stock by reclassification
or otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant
Price shall be proportionately decreased. If the outstanding shares of the class of Stock are combined or consolidated, by reclassification
or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately
decreased. Each adjustment in the number of Shares issuable will be to the nearest whole share and each adjustment of the Warrant Price
will be calculated to the nearest cent.
5. Notice
of Adjustments. Whenever the Warrant Price or the number of Shares purchasable hereunder shall be adjusted pursuant to Section 4
hereof, the Company shall prepare a notice setting forth, in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, the Warrant Price, and the number of Shares purchasable hereunder after
giving effect to such adjustment, and promptly deliver the notice to the Holder.
6. Fractional
Shares. No fractional shares of Stock will be issued in connection with any exercise hereunder, but in lieu of such fractional shares,
the Company shall make a cash payment therefor based on the fair market value of the Stock on the date of exercise as reasonably determined
in good faith by the Company’s board of directors.
7. Compliance
with Securities Act and Other Laws: Disposition of Warrant or Shares.
a. Compliance
with Securities Act. The Holder, by acceptance hereof, agrees that this Warrant, and the shares of Stock to be issued upon exercise
hereof are being acquired for investment and that such Holder will not offer, sell or otherwise dispose of this Warrant, or any shares
of Stock to be issued upon exercise hereof, except under circumstances that will not result in a violation of the Securities Act of 1933,
as amended (the “Act”). Upon exercise of this Warrant, unless the Shares being acquired are registered under the Act
or an exemption from such registration is available, the Holder hereof shall confirm in writing that the shares of Stock so purchased
are being acquired for investment and not with a view toward distribution or resale. This Warrant and all shares of Stock issued upon
exercise of this Warrant (unless registered under the Act) shall be stamped, imprinted, or otherwise notated with a legend in substantially
the following form:
“THE SECURITIES EVIDENCED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE
EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATIONS ARE NOT REQUIRED; (III) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL
AUTHORITIES; OR (IV) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED,
DIRECTLY OR INDIRECTLY.”
In addition, in connection with the issuance of this Warrant, the Holder
specifically represents to the Company by acceptance of this Warrant that:
i. The
Holder is aware of the Company’s business affairs and financial condition, and has acquired information about the Company sufficient
to reach an informed and knowledgeable decision to acquire this Warrant. The Holder is acquiring this Warrant for its own account for
investment purposes only and not with a view to, or for the resale in connection with, any “distribution” thereof for purposes
of the Act.
ii. The
Holder understands that this Warrant and any securities issuable upon the exercise hereof have not been registered under the Act in reliance
upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment
intent as expressed herein. In this connection, the Holder understands that, in the view of the Securities and Exchange Commission (the
“SEC”), the statutory basis for such exemption may be unavailable if the Holder’s representation was predicated
solely upon a present intention to hold the Warrant for the minimum capital gains period specified under tax statutes, for a deferred
sale, for or until an increase or decrease in the market price of the Warrant, or for a period of one (1) year or any other fixed
period in the future.
iii. The
Holder further understands that this Warrant and any securities issuable upon the exercise hereof must be held indefinitely unless subsequently
registered under the Act and any applicable state securities laws, or unless exemptions from registration are otherwise available.
iv. The
Holder is aware of the provisions of Rule 144, promulgated under the Act, which, in substance, permit limited public resale of “restricted
securities” acquired, directly or indirectly, from the issuer thereof (or from an affiliate of such issuer), in a non-public offering
subject to the satisfaction of certain conditions, if applicable, including, among other things: (i) the availability of certain
public information about the Company, the resale occurring not less than one (1) year after the party has purchased and paid for
the securities to be sold; (ii) the sale being made through a broker in an unsolicited “broker’s transaction” or
in transactions directly with a market maker (as said term is defined under the Securities Exchange Act of 1934, as amended); and (iii) the
amount of securities being sold during any three (3) month period not exceeding the specified limitations stated therein.
v. The
Holder further understands that at the time it wishes to sell this Warrant and any securities issuable upon the exercise hereof there
may be no public market upon which to make such a sale, and that, even if such a public market then exists, the Company may not be satisfying
the current public information requirements of Rule 144, and that, in such event, the Holder may be precluded from selling this Warrant
and any securities issuable upon the exercise hereof under Rule 144 even if the one (1) year minimum holding period had been
satisfied.
vi. The
Holder further understands that in the event all of the requirements of Rule 144 are not satisfied, registration under the Act, compliance
with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rule 144 is not
exclusive, the staff of the SEC has expressed its opinion that persons proposing to sell private placement securities other than in a
registered offering and otherwise than pursuant to Rule 144 will have a substantial burden of proof in establishing that an exemption
from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions
do so at their own risk.
vii. The
Holder is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the Act.
viii. At
no time was Holder presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of
general advertising or solicitation in connection with the offer, sale and purchase of the Warrant and any securities issuable upon the
exercise hereof.
b. Certain
Limitations on Voting, Access and Control. Notwithstanding the percentage of the outstanding Shares of the Company or the outstanding
SPAC Shares that the Holder may receive as a result of the exercise of the Warrant (or the automatic conversion of the Warrant into the
right to receive SPAC Shares pursuant to Section 2 hereof and subsequent exercise thereof), Holder agrees that it shall not exercise
voting rights relating to any such Shares of the Company or SPAC Shares representing a 10% or greater voting interest in the Company or
the SPAC on any matter subject to a vote of holders of Shares of the Company or SPAC Shares, and agrees that it shall not obtain or exercise,
as a result of its investment in the Company or the SPAC, (i) “Control,” as such term is defined at 31 C.F.R. 800.208,
of the Company, the SPAC or their respective subsidiaries, (ii) access to any “material non-public technical information”
within the meaning of 31 C.F.R. § 800.232 in the Company, the SPAC and their respective subsidiaries’ possession, (iii) the
right to appoint any board member or board observer to the board of directors of the Company or the SPAC or their respective subsidiaries
or (iv) any involvement in any “substantive decision-making” within the meaning of 31 C.F.R. § 800.245 related to
the Company, the SPAC or their respective subsidiaries.
c. Disposition
of Warrant or Shares. The Holder shall not transfer, assign, encumber or otherwise dispose of this Warrant without the Company’s
prior written consent, and any attempted transfer in violation of the foregoing shall be void ab initio. With respect to any permitted
offer, sale or other disposition of this Warrant or any shares of Stock acquired pursuant to the exercise of this Warrant, in each case
prior to registration of such Warrant or shares, the holder hereof and each subsequent holder of this Warrant agrees to give written notice
to the Company prior thereto, describing in sufficient detail the manner thereof, together with a written opinion of such holder’s
counsel (or other evidence of compliance reasonably satisfactory to the Company), if requested by the Company, to the effect that such
offer, sale or other disposition may be effected without registration or qualification (under the Act as then in effect or any federal
or state law then in effect) of this Warrant or such shares of Stock and indicating whether or not under the Act certificates for this
Warrant or such shares of Stock to be sold or otherwise disposed of require any restrictive legend as to applicable restrictions on transferability
in order to ensure compliance with such laws. Promptly upon receiving such written notice and reasonably satisfactory opinion (or other
evidence of compliance), if so requested, the Company, as promptly as practicable, shall notify such holder whether such holder may sell
or otherwise dispose of this Warrant or such shares of Stock, all in accordance with the terms of the notice delivered to the Company.
Notwithstanding the foregoing, at any time that the Stock of the Company is publicly traded, such Stock may, as to such federal laws,
be offered, sold or otherwise disposed of in accordance with Rule 144 under the Act, provided that the Company shall have been furnished
with such information as the Company and its counsel may reasonably request to provide assurance that the provisions of Rule 144
have been satisfied. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions.
d. Applicability
of Restrictions. Neither any restrictions of any legend described in this Warrant nor the requirements of Sections 7(a) or
7(c) above shall apply to any transfer of, or grant of a security interest in, this Warrant or any part hereof made
in accordance with all applicable securities laws: (i) to a partner of the Holder if the Holder is a partnership or to a member of
the Holder if the Holder is a limited liability company; (ii) to a partnership of which the Holder is a partner or to a limited liability
company of which the Holder is a member; (iii) to any affiliate of the Holder if the Holder is an entity; or (iv) if the Holder
is a natural person, during such Holder’s lifetime or on death by will or intestacy to such Holder’s immediate family or to
any custodian or trustee for the account of such Holder or such Holder’s spouse, lineal descendant, father, mother, brother, or
sister of the Holder; provided, however, in any such transfer or granting of security interest contemplated by clauses (i) through
(iv) above, if applicable, the transferee or grantee shall agree in writing to be bound by the terms of this Warrant as if an original
holder hereof.
8. No
Rights as a Stockholder. No holder of this Warrant, as such, shall be entitled to vote or receive dividends or be deemed the holder
of Stock or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything
contained herein be construed to confer upon the holder of this Warrant, as such, any of the rights of a stockholder of the Company or
any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive notice
of meetings, or to receive dividends or subscription rights or otherwise until this Warrant shall have been exercised and the Shares purchasable
upon the exercise hereof shall have become deliverable, as provided herein.
9. Representations
and Warranties. The Company represents and warrants to the Holder as follows:
a. This
Warrant has been duly authorized and executed by the Company and is a valid and binding obligation of the Company enforceable in accordance
with its terms, subject to laws of general application relating to bankruptcy, insolvency, and the relief of debtors, and the rules of
law or principles at equity governing specific performance, injunctive relief, and other equitable remedies.
b. The
Shares have been duly authorized and reserved for issuance by the Company and, when issued in accordance with the terms hereof, will be
validly issued, fully paid, and nonassessable.
c. The
execution and delivery of this Warrant are not, and the issuance of the Shares upon exercise of this Warrant in accordance with the terms
hereof will not be, inconsistent with the Company’s Certificate of Incorporation, as amended, or its bylaws, do not and will not
contravene any law, governmental rule or regulation, judgment or order applicable to the Company.
10. Miscellaneous.
a. Notice.
All notices and other communications relating to this Warrant shall be in writing and shall be deemed given upon the first to occur of
(x) deposit with the United States Postal Service or overnight courier service, properly addressed and postage prepaid; (y) transmittal
by e-mail properly addressed (with confirmation of transmission); or (z) actual receipt by the other party or an employee or agent
of the other party. Notice to the Company shall be given as follows:
If to the Company:
Mobix Labs, Inc.
15420 Laguna Canyon Drive, Suite 100
Irvine, California 92618
Attention: General Counsel
E-mail: Legal@mobixlabs.com
with a copy to:
Greenberg Traurig, LLP
18565 Jamboree Road, Suite 500
Irvine, California 92614
Attention: Raymond A. Lee
E-mail:
leer@gtlaw.com
if to the Holder, to the address set forth on the signature page hereof.
b. Severability.
Whenever possible, each provision of this Warrant will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in
any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this
Warrant will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never
been contained in this Warrant.
c. Entire
Agreement. This Warrant constitutes the entire agreement among the parties solely with respect to the subject matter hereof and thereof
and supersedes any prior understandings or agreements between or among the parties solely with respect to the subject matter hereof and
thereof. The parties hereto make no representations or warranties to each other, express (except as contained in this Warrant) or implied,
and any and all prior representations and warranties made by any party hereto or its representatives, whether verbally or in writing,
are deemed to have been merged into this Warrant and the contemplated hereby, it being intended that no such prior representations or
warranties shall survive the execution and delivery of this Warrant. The language used in this Warrant will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. Unless
expressly indicated otherwise, all section references are to sections of this Warrant.
d. Counterparts.
This Warrant may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other parties. In the event that any
signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an
executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such signature page were an original thereof.
e. Successors
and Assigns. This Warrant shall be binding upon and inure to the benefit of the Company and the Holder and their respective successors
and permitted assigns. This Warrant is intended for the benefit of the parties hereto and their respective successors and permitted assigns,
and is not for the benefit of, nor may any provision hereof be enforced by, any other person.
f. Governing
Law; Venue and Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this Warrant
shall be governed by and construed in accordance with the internal laws of the state of Delaware, without giving effect to any choice
of law or conflict of law provision or rule that would cause the application of the laws of any jurisdictions other than the state
of Delaware. Each party hereby irrevocably submits to the exclusive jurisdiction of the state of California for the adjudication and binding
arbitration of any dispute hereunder, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such tribunal, that such arbitration, action or proceeding is brought in
an inconvenient forum or that the venue of such suit, action or proceeding is improper. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT
IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY OR COURT TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH
OR ARISING OUT OF THIS WARRANT, AND AGREES THAT ALL DISPUTES ARISING HEREUNDER SHALL BE ADJUDICATED BY ARBITRATION AS SET FORTH IN THIS
WARRANT.
g. Mandatory
Arbitration. Any controversy, claim or dispute arising out of or relating to this Warrant, whether in contract or tort, shall be
settled solely and exclusively by a binding arbitration process administered by JAMS in Orange County, California. Such arbitration
shall be conducted in accordance with the then-existing JAMS Expedited Arbitration Procedures, as set forth in the JAMS Arbitration
Rules of Practice and Procedure, with the following exceptions if in conflict: (i) one arbitrator who is a retired judge
shall be chosen by JAMS; (ii) each party to the arbitration will pay one-half of the expenses and fees of the arbitrator,
together with other expenses of the arbitration incurred or approved by the arbitrator; and (iii) arbitration may proceed in
the absence of any party if written notice (pursuant to the JAMS rules and regulations) of the proceedings has been given to
such party. The parties agree to abide by all decisions and awards rendered in such proceedings. Such decisions and awards rendered
by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall be settled in this manner in lieu
of any action at law or equity; provided, however, that nothing in this subsection shall be construed as precluding the bringing of
an action for injunctive relief or specific performance as provided in this Warrant. This dispute resolution process and any
arbitration hereunder shall be confidential and no party shall disclose the existence, contents or results of such process without
the prior written consent of all parties, except where necessary or compelled in a court to enforce this arbitration provision or an
award from such arbitration or otherwise in a legal proceeding. If JAMS no longer exists or is otherwise unavailable, the parties
agree that the American Arbitration Association (“AAA”) shall administer the arbitration in accordance with its
then- existing Expedited Procedures as set forth in the Commercial Arbitration Rules as modified by this subsection. In such
event, all references herein to JAMS shall mean AAA. Notwithstanding the foregoing, recognizing the irreparable damage will
result to the parties in the event of the breach or threatened breach of any of the covenants hereof, and that the parties’
remedies at law for any such breach or threatened breach will be inadequate, the parties shall be entitled to an injunction,
including a mandatory injunction, to be issued by any court of competent jurisdiction ordering compliance with this Warrant or
enjoining and restraining such breach.
h. Amendments
and Waivers. No provision of this Warrant may be amended or waived without the prior written consent or agreement of the Company and
Holder.
i. Business
Days. Whenever the terms of this Warrant call for the performance of a specific act on a specified date, which date falls on a Saturday,
Sunday or legal holiday, the date for the performance of such act shall be postponed to the next succeeding regular business day following
such Saturday, Sunday or legal holiday.
j. No
Third-Party Beneficiary. Except for the parties to this Warrant and their respective successors and assigns, nothing expressed or
implied in this Warrant is intended, or will be construed, to confer upon or give any person other than the parties hereto and their respective
successors and assigns any rights or remedies under or by reason of this Warrant.
k. Titles
and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in construing
or interpreting this Warrant.
l. Transfers
in Violation of Agreement. Any transfer or attempted transfer of the Shares, or any capital stock in violation of any provision of
this Warrant shall be void, and the Company shall not record such transfer on its books or treat any purported transferee of such Shares
or capital stock as the owner of such stock for any purpose.
m. Further
Assurances. Upon the request of a party hereto, each of the parties hereto shall execute and deliver such instruments, documents and
other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of
this Warrant.
n. Electronic
Execution. The words “execution,”
“signed,” “signature,” and words of similar import in this Warrant shall be deemed to include electronic and digital
signatures and the keeping of records in electronic form, each of which shall be of the same effect, validity, and enforceability as manually
executed signatures and paper-based recordkeeping systems, to the extent and as provided for under applicable law, including the Electronic
Signatures in Global and National Commerce Act of 2000 (15 U.S.C. § 7001 et seq.), the Electronic Signatures and Records Act of 1999
(N.Y. State Tech. Law §§ 301-309), and any other similar state laws based on the Uniform Electronic Transactions Act.
[REMAINDER OF THIS PAGE LEFT INTENTIONALLY BLANK]
IN WITNESS WHEREOF, the Company has executed this
Warrant on the date first above written.
|
COMPANY: |
|
MOBIX LABS, INC. |
|
|
|
By: |
|
|
Keyvan Samini |
|
President / CFO and |
|
General Counsel |
|
|
|
ACKNOWLEDGED AND ACCEPTED BY |
|
|
|
HOLDER: |
|
|
|
Name: |
|
APPENDIX A
NOTICE OF EXERCISE
To: |
Mobix Labs, Inc. |
|
Attn: General Counsel |
|
15420 Laguna Canyon Rd., Suite 100 |
|
Irvine, CA 92618 |
1. The
undersigned (the “Holder”) hereby elects to exercise the attached warrant (the “Warrant”) as to
[ ] shares of Common Stock of Mobix Labs, Inc., a Delaware corporation (the “Company”),
pursuant to the terms of the Warrant, and tenders herewith payment of the purchase price of such shares in full. The purchase price is
being paid by (check one):
| ¨ | (i) |
check |
| ¨ | (ii) |
wire transfer |
2. Please
issue the shares in the name of the Holder, or as set forth below (if information is filled out below).
3. The
Holder represents that the aforesaid shares are being acquired for the account of the Holder for investment and not with a view to, or
for resale in connection with, the distribution thereof and that the Holder has no present intention of distributing or reselling such
shares.
|
HOLDER: |
|
|
|
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
Date: |
|
Exhibit 10.7
EXECUTION VERSION
NON-REDEMPTION
AGREEMENT
This
NON-REDEMPTION AGREEMENT (this “Agreement”), dated
as of December 20, 2023, is made by and among Chavant Capital Acquisition Corp., a Cayman Islands exempted company (the “Company”),
Mobix Labs, Inc., a Delaware corporation (“Mobix Labs”), and
the Backstop Investor (as defined below).
WHEREAS,
the Company is a special purpose acquisition company whose ordinary shares, par value $0.0001 per share “(“Ordinary
Shares”), are traded on The Nasdaq Capital Market under the symbol “CLAY”, and whose warrants to purchase Ordinary
Shares of the Company (“Warrants”) and units consisting of
one Ordinary Share and three-quarters of one Warrant (“Units”)
are traded on The Nasdaq Capital Market under the symbol “CLAYW” and “CLAYU”, respectively, among other securities
of the Company;
WHEREAS,
the Company, CLAY Merger Sub II, Inc., a Delaware corporation and newly formed, wholly- owned direct subsidiary of Chavant (“Merger
Sub”), and Mobix Labs entered into a business combination agreement (as amended, supplemented or otherwise modified, the
“Business Combination Agreement”), pursuant to which, among
other things, Merger Sub will merge with and into Mobix Labs, with Mobix Labs surviving the merger as a wholly-owned direct subsidiary
of the Company;
WHEREAS,
the Company and Backstop Investor on behalf of certain funds, investors, entities or accounts that are managed, sponsored or advised by
Backstop Investor or its affiliates (the “Backstop Investor”)
are entering into this Agreement in anticipation of the closing (the “Closing”)
of the business combination contemplated by the Business Combination Agreement (the “Business
Combination”);
WHEREAS,
the Backstop Investor has voting and investment power over 73,706 Ordinary Shares as of the date hereof (the “Backstop
Investor Shares”);
WHEREAS,
the Company held its extraordinary general meeting of the shareholders of the Company to approve the Business Combination on December
18, 2023;
WHEREAS,
pursuant to the terms of this Agreement, the Backstop Investor desires to agree to reverse redemptions previously submitted by it or submitted
by other investors, with respect to the Backstop Investor Shares; and
WHEREAS,
all capitalized terms used but not defined herein shall have the respective meanings specified in the Business Combination Agreement.
NOW, THEREFORE, in consideration of the mutual agreements
set forth herein, the parties agree as follows:
1. Non-Redemption Agreement. Subject to the conditions set forth in this Agreement, the Backstop Investor irrevocably and unconditionally
hereby agrees that it shall immediately rescind the redemption of the Backstop Investor Shares (the “Non-Redemption”)
and shall provide confirmation thereof to the Company promptly thereafter.
2. Non-Redemption Consideration. In consideration of the agreement set forth in Section 1 hereof, upon completion of the Non-Redemption
and subject to the Backstop Investor’s compliance with this Agreement, Mobix Labs shall issue to the Backstop Investor, promptly
after the Non-Redemption and receipt by the Company of confirmation thereof and prior to the Closing of the Business Combination, 202,692
warrants, each warrant exercisable to the purchase one share of common stock, $0.00001 par value per share, of Mobix Labs at an exercise
price of $0.01 per share, and such 202,692 warrants shall be converted into 202,489 shares of Class A Common Stock of the Company (following
the Domestication) upon the Closing.
3. Representations
and Warranties.
Each of the parties hereto
represents and warrants to the other party that: (a) it is a validly existing company, partnership or corporation, in good standing
under the laws of the jurisdiction of its formation or incorporation; (b) this Agreement constitutes a valid and legally binding
obligation on it in accordance with its terms, subject to laws relating to bankruptcy, insolvency and relief of debtors, and laws
governing specific performance, injunctive relief and other equitable remedies; (c) the execution, delivery and performance of this
Agreement by it has been duly authorized by all necessary corporate action, and (d) the execution, delivery and performance of this
Agreement will not result in a violation of its Certificate of Formation, Certificate of Incorporation or similar organizational
document, as applicable, or conflict with, or constitute a default (or an event that with notice or lapse of time or both would
become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement or
instrument to which it is a party or by which it is bound. The Backstop Investor represents and warrants to the Company and Mobix
Labs that, as of the date hereof, the Backstop Investor beneficially owns the Backstop Investor Shares.
4.
Additional Covenants. The Backstop Investor hereby covenants and agrees that, except for this Agreement, the Backstop Investor
shall not, at any time while this Agreement remains in effect, (i) enter into any voting agreement or voting trust with respect to the
Backstop Investor Shares (or any securities received in exchange therefor) inconsistent with Backstop Investor’s obligations pursuant
to this Agreement, (ii) grant a proxy, a consent or power of attorney with respect to the Backstop Investor Shares (or any securities
received in exchange therefore), (iii) enter into any agreement or take any action that would make any representation or warranty of Backstop
Investor contained herein untrue or inaccurate in any material respect or have the effect of preventing or disabling Backstop Investor
from performing any of its obligations under this Agreement, or (iv) purchase the Backstop Investor Shares at a price higher than the
price offered through the Company’s redemption process.
5.
Expenses. Each party shall be responsible for its own fees and expenses related to this Agreement and the transactions contemplated
hereby.
6. Termination.
This Agreement and all of its provisions shall terminate and be of no further force or effect upon the earliest to occur of (a) the termination
of the Business Combination Agreement in accordance with its terms, (b) the mutual written consent of the parties hereto, (c) January
22, 2024, if the Business Combination has not been consummated by such date, and (d) the later of the delivery of the Non-Redemption
Consideration pursuant to Section 2 hereof to the Backstop Investor and the Closing of the Business Combination. Upon such termination
of this Agreement, all obligations of the parties under this Agreement will terminate, without any liability or other obligation on the
part of any party hereto to any person in respect hereof or the transactions contemplated hereby; provided that, notwithstanding
the foregoing or anything to the contrary in this Agreement, the termination of this Agreement pursuant to clauses (a) and (d) above
shall not affect any liability on the part of any party for an intentional breach of this Agreement. Section 4 of this Agreement will
survive the termination of this Agreement until the Business Combination and Section 6 through and including Section 22 of this Agreement
will survive the termination of this Agreement.
7. Trust
Account Waiver. The Backstop Investor acknowledges that the Company has established a trust account (the “Trust
Account”) containing the proceeds of its initial public offering (“IPO”)
and certain proceeds of a private placement (including interest accrued from time to time thereon) for the benefit of its public shareholders
and certain other parties (including the underwriters of the IPO). For good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Backstop Investor hereby agrees (on its own behalf and on behalf of its related parties) that it does
not now and shall not at any time hereafter have any right, title, interest or claim of any kind in or to any assets held in the Trust
Account, and it shall not make any claim against the Trust Account, regardless of whether such claim arises as a result of, in connection
with or relating in any way to this Agreement, the Backstop Investor Shares or any other matter, and regardless of whether such claim
arises based on contract, tort, equity or any other theory of legal liability (any and all such claims are collectively referred to hereafter
as the “Released Claims”); provided, that the Released
Claims shall not include any rights or claims of the Backstop Investor or any of its related parties as a shareholder of the Company
to the extent related to or arising from any securities of the Company other than the Backstop Investor Shares. The Backstop Investor
hereby irrevocably waives (on its own behalf and on behalf of its related parties) any Released Claims that it may have against the Trust
Account now or in the future as a result of, or arising out of, this Agreement and will not seek recourse against the Trust Account with
respect to the Released Claims.
8. Public
Disclosure. The Company shall file a Current Report on Form 8-K with the SEC (the “Current
Report”) reporting the material terms of this Agreement within the time period required by the rules and regulations of
the SEC. The Company shall not, and shall cause its representatives to not, disclose any material non-public information to the
Backstop Investor concerning the Company, Ordinary Shares or the Business Combination, other than the existence of this Agreement,
such that the Backstop Investor shall not be in possession of any such material non-public information from and after the filing of
the Current Report. Notwithstanding anything in this Agreement to the contrary, the Backstop Investor agrees that the Company shall
have the right to publicly disclose the nature of the Backstop Investor’s commitments, arrangements and understandings under
and relating to this Agreement in any filing by the Company with the SEC.
9. Governing Law. This Agreement, the rights and duties of the parties hereto, and any disputes (whether in contract, tort
or statute) arising out of, under or in connection with this Agreement will be governed by and construed and enforced in accordance with
the laws of the State of Delaware, without giving effect to its principles or rules of conflict of laws to the extent such principles
or rules would require or permit the application of the laws of another jurisdiction. The parties irrevocably and unconditionally submit
to the exclusive jurisdiction of the United States District Court for the District of Delaware or, if such court does not have jurisdiction,
the Delaware state courts located in Wilmington, Delaware, in any action arising out of or relating to this Agreement. The parties irrevocably
agree that all such claims shall be heard and determined in such a Delaware federal or state court, and that such jurisdiction of such
courts with respect thereto will be exclusive. Each party hereby waives, and agrees not to assert, as a defense in any action, suit or
proceeding arising out of or relating to this Agreement that it is not subject to such jurisdiction, or that such action, suit or proceeding
may not be brought or is not maintainable in such courts or that the venue thereof may not be appropriate or that this Agreement may not
be enforced in or by such courts. The parties hereby consent to and grant any such court jurisdiction over the person of such parties
and over the subject matter of any such dispute and agree that mailing of process or other papers in connection with any such action,
suit or proceeding in the manner provided in Section 20 hereof or in such other manner as may be permitted by law, will be valid and sufficient
service thereof.
10. Waiver of Jury Trial. To the extent not prohibited by applicable law that cannot be waived, each of the parties hereto irrevocably
waives any right it may have to trial by jury in respect of any litigation based on, arising out of, under or in connection with this
Agreement or any course of conduct, course of dealing, verbal or written statement or action of any party hereto or thereto, in each case,
whether now existing or hereafter arising, and whether in contract, tort, statute, equity or otherwise. Each party hereby further agrees
and consents that any such litigation shall be decided by court trial without a jury and that the parties to this Agreement may file a
copy of this Agreement with any court as written evidence of the consent of the parties to the waiver of their right to trial by jury.
11. Form W-9 or W-8. The Backstop Investor shall, upon or prior to the consummation of the Business Combination, execute and
deliver to the Company a completed IRS Form W-9 or Form W-8, as applicable.
12.
Non-Reliance. The Backstop Investor has had the opportunity to consult its own advisors, including financial and tax advisors,
regarding this Agreement or the arrangements contemplated hereunder and the Backstop Investor hereby acknowledges that none of the Company,
Mobix Labs nor any representative or affiliate of the foregoing has provided or will provide the Backstop Investor with any financial,
tax or other advice relating to this Agreement or the arrangements contemplated hereunder.
13.
No Third-Party Beneficiaries. This Agreement shall be for the sole benefit of the parties and their respective successors
and permitted assigns. Except as expressly named in this Section 13, this Agreement is not intended, nor shall be construed, to give any
Person, other than the parties and their respective successors and assigns, any legal or equitable right, benefit or remedy of any nature
whatsoever by reason this Agreement.
14. Assignment. This Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the parties
hereto and their respective successors and permitted assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder
will be assigned (including by operation of law) without the prior written consent of the non-assigning party hereto (not to be unreasonably
withheld, conditioned or delayed). Notwithstanding the foregoing, the Backstop Investor may transfer its rights, interests and obligations
hereunder to one or more investment funds or accounts managed or advised by the Backstop Investor (or a related party or affiliate) and
to the extent such transferee is not a party to this Agreement, such transferee shall agree to be bound by the terms hereof prior to any
such transfer being effectuated.
15. Specific Performance. The parties agree that irreparable damage may occur in the event that any of the provisions of this
Agreement are not performed in accordance with their specific terms or are otherwise breached. It is accordingly agreed that monetary
damages may not be an adequate remedy for such breach and the non-breaching party shall be entitled to seek injunctive relief, in addition
to any other remedy that such party may have in law or in equity, and to enforce specifically the terms and provisions of this Agreement
in the chancery court or any other state or federal court within the State of Delaware.
16. Amendment. This Agreement may not be amended, changed, supplemented, waived or otherwise modified, except upon the execution
and delivery of a written agreement executed by the parties hereto.
17.
Severability. If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction,
the other provisions of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable
only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.
18.
No Partnership, Agency or Joint Venture. This Agreement is intended to create a contractual relationship between the Backstop
Investor, on the one hand, and the Company and Mobix Labs, on the other hand, and is not intended to create, and does not create, any
agency, partnership, joint venture or any like relationship between the parties.
19.
Notices. All notices, consents, waivers and other communications under this Agreement must be in writing and will be deemed
to have been duly given (a) if personally delivered, on the date of delivery; (b) if delivered by express courier service of national
standing for next day delivery (with charges prepaid), on the Business Day following the date of delivery to such courier service; (c)
if delivered by electronic mail, on the date of transmission if on a Business Day before 5:00 p.m. local time of the business address
of the recipient party (otherwise on the next succeeding Business Day), provided the sender receives no bounce-back or similar message
indicating non-delivery; in each case to the appropriate addresses set forth below (or to such other addresses as a party may designate
by notice to the other parties in accordance with this Section 19):
If
to the Company prior to consummation of the Business Combination:
Chavant Capital Acquisition Corp.
445 Park Avenue, 9th
Floor
New York, NY 10022
Attention: Jiong Ma
Email: jma@chavantcapital.com
With a required copy to (which shall not constitute notice):
Simpson Thacher & Bartlett
LLP
425 Lexington Avenue
New York, NY 10017
Attention: John C. Ericson; Benjamin P. Schaye
Email:
jericson@stblaw.com; bschaye@stblaw.com
If
to Mobix Labs prior to consummation of the Business Combination:
Mobix Labs, Inc.
15420 Laguna Canyon Rd., suite 100
Irvine, CA 92618
Attention: Keyvan Samini
Email: legal@mobixlabs.com
With a required copy to (which shall not constitute
notice):
Greenberg Traurig, LLP
One Vanderbilt Avenue
New York, New
York 10022
Attention: Raymond Lee; Laurie Green
Email: LeeR@gtlaw.com; GreenL@gtlaw.com
If
to the Company after consummation of the Business Combination:
Mobix Labs, Inc.
15420 Laguna Canyon Rd., suite 100
Irvine, CA 92618
Attention: Keyvan Samini
Email: legal@mobixlabs.com
With a required copy to (which shall not constitute
notice):
Greenberg Traurig, LLP
One Vanderbilt Avenue
New York, New York 10022
Attention: Raymond Lee; Laurie Green
Email: LeeR@gtlaw.com; GreenL@gtlaw.com
If
to the Backstop Investor:
Meteora Capital, LLC
1200 N Federal Hwy, Ste 200
Boca Raton, FL 33432
Email: notices@meteoracapital.com
with a copy (which will not constitute notice) to:
DLA Piper LLP (US)
555 Mission Street, Suite 2400
San Francisco, CA 94105-2933
Attention: Jeffrey C. Selman
Email: jeffrey.selman@us.dlapiper.com
20. Counterparts. This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form
of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. The
words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating
to this Agreement or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries
or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually
executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto
consent to conduct the transactions contemplated hereunder by electronic means.
21.
Entire Agreement. This Agreement and the agreements referenced herein constitute the entire agreement and understanding
of the parties hereto in respect of the subject matter hereof and supersede all prior understandings, agreements or representations by
or among the parties hereto to the extent that they relate in any way to the subject matter hereof.
[Signature page follows]
IN WITNESS WHEREOF, this Agreement has
been duly executed by the parties hereto as of the date first above written.
|
CHAVANT CAPITAL ACQUISITION CORP |
|
|
|
|
By: |
/s/ Jiong Ma |
|
Name: |
Jiong Ma |
|
Title: |
Chief Executive Officer |
|
|
|
|
|
|
|
MOBIX LABS, INC. |
|
|
|
|
By: |
/s/ Keyvan Samini |
|
Name: |
Keyvan Samini |
|
Title: |
President / CFO |
|
|
|
|
|
|
|
METEORA CAPITAL LLC as BACKSTOP INVESTOR |
|
|
|
|
By: |
Meteora Capital, LLC |
|
|
|
|
|
|
|
By: |
/s/ Vikas Mittal |
|
Name: |
Vikas Mittal |
|
Title: |
Managing Member |
Fund | |
CLAY NRA | | |
| |
Meteora Special Opportunity Fund I, LP | |
| 14,153 | | |
| 19.20 | % |
Meteora Capital Partners, LP | |
| 33,753 | | |
| 45.79 | % |
Meteora Select Trading Opportunities Master, LP | |
| 25,800 | | |
| 35.00 | % |
TOTAL Meteora Capital, LLC | |
| 73,706 | | |
| | |
Managed Accounts | |
Address | |
EIN |
Meteora Special Opportunity Fund i, LP | |
1200 N Federal Hwy, #200 Boca Raton FL 33432 | |
[****] |
Meteora Capital Partners, LP | |
1200 N Federal Hwy, #200 Boca Raton FL 33432 | |
[****] |
Meteora Select Trading Opportunities Master, LP | |
71 Fort St, PO Box 500, Grand Cayman KY1106 | |
[****] |
[Signature page to Non-Redemption Agreement]
Exhibit 10.8
Execution Version
NEITHER THIS WARRANT NOR
THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION
OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATIONS ARE NOT REQUIRED; (III) RECEIPT OF NO-ACTION
LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES; OR (IV) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.
DECEMBER 20, 2023 | |
202,692 SHARES |
WARRANT TO PURCHASE SHARES
OF COMMON STOCK
The Warrant
is issued concurrently with the Non-Redemption Agreement by and between Mobix Labs, Inc. (“Company”), Chavant Capital Acquisition
Corp., an exempted company incorporated under the Laws of the Cayman Islands (“SPAC”) and Holder (the “Non-Redemption
Agreement”). For value received, Meteora Capital LLC, and its permitted assignees (the “Holder”), is entitled
to purchase 202,692 shares (as may be adjusted pursuant to Section 4 hereof, the “Shares”) of common stock,
$0.00001 par value per share (the “Stock”), of MOBIX LABS, INC., a Delaware company, (the “Company”),
at an exercise price of $0.01 per share (such price and such other price as shall result, from time to time, from the adjustments specified
in Section 4 hereof is herein referred to as the “Warrant Price”), subject to the provisions and upon the terms
and conditions hereinafter set forth.
1. Term.
This Warrant shall terminate upon the earlier to occur of (i) the closing of the proposed business combination contemplated by the
Business Combination Agreement dated as of November 15, 2022, by and among the Company, SPAC and CLAY Merger Sub II, Inc., a
Delaware corporation (as amended, the “Business Combination Agreement”) and (ii) the termination of the Business
Combination Agreement (the “Termination Date”).
| 2. | Method of Exercise: Payment. |
a. Subject
to Section 1 hereof, and contingent upon the substantially concurrent occurrence of the Subscription Closing (as defined
in the Non-Redemption Subscription Agreement, the purchase right represented by this Warrant shall be exercisable by the Holder
hereof immediately prior to the Closing (as such term is defined in the Business Combination Agreement), in whole or in part, by the
surrender of this Warrant (with the notice of exercise form attached hereto as EXHIBIT A duly executed (the
“Notice of Exercise”) at the principal office of the Company and by the payment to the Company by check or wire
transfer to an account designated by the Company of an amount equal to the then applicable Warrant Price multiplied by the number of
Shares then being purchased. For the avoidance of doubt, to the extent not previously exercised, contingent upon the substantially
concurrent occurrence of the Subscription Closing (as defined in the Non-Redemption Agreement), this Warrant shall automatically
convert into the right to receive Class A common shares of the SPAC (the “SPAC Shares”) pursuant to the
merger in accordance with the terms of the Business Combination Agreement. The person in whose name any certificate representing
shares of Stock shall be issuable upon exercise of this Warrant shall be deemed to have become the holder of record of, and shall be
treated for all purposes as the record holder of, the shares represented thereby (and such shares shall be deemed to have been
issued) immediately prior to the close of business on the date or dates upon which this Warrant is exercised. In the event of any
exercise of the rights represented by this Warrant, certificates for the shares of Stock so purchased shall be delivered to the
Holder hereof as soon as reasonably practicable after such exercise; provided, that, as long as the Company is legally permitted to
reflect share issuances in book entry or dematerialized form, the Company may deliver an electronic representation or other evidence
of the valid issuance of the Shares as to which this Warrant has been exercised. Unless this Warrant has been fully exercised or
expired, a new Warrant representing the portion of the Shares, if any, with respect to which this Warrant shall not then have been
exercised shall also be issued to the Holder hereof as soon as practicable.
b. This
Warrant may be exercised for less than the full number of shares of Stock first shown above, provided that this Warrant may not be exercised
in part for less than a whole number of shares of Stock. Upon any such partial exercise, the Company at its expense will forthwith issue
to the Holder a new Warrant or Warrants of like tenor exercisable for the number of shares of Stock as to which rights have not been exercised
(subject to adjustment as herein provided).
3. Stock
Fully Paid: Reservation of Shares. All Shares that may be issued upon the exercise of the rights represented by this Warrant will,
upon issuance pursuant to the terms and conditions herein, be fully paid and nonassessable, and free from all preemptive or similar rights,
taxes, liens, and charges with respect to the issue thereof. During the period within which the rights represented by this Warrant may
be exercised, the Company will at all times have authorized, and reserved for the purpose of the issue upon exercise of the purchase rights
evidenced by this Warrant such number of its duly authorized shares of Stock as from time to time shall be issuable upon the exercise
of this Warrant and other similar Warrants.
4. Adjustment
of Warrant Price and Number of Shares. If the Company subdivides the outstanding shares of the class of Stock by reclassification
or otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant
Price shall be proportionately decreased. If the outstanding shares of the class of Stock are combined or consolidated, by reclassification
or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately
decreased. Each adjustment in the number of Shares issuable will be to the nearest whole share and each adjustment of the Warrant Price
will be calculated to the nearest cent.
5. Notice
of Adjustments. Whenever the Warrant Price or the number of Shares purchasable hereunder shall be adjusted pursuant to Section 4
hereof, the Company shall prepare a notice setting forth, in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, the Warrant Price, and the number of Shares purchasable hereunder after
giving effect to such adjustment, and promptly deliver the notice to the Holder.
6. Fractional
Shares. No fractional shares of Stock will be issued in connection with any exercise hereunder, but in lieu of such fractional shares,
the Company shall make a cash payment therefor based on the fair market value of the Stock on the date of exercise as reasonably determined
in good faith by the Company’s board of directors.
7. Compliance
with Securities Act and Other Laws: Disposition of Warrant or Shares.
a. Compliance
with Securities Act. The Holder, by acceptance hereof, agrees that this Warrant, and the shares of Stock to be issued upon exercise
hereof are being acquired for investment and that such Holder will not offer, sell or otherwise dispose of this Warrant, or any shares
of Stock to be issued upon exercise hereof, except under circumstances that will not result in a violation of the Securities Act of 1933,
as amended (the “Act”). Upon exercise of this Warrant, unless the Shares being acquired are registered under the Act
or an exemption from such registration is available, the Holder hereof shall confirm in writing that the shares of Stock so purchased
are being acquired for investment and not with a view toward distribution or resale. This Warrant and all shares of Stock issued upon
exercise of this Warrant (unless registered under the Act) shall be stamped, imprinted, or otherwise notated with a legend in substantially
the following form:
“THE SECURITIES EVIDENCED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE
EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATIONS ARE NOT REQUIRED; (III) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL
AUTHORITIES; OR (IV) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED,
DIRECTLY OR INDIRECTLY.”
In addition, in connection with the issuance of this Warrant,
the Holder specifically represents to the Company by acceptance of this Warrant that:
i. The
Holder is aware of the Company’s business affairs and financial condition, and has acquired information about the Company sufficient
to reach an informed and knowledgeable decision to acquire this Warrant. The Holder is acquiring this Warrant for its own account for
investment purposes only and not with a view to, or for the resale in connection with, any “distribution” thereof for purposes
of the Act.
ii. The
Holder understands that this Warrant and any securities issuable upon the exercise hereof have not been registered under the Act in reliance
upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment
intent as expressed herein. In this connection, the Holder understands that, in the view of the Securities and Exchange Commission (the
“SEC”), the statutory basis for such exemption may be unavailable if the Holder’s representation was predicated
solely upon a present intention to hold the Warrant for the minimum capital gains period specified under tax statutes, for a deferred
sale, for or until an increase or decrease in the market price of the Warrant, or for a period of one (1) year or any other fixed
period in the future.
iii. The
Holder further understands that this Warrant and any securities issuable upon the exercise hereof must be held indefinitely unless subsequently
registered under the Act and any applicable state securities laws, or unless exemptions from registration are otherwise available.
iv. The
Holder is aware of the provisions of Rule 144, promulgated under the Act, which, in substance, permit limited public resale of “restricted
securities” acquired, directly or indirectly, from the issuer thereof (or from an affiliate of such issuer), in a non-public offering
subject to the satisfaction of certain conditions, if applicable, including, among other things: (i) the availability of certain
public information about the Company, the resale occurring not less than one (1) year after the party has purchased and paid for
the securities to be sold; (ii) the sale being made through a broker in an unsolicited “broker’s transaction” or
in transactions directly with a market maker (as said term is defined under the Securities Exchange Act of 1934, as amended); and (iii) the
amount of securities being sold during any three (3) month period not exceeding the specified limitations stated therein.
v. The
Holder further understands that at the time it wishes to sell this Warrant and any securities issuable upon the exercise hereof there
may be no public market upon which to make such a sale, and that, even if such a public market then exists, the Company may not be satisfying
the current public information requirements of Rule 144, and that, in such event, the Holder may be precluded from selling this Warrant
and any securities issuable upon the exercise hereof under Rule 144 even if the one (1) year minimum holding period had been
satisfied.
vi. The
Holder further understands that in the event all of the requirements of Rule 144 are not satisfied, registration under the Act, compliance
with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rule 144 is not
exclusive, the staff of the SEC has expressed its opinion that persons proposing to sell private placement securities other than in a
registered offering and otherwise than pursuant to Rule 144 will have a substantial burden of proof in establishing that an exemption
from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions
do so at their own risk.
vii. The Holder is an “accredited investor”
as such term is defined in Rule 501 of Regulation D promulgated under the Act.
viii. At
no time was Holder presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of
general advertising or solicitation in connection with the offer, sale and purchase of the Warrant and any securities issuable upon the
exercise hereof.
b. Certain
Limitations on Voting, Access and Control. Notwithstanding the percentage of the outstanding Shares of the Company or the outstanding
SPAC Shares that the Holder may receive as a result of the exercise of the Warrant (or the automatic conversion of the Warrant into the
right to receive SPAC Shares pursuant to Section 2 hereof and subsequent exercise thereof), Holder agrees that it shall not exercise
voting rights relating to any such Shares of the Company or SPAC Shares representing a 10% or greater voting interest in the Company or
the SPAC on any matter subject to a vote of holders of Shares of the Company or SPAC Shares, and agrees that it shall not obtain or exercise,
as a result of its investment in the Company or the SPAC, (i) “Control,” as such term is defined at 31 C.F.R. 800.208,
of the Company, the SPAC or their respective subsidiaries, (ii) access to any “material non-public technical information”
within the meaning of 31 C.F.R. § 800.232 in the Company, the SPAC and their respective subsidiaries’ possession, (iii) the
right to appoint any board member or board observer to the board of directors of the Company or the SPAC or their respective subsidiaries
or (iv) any involvement in any “substantive decision-making” within the meaning of 31 C.F.R. § 800.245 related to
the Company, the SPAC or their respective subsidiaries.
c. Disposition
of Warrant or Shares. The Holder shall not transfer, assign, encumber or otherwise dispose of this Warrant without the
Company’s prior written consent, and any attempted transfer in violation of the foregoing shall be void ab initio. With
respect to any permitted offer, sale or other disposition of this Warrant or any shares of Stock acquired pursuant to the exercise
of this Warrant, in each case prior to registration of such Warrant or shares, the holder hereof and each subsequent holder of this
Warrant agrees to give written notice to the Company prior thereto, describing in sufficient detail the manner thereof, together
with a written opinion of such holder’s counsel (or other evidence of compliance reasonably satisfactory to the Company), if
requested by the Company, to the effect that such offer, sale or other disposition may be effected without registration or
qualification (under the Act as then in effect or any federal or state law then in effect) of this Warrant or such shares of Stock
and indicating whether or not under the Act certificates for this Warrant or such shares of Stock to be sold or otherwise disposed
of require any restrictive legend as to applicable restrictions on transferability in order to ensure compliance with such laws.
Promptly upon receiving such written notice and reasonably satisfactory opinion (or other evidence of compliance), if so requested,
the Company, as promptly as practicable, shall notify such holder whether such holder may sell or otherwise dispose of this Warrant
or such shares of Stock, all in accordance with the terms of the notice delivered to the Company. Notwithstanding the foregoing, at
any time that the Stock of the Company is publicly traded, such Stock may, as to such federal laws, be offered, sold or otherwise
disposed of in accordance with Rule 144 under the Act, provided that the Company shall have been furnished with such
information as the Company and its counsel may reasonably request to provide assurance that the provisions of Rule 144 have
been satisfied. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions.
d. Applicability
of Restrictions. Neither any restrictions of any legend described in this Warrant nor the requirements of Sections 7(a) or
7(c) above shall apply to any transfer of, or grant of a security interest in, this Warrant or any part hereof made in accordance
with all applicable securities laws: (i) to a partner of the Holder if the Holder is a partnership or to a member of the Holder if
the Holder is a limited liability company; (ii) to a partnership of which the Holder is a partner or to a limited liability company
of which the Holder is a member; (iii) to any affiliate of the Holder if the Holder is an entity; or (iv) if the Holder is a
natural person, during such Holder’s lifetime or on death by will or intestacy to such Holder’s immediate family or to any
custodian or trustee for the account of such Holder or such Holder’s spouse, lineal descendant, father, mother, brother, or sister
of the Holder; provided, however, in any such transfer or granting of security interest contemplated by clauses (i) through (iv) above,
if applicable, the transferee or grantee shall agree in writing to be bound by the terms of this Warrant as if an original holder hereof.
8. No
Rights as a Stockholder. No holder of this Warrant, as such, shall be entitled to vote or receive dividends or be deemed the holder
of Stock or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything
contained herein be construed to confer upon the holder of this Warrant, as such, any of the rights of a stockholder of the Company or
any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive notice
of meetings, or to receive dividends or subscription rights or otherwise until this Warrant shall have been exercised and the Shares purchasable
upon the exercise hereof shall have become deliverable, as provided herein.
9. Representations
and Warranties. The Company represents and warrants to the Holder as follows:
a. This
Warrant has been duly authorized and executed by the Company and is a valid and binding obligation of the Company enforceable in accordance
with its terms, subject to laws of general application relating to bankruptcy, insolvency, and the relief of debtors, and the rules of
law or principles at equity governing specific performance, injunctive relief, and other equitable remedies.
b. The
Shares have been duly authorized and reserved for issuance by the Company and, when issued in accordance with the terms hereof, will be
validly issued, fully paid, and nonassessable.
c. The
execution and delivery of this Warrant are not, and the issuance of the Shares upon exercise of this Warrant in accordance with the terms
hereof will not be, inconsistent with the Company’s Certificate of Incorporation, as amended, or its bylaws, do not and will not
contravene any law, governmental rule or regulation, judgment or order applicable to the Company.
d.
Upon closing of the closing of the proposed business combination contemplated by the Business Combination Agreement, the SPAC Shares
to be issued at the closing upon conversion of the Warrant will be eligible for clearing through The Depository Trust Company (the “DTC”),
through its Deposit/Withdrawal At Custodian (DWAC) system, and the SPAC is eligible and participating in the Direct Registration System
(DRS) of DTC with respect to the SPAC Shares. The SPAC’s transfer agent (the “Transfer Agent”) is a participant
in DTC’s Fast Automated Securities Transfer Program. To the Company’s knowledge, the SPAC Shares are not, and has not been
at any time, subject to any DTC “chill,” “freeze” or similar restriction with respect to any DTC services, including
the clearing of SPAC Shares through DTC.
a. Notice.
All notices and other communications relating to this Warrant shall be in writing and shall be deemed given upon the first to occur
of (x) deposit with the United States Postal Service or overnight courier service, properly addressed and postage prepaid;
(y) transmittal by e-mail properly addressed (with confirmation of transmission); or (z) actual receipt by the other party
or an employee or agent of the other party. Notice to the Company shall be given as follows:
If to the Company:
Mobix Labs, Inc.
15420 Laguna Canyon Drive, Suite 100
Irvine, California 92618
Attention: General Counsel
E-mail: Legal@mobixlabs.com
with a copy to:
Greenberg Traurig, LLP
18565 Jamboree Road, Suite 500
Irvine, California 92614
Attention: Raymond A. Lee
E-mail: leer@gtlaw.com
if to the Holder, to the address set forth on the signature
page hereof.
b. Severability.
Whenever possible, each provision of this Warrant will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in
any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this
Warrant will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never
been contained in this Warrant.
c. Entire
Agreement. This Warrant constitutes the entire agreement among the parties solely with respect to the subject matter hereof and thereof
and supersedes any prior understandings or agreements between or among the parties solely with respect to the subject matter hereof and
thereof. The parties hereto make no representations or warranties to each other, express (except as contained in this Warrant) or implied,
and any and all prior representations and warranties made by any party hereto or its representatives, whether verbally or in writing,
are deemed to have been merged into this Warrant and the contemplated hereby, it being intended that no such prior representations or
warranties shall survive the execution and delivery of this Warrant. The language used in this Warrant will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. Unless
expressly indicated otherwise, all section references are to sections of this Warrant.
d. Counterparts.
This Warrant may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other parties. In the event that any signature is delivered
by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature
page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the
same force and effect as if such signature page were an original thereof.
e. Successors
and Assigns. This Warrant shall be binding upon and inure to the benefit of the Company and the Holder and their respective successors
and permitted assigns. This Warrant is intended for the benefit of the parties hereto and their respective successors and permitted assigns,
and is not for the benefit of, nor may any provision hereof be enforced by, any other person.
f. Governing
Law; Venue and Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this
Warrant shall be governed by and construed in accordance with the internal laws of the state of Delaware, without giving effect to any
choice of law or conflict of law provision or rule that would cause the application of the laws of any jurisdictions other than
the state of Delaware. Each party hereby irrevocably submits to the exclusive jurisdiction of the state of California for the adjudication
and binding arbitration of any dispute hereunder, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such tribunal, that such arbitration, action or proceeding is
brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. EACH PARTY HEREBY IRREVOCABLY WAIVES
ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY OR COURT TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
WITH OR ARISING OUT OF THIS WARRANT, AND AGREES THAT ALL DISPUTES ARISING HEREUNDER SHALL BE ADJUDICATED BY ARBITRATION AS SET FORTH
IN THIS WARRANT.
g. Mandatory
Arbitration. Any controversy, claim or dispute arising out of or relating to this Warrant, whether in contract or tort, shall be
settled solely and exclusively by a binding arbitration process administered by JAMS in Orange County, California. Such arbitration
shall be conducted in accordance with the then-existing JAMS Expedited Arbitration Procedures, as set forth in the JAMS Arbitration
Rules of Practice and Procedure, with the following exceptions if in conflict: (i) one arbitrator who is a retired judge
shall be chosen by JAMS; (ii) each party to the arbitration will pay one-half of the expenses and fees of the arbitrator,
together with other expenses of the arbitration incurred or approved by the arbitrator; and (iii) arbitration may proceed in
the absence of any party if written notice (pursuant to the JAMS rules and regulations) of the proceedings has been given to
such party. The parties agree to abide by all decisions and awards rendered in such proceedings. Such decisions and awards rendered
by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall be settled in this manner in lieu
of any action at law or equity; provided, however, that nothing in this subsection shall be construed as precluding the bringing of
an action for injunctive relief or specific performance as provided in this Warrant. This dispute resolution process and any
arbitration hereunder shall be confidential and no party shall disclose the existence, contents or results of such process without
the prior written consent of all parties, except where necessary or compelled in a court to enforce this arbitration provision or an
award from such arbitration or otherwise in a legal proceeding. If JAMS no longer exists or is otherwise unavailable, the parties
agree that the American Arbitration Association (“AAA”) shall administer the arbitration in accordance with its
then- existing Expedited Procedures as set forth in the Commercial Arbitration Rules as modified by this subsection. In such
event, all references herein to JAMS shall mean AAA. Notwithstanding the foregoing, recognizing the irreparable damage will result
to the parties in the event of the breach or threatened breach of any of the covenants hereof, and that the parties’ remedies
at law for any such breach or threatened breach will be inadequate, the parties shall be entitled to an injunction, including a
mandatory injunction, to be issued by any court of competent jurisdiction ordering compliance with this Warrant or enjoining and
restraining such breach.
h. Amendments
and Waivers. No provision of this Warrant may be amended or waived without the prior written consent or agreement of the Company and
Holder.
i. Business
Days. Whenever the terms of this Warrant call for the performance of a specific act on a specified date, which date falls on a Saturday,
Sunday or legal holiday, the date for the performance of such act shall be postponed to the next succeeding regular business day following
such Saturday, Sunday or legal holiday.
j. No
Third-Party Beneficiary. Except for the parties to this Warrant and their respective successors and assigns, nothing expressed or
implied in this Warrant is intended, or will be construed, to confer upon or give any person other than the parties hereto and their respective
successors and assigns any rights or remedies under or by reason of this Warrant.
k. Titles
and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in construing
or interpreting this Warrant.
l. Transfers
in Violation of Agreement. Any transfer or attempted transfer of the Shares, or any capital stock in violation of any provision of
this Warrant shall be void, and the Company shall not record such transfer on its books or treat any purported transferee of such Shares
or capital stock as the owner of such stock for any purpose.
m. Further
Assurances. Upon the request of a party hereto, each of the parties hereto shall execute and deliver such instruments, documents and
other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of
this Warrant.
n. Electronic
Execution. The words “execution,”
“signed,” “signature,” and words of similar import in this Warrant shall be deemed to include electronic and
digital signatures and the keeping of records in electronic form, each of which shall be of the same effect, validity, and
enforceability as manually executed signatures and paper-based recordkeeping systems, to the extent and as provided for under
applicable law, including the Electronic Signatures in Global and National Commerce Act of 2000 (15 U.S.C. § 7001 et
seq.), the Electronic Signatures and Records Act of 1999 (N.Y. State Tech. Law §§ 301-309), and any other similar state
laws based on the Uniform Electronic Transactions Act.
[REMAINDER OF THIS PAGE LEFT INTENTIONALLY BLANK]
IN WITNESS WHEREOF, the Company has executed
this Warrant on the date first above written.
|
COMPANY: |
|
MOBIX LABS, INC. |
|
|
|
|
|
By: |
/s/
Keyvan Samini |
|
Keyvan Samini |
|
President / CFO and |
|
General Counsel |
|
|
|
|
|
ACKNOWLEDGED AND ACCEPTED BY |
|
|
|
HOLDER: |
|
|
|
By: Meteora Capital, LLC |
|
Meteora Special Opportunity Fund I,
LP |
|
Meteora Capital Partners, LP |
|
Meteora Select Trading Opportunities
Master, LP |
|
|
|
|
|
By: |
/s/ Vikas Mittal |
|
Vikas Mittal |
|
Managing Member |
|
|
|
Email: Notices@MeteoraCapital.com |
Fund | |
Warrant | | |
| |
Meteora Special Opportunity Fund I, LP | |
| 38,921 | | |
| 19.20 | % |
Meteora Capital Partners, LP | |
| 92,821 | | |
| 45.79 | % |
Meteora Select Trading Opportunities Master, LP | |
| 70,950 | | |
| 35.00 | % |
TOTAL Meteora Capital, LLC | |
| 202,692 | | |
| | |
Managed Accounts | |
Address | |
EIN |
Meteora Special Opportunity Fund i, LP | |
1200 N Federal Hwy, #200 Boca Raton FL 33432 | |
[****] |
Meteora Capital Partners, LP | |
1200 N Federal Hwy, #200 Boca Raton FL 33432 | |
[****] |
Meteora Select Trading Opportunities Master, LP | |
71 Fort St, PO Box 500, Grand Cayman KY1106 | |
[****] |
APPENDIX A
NOTICE OF EXERCISE
Attn: General Counsel
15420 Laguna Canyon Rd., Suite 100
Irvine, CA 92618
1. The
undersigned (the “Holder”) hereby elects to exercise the attached warrant (the “Warrant”) as to
[____] shares of Common Stock of Mobix Labs, Inc., a Delaware corporation (the “Company”), pursuant to the terms
of the Warrant, and tenders herewith payment of the purchase price of such shares in full. The purchase price is being paid by (check
one):
|
¨ |
(i) |
check |
|
¨ |
(ii) |
wire transfer |
2. Please
issue the shares in the name of the Holder, or as set forth below (if information is filled out below).
3. The
Holder represents that the aforesaid shares are being acquired for the account of the Holder for investment and not with a view to, or
for resale in connection with, the distribution thereof and that the Holder has no present intention of distributing or reselling such
shares.
|
HOLDER: |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
Date: |
|
Exhibit 99.1
Mobix Labs, Inc. Closes Business Combination
with Chavant Capital Acquisition Corp., Becomes Publicly Traded
- Trading to Commence on Nasdaq Under Ticker
Symbol “MOBX” on Friday, December 22, 2023 -
IRVINE,
Calif., December 21, 2023 – Mobix Labs, Inc. (“Mobix
Labs” or the “Company”), a fabless semiconductor company developing disruptive next-generation connectivity technologies
for 5G infrastructure, satellite communications and defense industries, today announced that its previously announced business combination
with Chavant Capital Acquisition Corp. (“Chavant”) (Nasdaq: CLAY) has closed, resulting in Mobix Labs becoming a publicly
traded company.
The business
combination and all other proposals presented were approved at an extraordinary general meeting of Chavant shareholders held on December
18, 2023. In connection with the completion of the business combination, Chavant was renamed Mobix Labs, Inc. and its common stock and
warrants will begin trading on the Nasdaq Stock Market (“Nasdaq”) under the ticker symbols “MOBX” and “MOBXW,”
respectively, on December 22, 2023. Mobix Labs’ current management team will continue to lead the Company.
“Today
marks a significant milestone for our company as we embark on a new chapter of growth and innovation,” said Fabian Battaglia, Chief
Executive Officer of Mobix Labs. “Going public on Nasdaq is not just a financial achievement, but a testament to the dedication
and expertise of our board, management team and talented employees, as we utilize the capital markets to help accelerate our acquisition
strategy and deliver best-in-class wireless and wired solutions to the global communications market.”
“As the
opening bell rings and our stock begins trading on Nasdaq, we recognize the exceptional efforts of both companies to get this deal closed,”
said Keyvan Samini, President and Chief Financial Officer of Mobix Labs. “Our entry into the public arena is further evidence of
our resolve and the confidence placed in our vision, as we grow Mobix Labs organically and through strategic acquisitions, bringing our
disruptive technologies to market while building shareholder value.”
About Mobix Labs, Inc.
Based
in Irvine, California, Mobix Labs is a fabless semiconductor company developing disruptive next generation wireless and connected solutions
that are designed to cater to a broad range of applications in markets including 5G infrastructure, satellite communications, automotive,
consumer electronics, e-mobility, healthcare, infrastructure and defense. Through its True5G™ and True Xero™ technologies,
the company develops ultra-compact, fully integrated, single-chip, single-die, CMOS-based beamformers, antenna solutions and RF/mixed
signal semiconductors, as well as hybrid active optical cables, transceivers and optical engines.
Forward-Looking Statements
This press release contains forward-looking statements. These
statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements
that are not historical facts, including statements about the Mobix Labs’ beliefs and expectations about the Company’s future
performance, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors
could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are
not limited to, (i) the effect of the Business Combination on Mobix Labs’ business relationships, performance, and business generally;
(ii) the outcome of any legal proceedings that may be instituted against Mobix Labs or against Chavant following the completion of the
Business Combination; (iii) the ability to meet Nasdaq listing standards; (iv) expectations regarding possible or assumed future results
of operations, (v) growth of the market and industries in which Mobix Labs serves, (vi) capital and credit market volatility, (vii) local
and global economic conditions, (viii) our anticipated growth strategies, (ix) regulatory authority and other governmental approvals
and regulations, and (x) our future business development, results of operations and financial condition. In some cases, forward-looking
statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,”
“target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,”
“continue,” “is/are likely to” or other similar expressions. All information provided in this press release is
as of the date of this press release, and Mobix Labs undertakes no duty to update such information, except as required under applicable
law.
# # #
Media and Investor Contacts:
George Medici/Laurie Berman
PondelWilkinson Inc.
310.279.5980
gmedici@pondel.com
lberman@pondel.com
v3.23.4
Cover
|
Dec. 19, 2023 |
Document Information [Line Items] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Dec. 19, 2023
|
Entity File Number |
001-40621
|
Entity Registrant Name |
Chavant Capital Acquisition Corp.
|
Entity Central Index Key |
0001855467
|
Entity Tax Identification Number |
85-2324794
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
15420 Laguna Canyon Rd.
|
Entity Address, Address Line Two |
Suite 100
|
Entity Address, City or Town |
Irvine
|
Entity Address, State or Province |
CA
|
Entity Address, Postal Zip Code |
92618
|
City Area Code |
949
|
Local Phone Number |
745-1086
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Entity Information, Former Legal or Registered Name |
Chavant Capital Acquisition Corp
|
Units, each consisting of one ordinary share, par value $0.0001 per share, and three-quarters of one redeemable warrant [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Class A Common Stock, par value $0.00001 per share
|
Trading Symbol |
MOBX
|
Security Exchange Name |
NASDAQ
|
Redeemable warrants, each warrant exercisable for one ordinary share, each at an exercise price of $11.50 per share [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Redeemable warrants, each warrant exercisable for one share of Class A Common Stock
|
Trading Symbol |
MOBXW
|
Security Exchange Name |
NASDAQ
|
Former Address [Member] |
|
Document Information [Line Items] |
|
Entity Address, Address Line One |
445 Park Avenue
|
Entity Address, Address Line Two |
9th Floor
|
Entity Address, City or Town |
New York
|
Entity Address, State or Province |
NY
|
Entity Address, Postal Zip Code |
10022
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=CLAY_UnitsEachConsistingOfOneOrdinaryShareParValue0.0001PerShareAndThreequartersOfOneRedeemableWarrantMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=CLAY_RedeemableWarrantsEachWarrantExercisableForOneOrdinaryShareEachAtExercisePriceOf11.50PerShareMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
Mobix Labs (NASDAQ:MOBX)
Gráfica de Acción Histórica
De Oct 2024 a Oct 2024
Mobix Labs (NASDAQ:MOBX)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024